Three Bangladeshi children die after receiving measles vaccine

by Tina Redlup on September 3, 2010

180px-measles_virus

Measles

Officials in Barisal, Banlgadesh, reported that three children recently died after being injected with a measles vaccine at Kalikapur Community Health Clinic in Hijla upazila of Barisal.

Malaria drugs sent to Africa being stolen at high rate

by Ashton Daigle on September 3, 2010

Tido-von-schoen-angerer

Tido von Schoen-Angerer

A recent study has shown that free malaria drugs sent to Africa by international donors are being stolen and resold on commercial markets.

Clinical trials to begin for new malaria vaccine

by Ted Purlain on September 3, 2010

Winzeler_elizabeth

Elizabeth Winzeler

An international team of scientists plans to begin clinical trials for a new malaria vaccine later this year.

Caifornia healthcare workers' flu vaccination rates lagging

by Jeffrey Bigongiari on September 3, 2010

Vaccine

Only 52 percent of California hospital employees have received flu vaccinations, a new study has shown, despite a U.S. Department of Health and Human Services recommendation that at least 60 percent be vaccinated.

European Medicines Agency investigating Pandemrix

by Tina Redlup on September 2, 2010

185px-h1n1_navbox

Swine flu

Officials with the European Medicines Agency are looking into the safety of the swine flu vaccine Pandemrix after reports surfaced that the treatment may be linked to a rare sleep disorder.

Walmart and Sam's Club to offer flu shots in 4,100 stores

by Ashton Daigle on September 2, 2010

Vaccine-1

Officials with Walmart and Sam’s Club announced this week that they will be offering flu shots in more than 4,100 stores across the country.

Phillipines sees dramatic rise in dengue cases

by Ted Purlain on September 2, 2010

A dramatic rise in the number of dengue hemorrhagic fever cases has led the Philippines Department of Health to issue a national warning against the disease.

Africa makes significant progress in polio fight

by Jeffrey Bigongiari on September 2, 2010

Poliovirus

Polio

Africa has made significant progress in efforts to eradicate polio, but some remedial actions need to be taken, according to a paper discussed on September 1 by the World Health Organization Regional Committee for Africa in Malabo, Equatorial Guinea.

China to vaccinate 100 million against measles

by Paul Tinder on September 1, 2010

180px-measles_virus

Measles

In an effort to eliminate measles, nearly 100 million children in China will be vaccinated against the disease this month.

Dynavax recieves funding to study hepatitis B

by Daniel Purt on September 1, 2010

230px-hepatitis-b_virions

Hepatitis B

Dynavax Technologies has received funding from the National Institute of Allergy and Infectious diseases to study the differences between individuals who do and do not respond to vaccinations against the hepatitis B virus.

Society for Healthcare Epidemiology of America calls for mandatory flu vaccinations

by Tina Redlup on September 1, 2010

Vaccine-1

The Society for Healthcare Epidemiology of America has called for mandatory flu vaccinations for all healthcare personnel in a recently released position paper jointly released with the Infectious Diseases Society of America.

DTRA awards funds to fight Rift Valley fever

by Ashton Daigle on September 1, 2010

230px-rift_valley_fever_tissue

Rift Valley fever

Officials with the Midwest Research Institute have announced that they have won a $1.6 million federal contract to study a virus that could be a biological threat.

Human trials begin on dengue fever vaccine

by Rita Uplend on September 1, 2010

Dengue-mosquito

Dengue mosquito

The Bloomberg School of Public Health at Johns Hopkins University has begun human clinical testing for a dengue fever vaccine.

Drop in pneumonia cases linked to increase in vaccinations

by Malik Wilson on September 1, 2010

Ss1

Sonia Saxena

A decline in English children’s pneumonia has been linked to increased levels of vaccination.

Victory over smallpox may lead to more pox viruses

by Tina Redlup on September 1, 2010

Heading_rimoin

Anne W. Rimoin

With cases of monkeypox are now raging in parts of Africa, University of California researchers say the world’s victory over smallpox may have had consequences.

New flu guidelines call for all children to be vaccinated

by Ashton Daigle on September 1, 2010

185px-h1n1_navbox

Influenza

New flu shot guidelines recently released by the American Academy of Pediatrics advise that all children six months of age and older should receive the annual trivalent influenza vaccine this flu season.

Massachusetts records its first West Nile virus case of 2010

by Rita Uplend on August 30, 2010

300px-em_wnvirus_j7908i

West Nile virus

The first human case of West Nile Virus to be documented in Massachusetts this year has been recorded in Boston.

Cervarix license amended for additional HPV strains

by Malik Wilson on August 30, 2010

220px-papilloma_virus__hpv__em

HPV

GlaxoSmithKline’s European license for Cervarix was amended recently to reflect Cervarix’s success in treating additional strains of human papillomavirus.

Hong Kong debuts new pneomococcal vaccine

by Tina Redlup on August 30, 2010

Vaccine-1

A new pneumococcal vaccine will replace the existing one used in Hong Kong government’s Childhood Immunization Program, officials have announced.

CDC makes changes to flu death estimates

by Ashton Daigle on August 30, 2010

185px-h1n1_navbox

Influenza

Officials with the U.S. Centers for Disease Control and Prevention have backed away from a decades-long estimate of the number of people who die annually from the flu, taking a new position that flu deaths vary widely from year to year.

Pakistan flooding brings polio fears

by Pat Dulnier on August 27, 2010

Poliovirus

Polio

Health officials in Pakistan are scrambling to shore up the nation’s threatened health care networks following floods that have caused untold damage to the nation.

Novartis to open Brazilian facility

by Malik Wilson on August 27, 2010

Novartis

Novartis has announced that it will open a new vaccine facility in Brazil.

Court finds no link between vaccines, autism

by Paul Tinder on August 27, 2010

Gavel

A lower court's findings rejecting a causal connection between childhood vaccines and the onset of autism have been upheld by the U.S. Court of Appeals for the Federal Circuit.

Link between swine flu vaccine, narcolepsy probed

by Daniel Purt on August 27, 2010

Vaccine-1

A link between the Pandemrix swine flu vaccine and the sleeping disorder narcolepsy will be probed by the European Medicines Agency after concerns have been raised in Finland and Sweden.

More than half of Americans concerned about vaccine safety

by Paul Tinder on August 26, 2010

Vaccine

With California reporting more than 3,000 cases of whooping cough and sitting on the cusp of its worst whooping cough outbreak in 50 years, a new Rasmussen Reports study has shown that more than half of American adults are concerned about the safety of va

Whooping cough outbreak in California grows

by Daniel Purt on August 26, 2010

Whoopingcough

Whooping cough

The number of whooping cough cases in California continues to grow as San Diego county has reported three new cases this week, raising the total number of infections in the state so far this year to 3,311 cases.

Report reveals methods to improve nation's response to pandemics

by Pat Dulnier on August 26, 2010

Vaccine

A recently released report by the President’s Council of Advisors on Science and Technology outlines ways to improve the nation’s response to global pandemics.

FDA warns of latex reactions from flu vaccines

by Malik Wilson on August 26, 2010

Vaccine-1

Concerns about latex labelings have led to FDA-mandated warnings on several prominent flu vaccines.

Cholera epidemic takes toll on Nigeria

by Rita Uplend on August 25, 2010

Cholera

Cholera

In only three months time, a cholera epidemic in Nigeria has resulted in 352 deaths.

Vaccinations needed to fight future mumps outbreaks

by Pat Dulnier on August 25, 2010

Mumps

Mumps

A recent study suggested that more vaccinations are required in order to prevent future outbreaks of the mumps.

Philadelphia whooping cough cases on the rise

by Malik Wilson on August 25, 2010

Whoopingcough

Whooping cough

A rise in reported cases of whooping cough in causing concern in the greater Philadelphia area, health officials say.

Infant rotavirus vaccine shows promise

by Ashton Daigle on August 25, 2010

Rotavirus

Rotavirus

Australian health officials recently announced that a new infant rotavirus vaccine has been successful in preventing rotavirus and non-rotavirus acute gastroenteritis hospitalizations in vaccinated children and older individuals who are unvaccinated.

GlaxoSmithKline begins final trials of shingles vaccine

by Rita Uplend on August 24, 2010

450px-herpes_zoster_neck

Shingles

GlaxoSmithKline announced on Monday that is has begun final trials for a new vaccine meant to prevent shingles.

Prevenar 13 granted prequalification status

by Jeffrey Bigongiari on August 24, 2010

Pfizer_90

The World Health Organization has granted Pfizer Inc.'s Prevenar 13, a children's pneumococcal vaccine, prequalification status, which opens the door for United Nations agencies and governments to begin ordering the vaccine.

Michigan reports two new EEE cases

by Tina Redlup on August 24, 2010

220px-eastern_equine_encephalitis

Eastern equine encephalitis

Two cases of eastern equine encephalitis have been reported in Michigan, coming on the heels of four EEE-related deaths in Florida earlier this season.

CDC director says no false alarms raised for H1N1

by Ashton Daigle on August 24, 2010

250px-thomas_frieden_official_cdc_portrait

Thomas Frieden

Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, recently told the annual Flu Conference that he did not raise false alarms about the seriousness of the H1N1 flu last year.

Whooping cough cases rise in Illinois

by Tina Redlup on August 23, 2010

Whoopingcough

Whooping cough

Health officials in Peoria, Illinois, have reported that seven cases of whooping cough, or pertussis, have been reported in the tri-county area.

Vaccine developed to fight hepatitis E

by Ashton Daigle on August 23, 2010

230px-hepatitis_e_virus

Hepatitis E

Health experts in China say they have developed an experimental vaccine that safely protects people against hepatitis E infection.

Pre-exposure to H1N1 may protect against H5N1

by Ted Purlain on August 23, 2010

H5n1

H5N1

A recent study has revealed that pre-exposure to the H1N1 influenza virus, or a single dose of DNA vaccine encoding H5N1 influenza proteins, can be useful in protecting the human body from H5N1 influenza virus infection.

Four Indian children die after receiving measles shot

by Jeffrey Bigongiari on August 23, 2010

Vaccine-1

Four children in Lucknow, India, died after being administered the measles vaccine followed by a vitamin A solution on August 20.

Crucell and Harvard to begin trial on AIDS vaccine

by Rita Uplend on August 20, 2010

Hiv

HIV

As part of a joint Phase I trial of an experimental AIDS vaccine, Dutch biopharmaceutical company Crucell NV and Harvard will enroll HIV-free adults in the United States and Africa to test a vaccine combining two adenovirus-based vaccines.

WNBA supports Measles Initiative

by Daniel Purt on August 20, 2010

Images

Candace Parker

The WNBA has teamed with the American Red Cross to support the Measles Initiative.

Department of Health and Human Services outlines national vaccine strategy

by Ted Purlain on August 20, 2010

250px-kathleen_sebelius_official_portrait

Kathleen Sebelius

The U.S. Department of Health and Human Services has issued a new report outlining a more aggressive national strategy for the production of medical countermeasures used to new viruses or superbugs in emergency situations.

Teen vaccination rates on the rise

by Ted Purlain on August 20, 2010

Schuchat

Anne Schuchat

Vaccination rates among U.S. teens have increased, though they are still below the desired level and also below rates for younger children.

Whooping cough cases in San Diego County continue to rise

by Tina Redlup on August 19, 2010

Whoopingcough

Whooping cough

The number of whooping cough cases in San Diego County has risen to 384 cases, surpassing the previous record set in 2005 at 371 cases.

Major drug stores ramp up flu vaccine availability

by Ashton Daigle on August 19, 2010

Walgreens-sign-0-lrg

While seasonal flu shots are already available in many local pharmacies across the country, retail pharmacy chains have begun changing their marketing plans to include new recommendations by the U.S. Centers for Disease Control.

U.S. bans CSL influenza vaccine

by Ted Purlain on August 19, 2010

Vaccine-1

Following febrile fits and deaths in children, the United States and Europe have banned an influenza vaccine for use in children produced by CSL, Ltd..

Susceptibility to meningitis pinpointed

by Jeffrey Bigongiari on August 19, 2010

Meningitis

Meningitis

There are genetic differences that make some people susceptible to meningococcal meningitis and septicemia and leave others immune, according to recently released research.

Positive results reported from flu vaccination challenge

by Tina Redlup on August 18, 2010

Vaccine

Joint Commission Resources has announced the successful results of its second annual Flu Vaccination Challenge.

U.N. begins preparedness exercise

by Ashton Daigle on August 18, 2010

Nhim

Nhim Vanda

The United Nations kicked off a four-day pandemic preparedness exercise this week in southeast Asia with the intent to increase the region’s ability to handle the widespread effects that accompany a pandemic.

Global health initiatives against specific diseases may do more harm than good

by Ted Purlain on August 18, 2010

Antwerp

Antwerp Institute of Tropical Medicine

A study conducted in Mali found that global health initiatives in developing countries to control specific diseases can often work against public health by diverting much needed resources.

Eastern equine encephalitis causes four Florida deaths

by Jeffrey Bigongiari on August 18, 2010

220px-eastern_equine_encephalitis

Eastern equine encephalitis

A mosquito-borne horse illness has claimed four Florida lives in the last two months, according to state public health officials.

Michigan sees rise in whooping cough rates

by Rita Uplend on August 17, 2010

Whoopingcough

Whooping cough

Whooping cough infections in Michigan are currently on track to be more than double what they have been in recent years, health experts have warned.

West Nile virus found in Boston

by Daniel Purt on August 17, 2010

Aedes_albopictus_2

Mosquitoes carrying the West Nile virus have been found in Boston for the first time this summer, public health officials have announced.

Belgian man first to die from new "super-bug"

by Ted Purlain on August 17, 2010

Klebsiella_pneumoniae_01

NDM-1

A Belgian man has become the first known to die from an infection caused by bacteria containing an enzyme gene called New Delhi metallo-lactamase-1, or NDM-1.

New methods of preventing MRSA revealed

by Jeffrey Bigongiari on August 17, 2010

Olaf

Olaf Schneewind

Two studies have emerged that suggest there may be ways to prevent infections caused by the drug resistant bacteria Staphylococcus aureus, also known as MRSA.

Thailand facing rising dengue fever infections

by Pat Dulnier on August 16, 2010

Dengue-mosquito

Dengue mosquito

Thailand's health minister recently announced that more than 50,000 citizens have been infected with dengue fever so far this year, resulting in 63 deaths.

Malawi records 197 measles deaths in 2010

by Daniel Purt on August 16, 2010

Measles

Measles

Malawi has seen 197 deaths so far this year as the result of a measles outbreak, which is the highest number of deaths recorded from measles in the last decade, health ministry officials recently announced.

Canadian groups call for changes to public health system

by Ted Purlain on August 16, 2010

H1n1

H1N1

Canada’s problems in handling the recent H1N1 pandemic have prompted three healthcare groups to call for an overhaul to the nation’s public health system.

Global travel aiding in spread of antibiotic resistant bacteria

by Jeffrey Bigongiari on August 16, 2010

Trwalsh-office_499x485

Tim Walsh

Researchers recently warned that the ease of global travel has helped to give bacteria an increased resistance to antibiotics and will leave doctors in a struggle to help infected patients.

Dengue fever reported in Broward County, Florida

by Tina Redlup on August 13, 2010

Paula

Paula Thaqi

Florida health officials this week confirmed the first case of dengue fever has been reported in Broward County.

Grant awarded to study immune response to vaccines

by Ashton Daigle on August 13, 2010

Pulendran

Bali Pulendran

Officials with the NIH and the National Institute of Allergy and Infectious Diseases have awarded $15.5 million grant to the Emory Vaccine Center to study human immune responses to vaccination.

ALMA calls for increase in malaria fight

by Ted Purlain on August 13, 2010

Malaria

Malaria

Members of the African Leaders Malaria Alliance met recently to discuss the continent’s malaria priorities.

Emergent BioSolutions, Inc., to acquire Trubion Pharmaceuticals

by Jeffrey Bigongiari on August 13, 2010

El-hibri_fuad

Fuad El-Hibri

Emergent BioSolutions, Inc., of Rockville, Maryland, has announced it will acquire the Seattle-based Trubion Pharmaceuticals, Inc.

New York reports new whooping cough cases

by Jeffrey Bigongiari on August 12, 2010

Screen_shot_2010-05-06_at_4

Pertussis

The Tioga County Health Department in New York state has reported five new cases of pertussis, or whooping cough, this week.

Emergent BioSolutions, Inc., to develop Avian flu vaccine

by Daniel Purt on August 12, 2010

Hdsht_daniel_abdun_nabi

Daniel J. Abdun-Nabi

Officials with Emergent BioSolutions, Inc., and Temasek Life Science Ventures recently announced a joint agreement to develop a vaccine to protect humans from strains of H5 influenza, or Avian flu.

New superbug invades United Kingdom

by Tina Redlup on August 12, 2010

713px-escherichiacoli_niaid

E. coli

Health officials warn that a new superbug that is resistant to even the strongest antibiotics has entered into United Kingdom hospitals.

Invasive MRSA may be in decline

by Ashton Daigle on August 12, 2010

Mrsa

MRSA

Invasive MRSA may be in decline according to a recent Journal of the American Medical Association study.

WHO declares swine flu pandemic over

by Tina Redlup on August 11, 2010

Margaret_chan_bio

Margaret Chan

Margaret Chan, director general for the World Health Organization, announced August 10 that the swine flu pandemic was officially at an end.

Siberian research co. reports HIV vaccine candidate

by Ashton Daigle on August 11, 2010

Hiv

HIV

Officials with the Siberia-based State Research Center for Virology and Biotechnology, Vector, reported that they have successfully accomplished development of a candidate HIV vaccine.

Human clinical trials begin on dengue virus vaccine

by Ted Purlain on August 11, 2010

Faucismilelabsmall

Anthony Fauci

Human clinical trials have begun on a tetravalent vaccine candidate to protect against the mosquito-borne dengue virus.

Cameroon facing largest cholera outbreak in a decade

by Jeffrey Bigongiari on August 11, 2010

0

Gervais Ondobo

A cholera outbreak in Cameroon has killed more than 150 people since May, with public health officials calling it the worst outbreak in a decade.

H1N1 vaccines to expire sooner than thought

by Tina Redlup on August 10, 2010

Vaccine

Approximately 16 million remaining doses of monovalent 2009 H1N1 vaccine made by Sanofi Pasteur and packaged in multidose vials will expire sooner than expected.

Experts fear antibiotics not being advanced fast enough

by Ashton Daigle on August 10, 2010

Sharfstein_-_small

Joshua Sharfstein

Fewer and fewer antibiotics are being restocked, leading some doctors to fear that this practice could have a devastating overall impact.

Sen. Kerry calls for national hepatitis strategy

by Ted Purlain on August 10, 2010

225px-john_f

John Kerry

Sen. John Kerry (D – Mass.) introduced legislation on August 4 that would fund and direct the Department of Health and Human Services to create a national strategy to control viral hepatitis.

Scientists advancing work on therapeutic Parkinson's vaccine

by Jeffrey Bigongiari on August 10, 2010

1000198

Rowen Chang

Protein chemists from the University of Texas Health Science Center at Houston are working towards the development of a therapeutic vaccine for the Parkinson’s disease.

CDC investigating two salmonella outbreaks

by Tina Redlup on August 9, 2010

Salmonella

Salmonella

The Centers for Disease Control and Prevention has begun investigating two salmonella outbreaks that have been ongoing since April.

Meningitis vaccine breakthrough

by Ashton Daigle on August 9, 2010

Meningitis

Meningitis

Medical researchers in London and Singapore say they might have discovered a breakthrough in finding a vaccine for one of the most fatal strains of meningitis.

Outbreaks of H3N2 in Iowa, 11 other states

by Ted Purlain on August 9, 2010

H3n2

H3N2

Two small outbreaks of influenza A/H3N2 in Iowa and cases of H3N2 in 11 other states have caused the Centers for Disease Control and Prevention to urge healthcare providers to be vigilant.

Report reveals means of H1N1's cellular attack

by Jeffrey Bigongiari on August 9, 2010

Kawaokay

Yoshihiro Kawaoka

The H1N1 influenza virus uses a unique and never before seen means of hijacking host cells and amplifying its infection in humans, a new study reports.

Rotavirus vaccines save poorest children

by Tina Redlup on August 6, 2010

Rotavirus

Rotavirus

Researchers in Asia and Africa said this week that trials have shown rotavirus vaccines can save the lives of young children and that vaccination programs should begin immediately.

Doctors told to avoid one flu shot brand for small kids

by Ashton Daigle on August 6, 2010

Vaccine

The Advisory Committee on Immunization Practices has recommended that doctors not use one specific brand of flu vaccine this upcoming influenza season due to problems with the vaccine in Australia and New Zealand.

Experts say America not ready for mumps outbreak

by Ted Purlain on August 6, 2010

Mumps

Mumps

American’s immunity against the mumps is at a level barely capable of preventing an outbreak, experts have revealed.

Doctor who isolated measles virus dies

by Jeffrey Bigongiari on August 6, 2010

Measles

Measles

Dr. Thomas Peebles, the doctor who isolated a strain of the measles virus that lead to the creation of a vaccine, died on July 8 at his home in Port Charlotte, Fla., at the age of 89.

First hospital to mandate flu vaccinations reports on success

by Tina Redlup on August 5, 2010

Vaccine

Officials with Seattle’s Virginia Mason Medical Center, the first U.S. hospital to successfully institute mandatory flu vaccinations for its healthcare workers, said the payoffs have been well worth some of the challenges.

UNICEF and Who aiding Angola polio immunization drive

by Ashton Daigle on August 5, 2010

Polio

Polio

Officials with UNICEF and the World Health Organization have put out a call to all sectors of government and the community to help participate in Angola’s upcoming polio immunization campaign to make sure all 5.5 million children under the age of five are

Oxfam say West Africa not prepared for outbreaks

by Ted Purlain on August 5, 2010

Yellow_fever_virus

Yellow fever

Oxfam and the U.N. Children’s Fund recently reported that West Africa is not yet fully prepared for the rapid outbreaks of cholera, dengue fever and yellow fever that are expected to coincide with the onset of this year’s rainy season.

Cholera outbreak hits Cameroon

by Jeffrey Bigongiari on August 5, 2010

Cholera

Cholera

Northern Cameroon is facing an outbreak of cholera that has left 94 dead and appears to be spreading.

Vaccine may block tumor growth for some cancers

by Ted Purlain on August 4, 2010

Vaccine

An experimental vaccine may be able to block tumor growth in some forms of cancer even when an immune system has become suppressed, a recent Journal of Clinical Investigation study has revealed.

Florida reports increase in dengue fever infections

by Ashton Daigle on August 4, 2010

Dengue-mosquito

Dengue mosquito

Officials with the Florida Department of Health have confirmed an increase in the number of cases of dengue fever in the Key West area.

WHO withdraws pre-qualification of Sanofi-Aventis vaccine

by Ted Purlain on August 4, 2010

Vaccine

The French drug manufacturer Sanofi-Aventis announced on August 3 that one of its subsidiaries in India, Shantha Biotechnics Ltd., had failed to meet quality standards for the World Health Organization with regards to its Shan5 combination vaccine.

Nebraska reports increase in pertussis infections

by Jeffrey Bigongiari on August 4, 2010

Pertussis

Pertussis

Nebraska is the latest state to show a surge in pertussis, or whooping cough, cases, while national totals continue to rise.

Pertussis cases on the rise nationally

by Tina Redlup on August 3, 2010

While health officials in California have reported the seventh infant death in the state this year, other states across the country are beginning to report an increase in pertussis whooping cough cases.

Seasonal influenza vaccines approved

by Ashton Daigle on August 3, 2010

Officials with the U.S. Food and Drug Administration announced last week that they have approved vaccines for the 2010-2011 influenza season.

Scientists close to leprosy vaccine

by Ted Purlain on August 3, 2010

Scientists from the Infectious Disease Research Institute of Seattle hope to have a new leprosy vaccine ready for safety trials by 2011.

Case Western creates new means of tracking malaria

by Jeffrey Bigongiari on August 3, 2010

Case Western Reserve University investigators have recently used tailored genetic assays and non-traditional mathematical analysis to uncover and track the deadliest forms of drug-resistant malaria.

Third EEE fatality reported in Florida

by Tina Redlup on August 2, 2010

The third recorded fatality in southern Florida this year attributed to Eastern Equine Encephalitis has many area residents wondering what they can do to protect themselves and their loved ones.

Immunovaccine adds Albert Scardino to its board of directors

by Ashton Daigle on August 2, 2010

Officials with Immunovaccine Inc. recently announced that Pulitzer Prize-winning journalist Albert Scardino has joined its board of directors.

Testing under way for malaria vaccine

by Ted Purlain on August 2, 2010

A malaria vaccine for children, dubbed RTSS, is currently being tested in Uganda.

Immunization rates tied to cost, social networks

by Jeffrey Bigongiari on August 2, 2010

Researchers have found that public immunization rates may be more sensitive to changes in a vaccination’s cost than previously thought, and that social networks can play a vital role in determining the severity of an outbreak.

FDA cites Sanofi Pasteur vaccine manufacturing facility

by Ted Purlain on July 30, 2010

Fda-logo

The Food and Drug Administration recently cited several major problems it found during an inspection at a Sanofi Pasteur vaccine manufacturing facility in Marcy l’Etoile, France.

CDC adopts advisory board call for universal flu vaccine

by Jeffrey Bigongiari on July 30, 2010

Cdc

As public health groups begin to shift gears from focusing on the pandemic H1N1 influenza vaccine to the new seasonal vaccine, the Centers for Disease Control has adopted its advisory board’s call for universal influenza vaccination.

Poilio eradicated in Sudan, Ethiopia, Kenya and Uganda

by Paul Tinder on July 30, 2010

Polio

The Global Polio Eradication Initiative's new strategy to stop polio in Africa has reached a major objective, announcing that Sudan, Ethiopia, Kenya and Uganda have reported no wild poliovirus cases for more than a year.

Seventh infant death in California whooping cough outbreak

by Daniel Purt on July 30, 2010

Pertussis

Whooping cough

A seventh infant has died as a result of California's whooping cough epidemic, which officials have said could be the worst outbreak in 50 years.

Breakthrough announced in search for malaria vaccine

by Pat Dulnier on July 29, 2010

Malaria

Malaria

European researchers, in what is being touted as a major breakthrough for malaria treatment, have shown that infected mice that are administered antibiotics develop immunity against becoming infected again.

Dengure fever in Caribbean raises fears of U.S. outbreak

by Ted Purlain on July 29, 2010

Dengue-mosquito

Dengue mosquito

An epidemic of dengue fever that has hit Latin America and the Caribbean has increased the risk of a similar outbreak occurring in South Florida, an expert on the disease has told Reuters.

FDA aproves new flu test

by Jeffrey Bigongiari on July 29, 2010

H1n1

H1N1

The U.S. Food and Drug Administration has cleared the ProFast+ assay for use as a simultaneous test for the seasonal A/H1, seasonal A/H3 and 2009 H1N1 strains of influenza.

Oregon health officials express fears that whooping cough migrating

by Daniel Purt on July 29, 2010

Pertussis

Whooping cough

Oregon health officials have expressed concern that the whooping cough epidemic currently taking place in California could soon cross the border into their state.

Antigenics reports positive results for herpes vaccine

by Ted Purlain on July 28, 2010

Antigenics

Antigenics, a Massachusetts-based biotech firm, recently reported positive results for a human trial of a potential herpes vaccine.

Universal flu vaccine begins Phase I testing

by Jeffrey Bigongiari on July 28, 2010

Flu_vaccine

Dynavax Technologies Corporation has recently begun Phase I human testing of its universal influenza vaccine.

Emergency vaccinations to aid Haitian children

by Paul Tinder on July 28, 2010

Unicef

A second round of emergency immunizations in Haiti against diphtheria, tetanus, pertussis, measles, rubella and polio has been announced by the United Nations to aid an additional 500,000 children.

J. Tyler Martin named president of Dynavax Technologies

by Daniel Purt on July 28, 2010

Martin

J. Tyler Martin

J. Tyler Martin has been promoted by Dynavax Technologies to the newly-created position of president.

Health officials searching for source of California pertussis outbreak

by Ted Purlain on July 27, 2010

Pertussis

Pertussis

Federal health officials are currently searching for the cause of what is set to be California’s worst pertussis, or whooping cough, outbreak in the last 50 years, in hopes that the information may be able to slow the disease's transmission.

Immune Design receives funds to create new adjuvants

by Jeffrey Bigongiari on July 27, 2010

Stevenreed

Steve Reed

Immune Design, a biotech company based in Seattle, Wash., has received $32 million in Series B investment to finance the next stage of its development plans for new and better vaccines.

Texas sees whooping cough cases rise

by Paul Tinder on July 27, 2010

Whoopingcough

Whooping cough

As California faces one of the state's worst whooping cough outbreaks in more than 50 years, which has resulted in six infant deaths and 1500 confirmed infections, Texas health department officials have now begun reporting increases in whooping cough infe

Polio drive kicks off in Afghanistan

by Daniel Purt on July 27, 2010

Polio

Polio

Fourteen provinces in Afghanistan began seeing more than 20,000 volunteers and health workers moving door-to-door to administer two drops of the oral polio vaccine to children under the age of five on Monday.

Trovan lawsuit stalls

by Tina Redlup on July 26, 2010

Vaccine

A lawsuit filed by the Nigerian victims of the 1996 Trovan meningitis vaccine test hit a snag after officials with Federal High Court in Abuja, Nigeria, set aside the service of the court’s processes on Pfizer Specialties.

Results of Vac-4x HIV vaccine announced

by Ashton Daigle on July 26, 2010

Hiv

HIV

Researchers with the Oslo University and Bionor Immuno at the XVIII International AIDS Conference in Vienna, Austria, recently released the results of a re-vaccination study of Norway’s largest hospital using the company's furthest advance HIV vaccine can

Smallpox inoculation may slow HIV infection

by Ted Purlain on July 26, 2010

Smallpox-virus-ns

Smallpox

According to a new study released on July 22, smallpox inoculation may offer some protection against primary HIV infection.

Trinidad reports third dengue fever death

by Jeffrey Bigongiari on July 26, 2010

Malaria_mosquito

Trinidad has announced its third fatality from the hemorrhagic form of dengue fever, health officials reported on July 25.

Vaccine may prevent infant pneumonia infection

by Paul Tinder on July 23, 2010

Strep-pneumoniae

Streptococcus pneumoniae

A pneumococcal conjugate vaccine introduced a decade ago in the United States appears to reduce pneumonia and serious associated complications in children under one year of age, researchers have recently revealed.

FluMist vaccine begins shipping

by Daniel Purt on July 23, 2010

Vaccine

Shipments of FluMist have begun to influenza vaccine distributors servicing healthcare providers nationwide today, MedImmune has announced.

Discovery could lead to celiac disease vaccine

by Ted Purlain on July 23, 2010

Coeliac_path

Celiac disease

It has been 60 years since scientists found the link between gluten and celiac disease, but only recently have they found the precise cause of the immune reaction that can cause so much pain and discomfort to sufferers.

Idaho seeing twice as much whooping cough this year

by Jeffrey Bigongiari on July 23, 2010

Pertussis

Pertussis

Twice the average numbers of cases of pertussis, or whooping cough, have been reported so far this year in Idaho.

Merck buys dengue fever vaccine research unit

by Pat Dulnier on July 22, 2010

099_merck

Merck & Co. has agreed to purchase the dengue fever vaccine research unit of Hawaii Biotech.

MabVax begins Phase II testing of sarcoma vaccine

by Daniel Purt on July 22, 2010

Vaccine

MabVax Therapeutics, Inc., has announced the enrollment of patients into a Phase II clinical trial to assess the efficacy and safety of a vaccine to prevent or delay the recurrence of sarcoma.

California reports first West Nile cases of the year

by Ted Purlain on July 22, 2010

Malaria_mosquito

California health officials have recently urged residents to take precautions after the first two positive cases of West Nile Virus were reported in the state.

Pfizer sued for $384 billion over 1996 meningitis trials

by Ashton Daigle on July 22, 2010

Meningitis_virus

Meningitis

Nigerian victims of the 1996 Pfizer meningitis Trovan vaccine test announced July 20 that they are suing the company for $384 billion.

Los Angeles County reports third whooping cough death this year

by Tina Redlup on July 21, 2010

Pertussis

Pertussis

Officials with the L.A. Dept. of Public Health have reported the third death attributed to whooping cough, or pertussis, in the county this year, bringing the death toll in California's whooping cough outbreak to six.

HPV vaccine may protect against genital warts

by Jeffrey Bigongiari on July 21, 2010

277161177_0a810dfcd2

Human papillomavirus

The results of a four-year study released on July 20 by the British Medical Journal show that vaccination against certain types of human papillomavirus gives protection against genital warts and pre-cancerous growths of the cervix.

Vaccine against rotavirus could be safe for newborns

by Ted Purlain on July 21, 2010

Rotavirus

A new vaccine against the deadly rotavirus is being developed in Melbourne, Australia that, unlike current vaccines, has the potential to protect infants from birth.

WHO won't declare end to H1N1 pandemic

by Ashton Daigle on July 21, 2010

Who

Officials with the World Health Organization have announced that the WHO's emergency committee will not meet this week to review the H1N1 pandemic and that it will not declare an end to the pandemic.

Promising results reported from Finnish HIV vaccination tests

by Tina Redlup on July 20, 2010

Hiv

HIV

Officials with the Finnish pharmaceutical company Fit Biotech announced recently that results of an HIV vaccination they have been developing are promising.

Whooping cough vaccine not linked to seizures

by Ashton Daigle on July 20, 2010

Pertussis

Whooping cough

Researchers with the U.S. Centers for Disease Control and Prevention announced this week that the whooping cough vaccine is not linked to toddler seizures.

NanoViricide, Inc., presents research on anti-Ebola agents

by Ted Purlain on July 20, 2010

Ebola_virus_em

Ebola

The results of NanoViricide, Inc.’s research into anti-Ebola agents were presented on July 17 to the Annual Meeting of the American Society for Virology at Montana State University in Bozeman, Montana.

Dengue fever spreading in the Caribbean

by Jeffrey Bigongiari on July 20, 2010

Dengue-mosquito

Dengue mosquito

Health officials across the Caribbean are concerned about the near epidemic level of mosquito-borne dengue fever, saying it could get more severe as the rainy season progresses.

Three waterborne illnesses cost U.S. $539 million annually

by Tina Redlup on July 19, 2010

800px-giardiasis_duodenum_high

Giardiasis

A new study has revealed that three waterborne illnesses cost the U.S. healthcare system up to $539 million a year.

HIV-negative people may falsely test postive after clinical vaccine trials

by Ashton Daigle on July 19, 2010

1075

Michael Horberg

A recent study showed that nearly half the HIV-negative people who participate in clinical trials for potential vaccines end up testing positive although they are not infected with the virus.

Microneedles could simplify vaccine delivery

by Ted Purlain on July 19, 2010

Prausnitz

Mark Prausnitz

Researchers at the Georgia Institute of Technology, in collaboration with researchers from Emory University, have developed a new method of vaccine delivery that requires a simple patch and could potentially be done at home.

ISDA calls for mandatory vaccinations for healthcare workers

by Jeffrey Bigongiari on July 19, 2010

Vaccine

The Infectious Diseases Society of America has formally requested in a July 15 letter that the Centers for Disease Control recommend mandatory vaccinations for influenza for healthcare workers.

New malaria fighting technique announced

by Jeffrey Bigongiari on July 16, 2010

Riehle

Michael Riehle

Scientists from the University of Arizona have successfully developed a mosquito that is immune to the parasite Plasmodium, the cause of malaria, and hope to one day replace wild mosquitoes with their lab-bred population.

Two-step flu vaccine could protect against all strains

by Paul Tinder on July 16, 2010

Vaccine

Researchers announced a new, two-step influenza vaccine this week that uses DNA to "prime" the body's immune system followed by a traditional seasonal flu vaccine that potentially protects the body against all strains of the influenza virus.

Miami-Dade reports dengue fever case

by Ashton Daigle on July 16, 2010

Dengue-mosquito

Dengue mosquito

Officials with the Miami-Dade Health Department this week reported the first suspected case of dengue fever in the county.

Austalia to develop Hendra antibody

by Ted Purlain on July 16, 2010

Paullucas

Paul Lucas

The government of Queensland, Australia, has invested 300,000 for the development of an antibody for the Hendra virus.

H1N1 assessment pushed back to August

by Jeffrey Bigongiari on July 16, 2010

415px-margaret_chan

Margaret Chan

The experts handling the H1N1 pandemic for the World Health Organization may wait until the end of August to reassess the outbreak’s status, according to WHO head Margaret Chan.

Precautions to stem flu spread not taken, study says

by Tina Redlup on July 16, 2010

H1n1

H1N1

Despite warnings that it would aid in the spread of H1N1, approximately one out of every four people failed to cover their mouths when they cough, research presented at the International Conference on Emerging Infectious Diseases revealed.

Nasal vaccine against flu gets green light in Canada

by Ashton Daigle on July 16, 2010

Flumist

Officials with Health Canada have recently approved the first nasal vaccine to protect users against seasonal influenza.

Connecticut citizens might have been exposed to measles

by Ted Purlain on July 15, 2010

Measles

Measles

The Connecticut Department of Health issued a warning this week that members of the public may have been exposed to measles.

Arctic bacteria used to create new vaccines

by Ted Purlain on July 15, 2010

Fran_bad_photo_1

Francis Nano

By replacing some of the genes in mammalian pathogens with those found in arctic bacteria, Francis Nano of the University of Victoria in Canada may have found the key to make a new class of vaccines.

Lessens learned from H1N1 pandemic revealed

by Jeffrey Bigongiari on July 15, 2010

H1n1

H1N1

Pharmaceutical companies have begun the process of finding out where things went wrong in their experiences during the less damaging than expected H1N1 pandemic.

Research shows dengue moving north

by Daniel Purt on July 14, 2010

Dengue-mosquito

Dengue mosquito

According to government research released this week, five percent of the population of Key West, Florida, has been infected at some point with the dengue virus.

Calif. urgers pertussis vaccination for pregnant women

by Paul Tinder on July 14, 2010

Screen_shot_2010-05-06_at_4

Pertussis

The state of California and the city and county of San Francisco have recommended a pertussis vaccine for women in their third trimester in light of the recent whooping cough epidemic in the state.

Case Western given grant to fight malaria

by Ted Purlain on July 14, 2010

Jwk_head_shot_1

Dr. James Kazura

The National Institute of Health has given a $7.9 million grant to the Case Western Reserve University School of Medicine to send a research team to Southeast Asia to help eradicate malaria.

CDC asks for public comment on H1n1 guidelines

by Jeffrey Bigongiari on July 14, 2010

Cdc

CDC

The Centers for Disease Control recently asked for the public to comment on its new guidance for preventing transmission of influenza in health care settings, as well the replacement for its interim guidance for H1N1.

QIAGEN HPV test improves cervical cancer control

by Tina Redlup on July 14, 2010

277161177_0a810dfcd2

Human papillomavirus

Researchers with QIAGEN said a recent study has shown that Latin American women who used its human papillomavirus test showed improved cervical cancer control when compared to regular cytology testing.

Rotavirus vaccines show efficacy in study

by Ashton Daigle on July 14, 2010

Rotavirus

Rotavirus

Florida researchers have announced the results of an investigation into the effectiveness of two Rotavirus vaccines in a retrospective study that shows the vaccines may have resulted in fewer hospitalizations.

As many as 900 exposed to whooping cough at MSU

by Paul Tinder on July 13, 2010

Pertussis

Whooping cough

As many as 900 people may have been exposed to an whooping cough by someone with an undiagnosed case of the infection at Michigan State University's Grandparents University from June 29 to July 1.

Live vaccinations could fight flu more efficiently

by Pat Dulnier on July 13, 2010

Vaccine

A new, quicker and more efficient manner for developing vaccines against flu strains has been developed by scientists.

Unvaccinated farmworkers not the cause of Calif. whooping cough

by Daniel Purt on July 13, 2010

Pertussis-lympho

Pertussis

California county and state health reports have debunked speculation that the reason Fresno County was hardest hit by the current whooping cough epidemic was because of unvaccinated Hispanic farmworkers spreading the disease.

Australian anti-vaccine group found to be misleading

by Ashton Daigle on July 13, 2010

Avnapple_logo

An anti-vaccination group in Australia has been ordered by the Health Care Complaints Commission to include disclaimers on its Web site after the group was found guilty of providing misleading information on immunizations,.

Orange County whooping cough cases nearly double in two weeks

by Tina Redlup on July 10, 2010

Pertussis

Whooping cough

Health officials in Orange County, California, have reported that whooping cough cases continue to climb, although no new local deaths have been reported.

Newly discovered antibodies may boost AIDS vaccine research

by Ashton Daigle on July 10, 2010

Hiv

HIV

Researchers have discovered three human antibodies that neutralize HIV, raising hopes of a breakthrough HIV vaccine.

NIH gives grant for malaria research center

by Ted Purlain on July 10, 2010

07-08vinetz

Joseph Vinetz

The National Institutes of Health have given the University of California San Diego a seven-year, $9.2 million grant to develop a joint Peruvian/Brazilian malaria research center.

H1N1 pandemic to be downgraded

by Jeffrey Bigongiari on July 10, 2010

H1n1

H1N1

The World Health Organization is preparing to downgrade the status of the H1N1 influenza pandemic at a meeting of its emergency committee, which is expected to take place in late July

Dynavax to being trials of universal flu vaccine

by Rita Uplend on July 9, 2010

Mmr_vaccine

The MMR vaccine

Dynavax Technologies Corp., announced on Wednesday that it has started the first human clinical trials for its universal flu vaccine.

CDC says mumps outbreak continues in N.Y.

by Paul Tinder on July 9, 2010

Mumps

Mumps

The Center for Disease Control has issued a preliminary set of data regarding mumps cases for 2010 in the United States.

Watchdog group calls for vaccine pricing investigation

by Ashton Daigle on July 9, 2010

Vaccine

The watchdog group Citizens for Responsibility and Ethics in Washington has called for an investigation into the vaccine pricing polices of two pharmaceutical companies.

Nevada warns of whooping cough

by Jeffrey Bigongiari on July 9, 2010

Pertussis

Pertussis

Officials from the Southern Nevada Health District, which includes the city of Las Vegas, urged that residents, particularly children, be immunized against pertussis, also known as whooping cough.

Pertussis activity spiking nationwide

by Ted Purlain on July 8, 2010

Screen_shot_2010-05-06_at_4

Pertussis

Following the declaration by the California Department of Public Health of a pertussis epidemic, reports of pertussis activity have spiked nationwide.

Failure of trial of H5N1 influenza patch revealed

by Pat Dulnier on July 8, 2010

H5n1

H5N1

The reason for the failure of a Phase II clinical trial of Intercell AG's Vaccine Enhancement Patch for H5N1 influenza could be a faulty hemagglutinin inhibition assay, a newly released report reveals.

Dynavax awarded grant for universal HPV vaccine

by Tina Redlup on July 8, 2010

Hpv

Human papillomavirus

Officials with Dynavax Technologies Corporation announced on July 6 that they were awarded a $600,000 grant from the National Institutes of Health to develop a universal vaccine for human papilloma virus .

Trial planned for AIDS vaccine

by Ashton Daigle on July 8, 2010

Hivx

HIV

Officials with the AIDS Research Consortium of Atlanta recently called for volunteers to test a DNA-based AIDS vaccine by GeoVax.

Experts converge on Montreal for HPV conference

by Tina Redlup on July 7, 2010

Hpv

Human papillomavirus

Medical experts from across the world are meeting this week in Montreal, Canada, for the 26th annual International Papillomavirus Conference.

U.K. receives high marks for H1N1 response

by Ashton Daigle on July 7, 2010

H1n1

H1N1

Health officials in the United Kingdom have received good marks by an independent review committee for their response to the H1N1 pandemic.

Woman contracts smallpox from recently vaccinated man

by Jeffrey Bigongiari on July 7, 2010

Smallpox-virus-ns

Smallpox

In the state of Washington, a woman in her 20s has reportedly been infected with smallpox after having sexual relations with her boyfriend in the military who had recently been vaccinated for smallpox.

Third dengue death in Puerto Rico sparks fears

by Ted Purlain on July 7, 2010

Dengue-mosquito

Dengue mosquito

Puerto Rico’s health secretary issued a warning on July 5 that the island could potentially face its worst outbreak of dengue fever if action is not taken immediately.

Calif. considers mandatory whooping cough vaccinations

by Tina Redlup on July 6, 2010

Pertussis

Pertussis

The whooping cough epidemic in California - the worst in 50 years - has given credence to a proposed bill for mandatory whooping cough booster shots.

Analysts say WHO communication errors spurred 'false pandemic' charges

by Ashton Daigle on July 6, 2010

Who

Two former World Health Organization consultants have said that communication missteps fueled accusations that the organization exaggerated the H1N1 threat in order to enrich pharmaceutical companies.

Hepatitis A vaccination rates slowing

by Ted Purlain on July 6, 2010

Vaccine

The surge in childhood vaccination coverage for hepatitis A that began in 2006 has since fallen off, the July 2 issue of the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report reveals.

Scientists developing tularemia vaccine

by Jeffrey Bigongiari on July 6, 2010

Tularemia

Tularemia

Scientists from the University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases have been granted a U.S. patent that covering the development of a process to create a vaccine for tularemia.

Post-exposure Marburg vaccine shows promise

by Ted Purlain on July 3, 2010

Marburg

Marburg

According to research published online in the July edition of Emerging Infectious Diseases, an experimental post-exposure vaccine for the Marburg haemorrhagic fever virus allowed five of six monkeys to survive infection.

Abbott Laboratories mulling sale of vaccine unit

by Daniel Purt on July 3, 2010

Abbott-laboratories-logo

The drug and medical device manufacturer Abbott Laboratories is considering selling its vaccine unit.

China, U.S. open disease study center in Shanghai

by Ashton Daigle on July 3, 2010

Vaccine

American and Chinese health officials have opened en epidemiology center in Shanghai this week that will be used to train professionals in detecting and preventing epidemic diseases.

Expiration date for 40 million H1N1 doses passes

by Jeffrey Bigongiari on July 3, 2010

Swine-flu

H1N1

June 30 marked the expiration date of 40 million doses of H1N1 swine flu vaccine that had been manufactured for the U.S. public.

Hepatitis B rates down significantly in children

by Jeffrey Bigongiari on July 2, 2010

Hepatitisb

Hepatitis B

According to the researchers at the Centers for Disease Control, rates of hepatitis B in children and young adults in the U.S. are down significantly.

FDA monitoring Australian influenza vaccine producing facility

by Ted Purlain on July 2, 2010

Vaccine

The U.S. Food and Drug Administration released a copy of a June 28 letter sent to CSL Biotherapies, the operators of an Australian influenza vaccine producing facility, detailing irregularities there.

H1N1 vaccine enhancer shows promise

by Tina Redlup on July 2, 2010

H1n1

H1N1

Officials with SciClone Pharmaceuticals and its partner. Sigma-Tau S.p.A., recently announced the final results from the clinical trial of ZADAXIN, an H1N1 vaccine enhancer.

New meningitis vaccine may stop outbreaks

by Ashton Daigle on July 2, 2010

Meningitis

Meningitis

The development of a new meningitis vaccine may help prevent epidemics in Africa for the first time.

Progress made on pancreatic cancer vaccine

by Paul Tinder on July 1, 2010

Dividing_cancer_cell-small

Cancerous cells

Progress has been announced on a vaccine to fight pancreatic cancer, which currently kills three-quarters of those diagnosed within a year and 95 percent within five years.

Low immunization rates tied to Calif. whooping cough epidemic

by Ted Purlain on July 1, 2010

Pertussis

Whooping cough

California's low immunization rates might be at the heart of the recent whooping cough epidemic, public health officials have said.

Ohio sees rises in whooping cough cases

by Ashton Daigle on July 1, 2010

Pertussis

Pertussis

While health officials in California have recently declared a whopping cough epidemic, their counterparts in Columbus, Ohio have also noted a significant rise in cases.

Emergency status of H1N1 tests terminated

by Tina Redlup on July 1, 2010

H1n1

H1N1

Molecular diagnostic tests used during the peak of the H1N1 outbreak in 2009 have officially had their emergency use statuses terminated last week.

Type 1 diabetes vaccine passes Phase 1 clinical trial

by Paul Tinder on June 30, 2010

Type1diabetes

Type 1 diabetes

Bacillus Calmette-Guerin, a vaccine that could reverse Type 1 diabetes, has passed a Phase 1 clinical trial.

Demand for Provenge overwhelming Dendreon production

by Ted Purlain on June 30, 2010

Dendreon

After the U.S. Food and Drug Administration approved Provenge, Dendreon's groundbreaking prostate cancer vaccine, in late April, the company announced that it would only be able to supply 2,000 patients over the following 12 months.

Breakthrough in search for universal flu vaccine

by Pat Dulnier on June 30, 2010

Influenza

Influenza

A Seattle biotech company on the trail of a universal flu vaccine has announced the discovery of a common weakness in virtually all strains, past and present, of the flu virus.

Combined MMR vaccine tied to febrile seizures

by Daniel Purt on June 30, 2010

Mmr_vaccine

The MMR vaccine

A higher risk of brief, fever-related seizures has been tied to a combination vaccine for measles, mumps, rubella and chickenpox as compared to giving two separate shots.

West Nile virus reported in Washington

by Tina Redlup on June 29, 2010

Mosquito

The discovery of the existence of West Nile virus in mosquitoes has been announced in Benton County, Wash.

CDC recommends two doses of flu vaccine for young children

by Jeffrey Bigongiari on June 29, 2010

Swine-flu

H1N1

In response to the pandemic H1N1 virus, the Centers for Disease Control and Prevention recently recommended that unvaccinated children from the ages of six months to nine years of age be administered two doses of next autumn’s trivalent vaccine.

Whooping cough cases on the rise nationwide

by Ted Purlain on June 29, 2010

Cdc

While California faces one of its worst whooping cough outbreaks in 50 years, New York, Indiana and Oregon have seen cases of the disease steadily increase, worrying public health officials.

Rural Calif. doctors face mounting whooping cough vaccination costs

by Daniel Purt on June 29, 2010

Pertussis

Pertussis

In the face of one of the worst whooping cough outbreaks in the state's history, California's rural doctors have raised concerns that vaccines to prevent the disease are too expensive.

HHS declares H1N1 public health emergency over

by Ted Purlain on June 26, 2010

Swine-flu

H1N1

H1N1 influenza, in federal terms, is no longer a public health emergency.

American companies found to have reacted well to H1N1

by Daniel Purt on June 26, 2010

H1n1

H1N1

Medical News Today reports that American employers were proactive in dealing with the 2009 H1N1 flu pandemic according to a recently released survey.

CDC proposes new flu guidelines for healthcare facilities

by Tina Redlup on June 26, 2010

Cdc

Officials with the U.S. Centers for Disease Control and Prevention released a rough draft Wednesday of proposed guidelines for preventing H1N1 and seasonal influenza in a healthcare setting.

Whooping cough epidemic in California kills five

by Ashton Daigle on June 26, 2010

Pertussis

Pertussis

Health officials in California have reported that almost 1,000 cases of whooping cough have been confirmed in the state since June 15, with five infant deaths attributed to the outbreak.

CDC announces new H1N1 test

by Ted Purlain on June 25, 2010

Cdc

The U.S. Centers for Disease Control and Prevention reports that it has developed a test to diagnose human infections with the H1N1 influenza virus that can now be used by the U.S. Food and Drug Administration.

New polio vaccine more powerful than current vaccines

by Daniel Purt on June 25, 2010

Poliovirus

Polio

A polio vaccine that requires just one-fifth of what was commonly thought to be needed to defend babies from the crippling virus may be as effective as what was previously thought needed as long as the vaccine is injected just beneath the skin.

WHO suggests revising swine flu containment measures

by Tina Redlup on June 25, 2010

H1n1

H1N1

Officials with the World Health Organization have announced that swine flu containment measures failed to work as planned and will likely need to be revised before future pandemics occur.

Media coverage responsible for growth in vaccination rates

by Ashton Daigle on June 25, 2010

Who

A recent study has indicated that mass media coverage of flu-related stories has actually helped to increase vaccination rates.

CDC declines to endorse mandatory vaccinations

by Ted Purlain on June 24, 2010

Vaccine

The U.S. Centers for Disease Control and Prevention has recently declined to include mandatory vaccination policies for healthcare workers as a strategy to improve vaccination rates.

Computer-Aided influenza virus vaccine created

by Daniel Purt on June 24, 2010

Stonybrook

Stony Brook University biologists and computer scientists announced recently that they have used a novel approach to weaken the influenza virus.

West Nile Virus reported in Georgia

by Tina Redlup on June 24, 2010

Westnile

West Nile Virus

Several cases of West Nile Virus have been reported in Georgia so far this year, leading experts to worry that the virus has appeared earlier than usual.

New vaccine strategies could safely control Rift Valley Fever

by Ashton Daigle on June 24, 2010

Rvf

Rift Valley Fever

Researchers at the University of Pittsburgh Center for Vaccine Research have announced two new approaches that could possibly lead to the first vaccine for Rift Valley Fever.

Hybrid pandemic flu virus found in Chinese pigs

by Ted Purlain on June 23, 2010

H1n1

H1N1

Chinese researchers have announced that a hybrid virus that has been found in pigs in Hong Kong contains elements of the 2009 human pandemic flu virus as well as two swine flu strains.

FDA warns of generic Tamiflu

by Daniel Purt on June 23, 2010

Tamiflu

Tamiflu

The U.S. Food and Drug Administration has released a warning about a potentially harmful product representing itself as "Generic Tamiflu" sold over the Internet.

Vaccine on the horizon to fight asthma and hay fever

by Tina Redlup on June 23, 2010

Vaccine

Swiss researchers recently announced that they have created a “one size fits all” shot that could be used to combat multiple ailments, including asthma and hay fever.

Secondary transmission of H1N1 in households low

by Ashton Daigle on June 23, 2010

H1n1

H1N1

Two recent medical studies have concluded that secondary transmission of H1N1 virus in households is low. Both reports were published recently on the online edition of Epidemiology and Infection.

Dengue fever outbreak in Honduras

by Ted Purlain on June 22, 2010

Dengue-mosquito

Dengue mosquito

Approximately 11,000 people in Honduras have been infected with dengue and at least 10 have died, leading the nation's authorities to announce a nationwide red alert.

FDA extends review of Gardasil for older recipients

by Daniel Purt on June 22, 2010

Fda-logo

The FDA announced last week that it would be extending its review of Merck's application to broaden the age range for Gardasil to include women between the ages of 27 and 45.

Mymetics receives positive Phase Ib trial results for malaria vaccine

by Tina Redlup on June 22, 2010

Malaria-1

Malaria

Officials with Mymetics Corporation announced have announced that the company's malaria vaccine has successfully completed Phase Ib clinical trials in Tanzania.

Breakthrough in search for malaria vaccine

by Ashton Daigle on June 22, 2010

Malaria

Malaria

A novel discovery could lead to an effective vaccine against malaria, according to a news.oneindia.in news report.

FDA to begin posting evaluations of vaccines online

by Tina Redlup on June 19, 2010

Fda-logo

The results of safety evaluations for recently approved drugs and vaccines are now being posted online by the Food and Drug Administration.

Merck resumes lung cancer vaccine testing

by Ted Purlain on June 19, 2010

099_merck

Testing has resumed on an experimental lung cancer vaccine by Germany's Merck KGaA and Oncothyreon, its U.S. partner.

DNA-based flu therapy could reduce need for new vaccines

by Daniel Purt on June 19, 2010

H5n1

H5N1

A new DNA-based therapy to be used in the battle against the flu could give current flu vaccine makers "a run for their money," according to the company that's developing it.

Travelers bringing dengue to the U.S.

by Ashton Daigle on June 19, 2010

Dengue-mosquito

Dengue mosquito

The U.S. Centers for Disease Control and Prevention reported Thursday that the number of dengue fever in U.S. travelers returning home has risen drastically in the past few years.

Outbreak predicting study results revealed

by Jeffrey Bigongiari on June 18, 2010

Ling_geoffrey

Colonel Geoffrey Ling

The preliminary results of a study aimed at predicting the demonstrable outbreak of certain illnesses soon after initial exposure were announced this week at the 8th Annual Biodefense Vaccines and Therapeutics in Washington, D.C.

Current H1N1 vaccine protects against 1918 strain

by Ted Purlain on June 18, 2010

H1n1

H1N1

In a finding that could reduce concern over a potential release of the strain, a team of researchers in the U.S. reported this week that the current H1N1 vaccine protects mice and possibly humans against the 1918 pandemic virus.

Economic downturn threatens vaccination projects

by Daniel Purt on June 18, 2010

Vaccine

The global economic downturn is now threatening the launch of new vaccination projects, according to the head of the UN-backed Global Alliance on Vaccines and Immunisation.

DNA vaccines come of age

by Tina Redlup on June 18, 2010

Dna

DNA

Officials with Inovio Pharmaceuticals have announced the publication of an article exploring the “rebirth” of DNA vaccines in the July issue of Scientific American magazine.

International influenza conference to convene in September

by Ashton Daigle on June 18, 2010

Malik

Malik Peiris

An international influenza conference, titled Options for the Control of Influenza VII, will be held this September in Hong Kong.

Morocco certified malaria free

by Ted Purlain on June 17, 2010

Malaria

Malaria

The World Health Organization has certified Morocco - a country with a population of approximately 31.6 million people - as malaria-free, according to a press release from the WHO.

Air travel linked to greater chance of contracting H1N1

by Daniel Purt on June 17, 2010

Swineflu

H1N1

The Gaea Times reports that a published study in the British Medical Journal links long-haul flights to possibly contracting the H1N1 virus.

Plastic antibodies pass initial test

by Tina Redlup on June 17, 2010

Kshea

Kenneth Shea

Researchers in California have reported a first – that a plastic antibody works in the body of a living animal.

Study raises questions about age-group impact of H1N1

by Ashton Daigle on June 17, 2010

H1n1

H1N1

French researchers now believe that the effects of H1N1 may not have differed from seasonal flu epidemic effects on certain age groups as much as was initially believed.

Threat of insect-based bioterror reviewed

by Tina Redlup on June 16, 2010

Dengue-mosquito

A recent workshop at the University of Florida looked at the possibility of an insect-based form of terrorism that could be launched in the state.

Gates, Slim announce $150 million health donation for Central America

by Ashton Daigle on June 16, 2010

Carlosslim

Carlos Slim

Bill Gates and Carlos Slim, two of the wealthiest men in the world, will team up with Spain to donate $150 million to fight dengue fever, malaria and malnutrition in Mexico and Central America.

Oseltamivir rings can slow rate of H1N1 outbreak

by Ted Purlain on June 16, 2010

Swine-flu

H1N1

Oseltamivir ring prophylaxis helped slow down H1N1 influenza outbreaks in Singapore military camps in 2009, according to the results of a study reported in the June issue of the New England Journal of Medicine.

Oral vaccine could fight source of stomach cancers

by Daniel Purt on June 16, 2010

Hp

Hhelicobacter pylori

According to The Global Times in China, scientists in Chongqing believe they have created an oral vaccine that can combat stomach bacteria helicobacter pylori, which is strongly tied to the development of stomach cancer.

Pandemic flu on the rise in several nations

by Ted Purlain on June 15, 2010

H1n1

H1N1

Pandemic flu activity is picking up in parts of India and Colombia, and New Zealand is seeing a rise in flu-like illnesses in young children, CIDRAP News has reported.

Capitol Hill briefing addresses neglected tropical diseases

by Ted Purlain on June 15, 2010

Yellowfevirus

Yellow fever

Government officials, researchers and pharmaceutical representatives agreed last week at the Congressional Malaria and NTD Caucus in Washington, D.C., that progress is being made to curb neglected tropical diseases.

Bill Gates to finance Argentine vaccine development

by Tina Redlup on June 15, 2010

Gates-bill

Bill Gates

Officials with the Argentine government announced recently that a local scientist’s vaccine development program will soon receive funding from Bill Gates’ foundation, according to a news report in the Latin American Herald Tribune.

FDA seeks additional GlaxoSmithKline meningitis vaccine data

by Ashton Daigle on June 15, 2010

Meningitisbacteria

Meningitis bacteria

Officials with GlaxoSmithKline have announced that the U.S. Food and Drug Administration has requested more information about the company’s experimental meningitis vaccine, MenHibrix, before deciding if they will approve it.

Novavax completes construction of vaccine facility

by Daniel Purt on June 12, 2010

Vaccine

Novavax officials announced this week that they have completed construction of a new vaccine facility in India.

Flu summit held in West Virginia

by Ted Purlain on June 12, 2010

Flu_vaccine

Health officials in West Virginia are hoping to encourage influenza immunizations by holding the state's first annual flu summit.

Hong Kong to trash 2.8 million swine flu vaccine doses

by Tina Redlup on June 12, 2010

H1n1

H1N1

Health officials in Hong Kong announced on Thursday that they intend to throw away 2.8 million doses of unwanted swine flu vaccines valued at approximately $28.2 million.

Shingles vaccine largely ignored

by Ashton Daigle on June 12, 2010

Shingles

Shingles

Although a vaccine for shingles has been available since 2006, a report released by the New York TImes said many people aren’t getting the vaccine.

Potential measles outbreak at Walmart shareholders meeting

by Tina Redlup on June 11, 2010

Measles

Measles

Approximately 142 Walmart shareholders in Fayettville, Arkansas, were given measles vaccines as a precautionary measure after an attendee took ill with measles-like symptoms, according to officials with the Arkansas Department of Health.

Hepatitis A outbreak feared in Colorado

by Tina Redlup on June 11, 2010

Hepatitis-a

Hepatitis A

Officials with the Pueblo City-County Health Department in Pueblo, Colorado, alerted the public to a possible hepatitis A exposure that may have occurred on May 31 at Desert Hawk at Pueblo West golf course.

More than 100 whooping cough cases in San Luis Obispo

by Daniel Purt on June 11, 2010

Whooping

Pertussis

The San Luis Obispo County Public Health Department in San Luis Obispo, California, has identified more than 100 cases of whooping cough this year, according to a San Luis Obispo Tribune news report.

Strong effort presented in fight Afghani polio fight

by Ashton Daigle on June 11, 2010

Polio

Polio

Officials with the World Health Organization reported this week that they have vaccinated more than 1.2 million children in Afghanistan in an effort to fight polio following an outbreak in Tajikstan, according to a news report filed by the UN News Centre.

Scientists reject questions of WHO pandemic warning

by Ted Purlain on June 10, 2010

Who

Two investigations suggesting that the World Health Organization exaggerated a pharmaceutical industry warning of the H1N1 flu becoming a pandemic have been rejected by scientists.

Solar powered refrigerator to make vaccines accessible worldwide

by Daniel Purt on June 10, 2010

Flu_vaccine

A solar powered refrigerator has been developed by Appropriate Technology Collaborative that will allow vaccines to be cooled in parts of the world without electricity.

Key to fighting malaria found in yellow fever vaccine

by Tina Redlup on June 10, 2010

Malaria

Malaria

Researchers at Rockefeller University may have found a way to fend off malaria by using a yellow fever vaccine, according to a newswire.rockefeller.edu report.

WHO responds to BMJ investigative report

by Ashton Daigle on June 10, 2010

Who

World Health Organization Director-General Margaret Chan fired back Tuesday in response to an investigative report recently published in British Medical Journal.

Hay fever vaccine on the horizon

by Daniel Purt on June 9, 2010

Misc_pollen

Pollen

For many, hay fever could be a thing of the past, thanks to a vaccine that may be available as early as 2011, according to the London Daily Mail.

Tamiflu shows effectiveness in infants

by Ted Purlain on June 9, 2010

Tamiflu

German researchers have announced that Tamiflu given to infants hospitalized with influenza had similar benefits to those in older children, though mild gastrointestinal symptoms were a common side effect.

Bill Gates says battle against polio is close to being won

by Tina Redlup on June 9, 2010

Billgates

Bill Gates

Although Nigeria has seen a 99 percent drop in reported cases of polio between 2009 and 2010, Microsoft founder Bill Gates recently told 234next.com that more contributions are needed from the richer nations and global donors.

AVI BioPharma gets up to $18M to study swine flu

by Ashton Daigle on June 9, 2010

Swine-flu

Swine flu

Officials with AVI BioPharma Inc., recently announced that they have entered into an $18 million deal with the U.S. Defense Threat Reduction Agency, according to a Portland Business Journal news report.

Canadian swine flu vaccination programs failing

by Tina Redlup on June 9, 2010

H1n1

H1N1

Many provinces in Canada are beginning to report that their swine flu vaccination programs are failing.

Movement on for mandatory flu shots

by Ashton Daigle on June 9, 2010

Flu_vaccine

The movement for mandatory flu shots in medical facilities is beginning to catch on, according to a recent report by healthleadersmedia.com.

New TB vaccines needed, conference reports

by Ted Purlain on June 8, 2010

Tuberculosis

Tuberculosis

The Bangladesh New Nation reports that new tuberculosis vaccines are promising but need to be researched far more before they become available to the public.

WHO under fire for H1N1 pandemic classification

by Daniel Purt on June 8, 2010

Who

The Med Guru reports that the World Health Organization is under fire for declaring that the H1N1 virus was a pandemic.

Brain cancer vaccine shows promise

by Tina Redlup on June 8, 2010

Braincancer

Brain cancer

Officials with ImmunoCellular Therapeutics Ltd. announced las week that the early clinical trial of its brain cancer vaccine is showing progress, Reuters reports.

Molecular explanation for the evolution of Tamiflu resistance found

by Ashton Daigle on June 8, 2010

Tamiflu

Tamiflu

Caltech biologists have identified molecular changes that have assisted resistance in the antiviral drug Tamiflu, according to a statement released by Caltech officials.

Only a third of women being vaccinated for HPV

by Ted Purlain on June 5, 2010

Gardasil_first_dose

Gardasil

FoxNews has reported that only a third of young women are being vaccinated for cervical cancer prevention.

H1N1 vaccine not a high risk for Guillain-Barre syndrome

by Daniel Purt on June 5, 2010

H1n1

H1N1

There is no more notable risk of a form of paralysis for people who received H1N1 pandemic influenza vaccine compared to those who received a seasonal flu shot.

WHO says H1N1 pandemic slowing

by Ted Purlain on June 4, 2010

Swineflu

H1N1

In a statement released on its website, the World Health Organization's Emergency Committee said on Tuesday that the worst of the H1N1 pandemic influenza outbreak that spread rapidly last summer appears to have passed, though it did not go so far as to ca

Dengue fever drug shows efficacy

by Daniel Purt on June 4, 2010

Dengue

Dengue fever

There are no approved vaccines for the prevention of Dengue virus, but that could change, according to NanoVircides, Inc.

Study examines public behavior during H1N1 pandemic

by Tina Redlup on June 4, 2010

Flu_vaccine

Flu vaccine

The recently-published results of a new Harvard study concluded that a significant portion of the American public may not be willing to get immunized with another new flu vaccine, according to a Homeland Security Today news report.

Dengue fever returns to U.S.

by Ashton Daigle on June 4, 2010

Dengue-mosquito

Dengue mosquito

After a 65-year absence, dengue fever has returned to the United States, according to a report by newscientist.com.

Whooping cough returning on the West Coast

by Daniel Purt on June 3, 2010

Pertussis

Pertussis

Whooping cough is making a comeback on the West Coast, HealthNews reports in a May 30 article.

Skin cancer vaccine on the horizon

by Daniel Purt on June 3, 2010

Melanoma

Melanoma

British researchers have begun testing a new vaccine that could potentially end up reversing the deadly skin cancer melanoma, according to a recent report by TopNews.in.

Massive measles immunization program set for Zimbabwe

by Ashton Daigle on June 3, 2010

Measles

Measles

The largest vaccination campaign in Zimbabwe history, which will fight measles, will kick off soon, European Commission medical expert and overseer of the campaign Dr. Torben Bruhn recently told ReliefWeb.int.

Child swine flu vaccine results positive

by Tina Redlup on June 3, 2010

Flu_vaccine

Researchers in the U.K. say that a trial of swine flu vaccines has shown to provide “good protection” against the virus, according to the results of a Health Production Agency study released by the BBC.

Dynavax's two Phase III hepatitis vaccine trials obtains DSMB clearance

by Ashton Daigle on June 3, 2010

Hep

Hepatitis

Officials with Dynavax Technologies recently announced the second of its planned safety assessments have been completed for Phase III trials of Heplisav, a vaccine designed to protect against hepatitis B., according to a tradingmarkets.com report.

Studies show efficacy of H1N1 vaccines

by Rita Uplend on June 2, 2010

Swineflu

H1N1

MedPage Today reports that recent studies have shown one of the two vaccines used in England to prevent the H1N1 pandemic from spreading was more effective on children but also caused more side effects.

Three measles cases confirmed in Missouri

by Pat Dulnier on June 2, 2010

Measles

Measles

Health officials in Greene County, Mo., are reporting three confirmed cases of measles in May, according to the Springfield News-Leader.

Men could also benefit from HPV vaccine

by Ted Purlain on June 2, 2010

Gardasil

Gardasil

Time Magazine reports that the Centers for Disease Control and Prevention says men can also benefit from the HPV vaccine Gardasil and that it is a safe method of preventing genital warts.

Molecular pumps could make vaccines stronger

by Daniel Purt on June 2, 2010

Flu_vaccine

Scientists at the University of California - Berkeley have found that molecular pumps in Listeria bacteria that expel antibiotics, which make the bug harder to kill with standard drugs, also expel small signaling molecules that stimulate a strong immune r

Typhoid fever found at Miami restaurant

by Pat Dulnier on June 2, 2010

Typhoid

Typhoid fever

More than 70 employees at a Chili's restaurant in Miami are being screened by health officials after a cook was diagnosed with typhoid fever.

H1N1 could be important to future vaccination laws, expert says

by on May 28, 2010

Parmet

Wendy E. Parmet

A legal expert says the way that the H1N1 flu pandemic unfolded could be an important reference for how future laws can make vaccines more readily available at a time of need but can also hinder efforts to immunize the public.

Former HHS deputy secretary says Wakefield has much to answer for

by Daniel Purt on May 28, 2010

Tevi_david_troy_hhs_2007

Tevi Troy

Tevi Troy, the former Deputy Secretary of United States Department of Health and Human Services, says in an an article penned for the National Review that disgraced British doctor Andrew Wakefield "has a lot to answer for" about his study linking the meas

"Vaccine choice" rally held in Chicago

by Tina Redlup on May 28, 2010

Andrewwakefield

Andrew Wakefield

A “vaccine choice” rally was recently held in Chicago's Grant Park that featured the doctor at the center of the vaccine-autism debate, chicagobreakingnews.com reports.

Malaria vaccine shows postitive effectiveness in tests

by Ashton Daigle on May 28, 2010

Malariared

Malaria

Advanced Life Sciences Holdings recently announced that studies testing the effectiveness of its drug Restanza, an oral antibiotic used to combat a type of Plasmodium that cause malaria, have been positive.

H1N1 outbreak in Alabama declared over

by Ted Purlain on May 27, 2010

Swineflu

H1N1

The H1N1 virus outbreak appears to be contained and conquered in Alabama, according to a report by WAFF.

Obama's advisors identify vaccine fixes

by Ted Purlain on May 27, 2010

H1n1

H1N1

Quicker identification of pandemic viruses and a switch from egg to cell-based production were short term measures President Obama’s Council of Advisors on Science and Technology made to help quicken influenza vaccine production, according to a report by

Preclinical development of dengue vaccine announced

by Ashton Daigle on May 27, 2010

Dengue-mosquito

Dengue mosquito

Advanced BioScience Laboratories, Inc., and Hawaii Biotech, Inc., announced on May 25 that they will be joining forces with the National Institute of Allergy and Infectious Diseases for preclinical development of a dengue vaccine.

WHO delegates step up fight against vaccine treatable diseases

by Daniel Purt on May 27, 2010

Vaccine

At the conclusion of their five-day meeting, World Health Organization delegates decreed that they will promote efforts to reduce the child morality rate, according to CIDRAP News.

FDA clears H1N1 test

by Ted Purlain on May 26, 2010

H1n1

H1N1

A test for the 2009 H1N1 Influenza Virus in patients displaying signs and symptoms of respiratory infection has been cleared by the U.S. Food and Drug Administration.

Universal flu vaccine moves one step closer

by Daniel Purt on May 26, 2010

Flu_vaccine

Flu vaccine

A new influenza vaccine has been developed by researchers at Mount Sinai School of Medicine that brings a universal influenza vaccine one step closer and would eliminate the need for seasonal flu shots.

Delayed childhood vaccines not beneficial, study says

by Tina Redlup on May 26, 2010

Vaccine

Two University of Louisville School of Medicine doctors have concluded that delaying childhood vaccinations does not improve children’s health, according to a study in the medical journal Pediatrics.

U.K. bans doctor who linked autism to vaccine

by Ashton Daigle on May 26, 2010

Andrewwakefield

Andrew Wakefield

In an eight-page decision released on May 24, Britain’s General Medical Council revoked the license of a doctor whose now debunked work found a link between autism and vaccines.

New TB fighting theory combines injections and antibiotics

by Ted Purlain on May 25, 2010

Tuberculosis

Tuberculosis

Pharmaceutical giant Archivel Farma has announced that it is considering a new theory about tuberculosis and is taking steps to combat the disease, which has caused two million deaths in the past year.

Inhalable measles vaccine and lozenge delivery system under development

by Daniel Purt on May 25, 2010

Measles

Measles

Children may not be able to avoid the trip to the doctor, but they may soon be able to avoid getting a measles shot if a new vaccine makes it through human trials successfully.

As many as nine exposed to Hendra virus in Australia

by Tina Redlup on May 25, 2010

Hendra

Hendra virus

A girl that attended a dying horse may have been exposed to the lethal Hendra virus on Queensland’s Sunshine Coast, according to a news report in the Solomon Star.

Experimental vaccine shields monkeys against Ebola

by Ashton Daigle on May 25, 2010

Ebola

Ebola

Researchers recently announced that they have designed a vaccine that protects monkeys from at least three different strains of the Ebola virus.

New plan to fight polio revealed

by Ted Purlain on May 22, 2010

Polio

Polio

Scientists and researchers gathered in Geneva this week at the World Health Organization's annual meeting of health ministers discussed a new strategy to rid the world of polio, The Associated Press reports.

More mumps cases reported in Iowa

by Daniel Purt on May 22, 2010

Mumps

Mumps virus

The Associated press reports that more mumps cases have been confirmed in Iowa this week.

H1N1 vaccine skippers didn't think fu was dangerous

by Tina Redlup on May 22, 2010

H1n1

H1N1

While the reasons varied, the overall consensus was the same – most people who did not receive the H1N1 vaccine last year did not think the flu was a serious risk according to a review that was recently published in the online version of the New England J

Encouraging data on brain tumor vaccine announced

by Ashton Daigle on May 22, 2010

Brain_tumor

Brain tumor

Officials with the vaccine company Antigenics announced on May 20 that data from a clinical trial for its product Oncophage was encouraging.

Group calls for independent vaccine safety agency

by Ashton Daigle on May 21, 2010

Vaxvial80

The Coalition for Vaccine Safety

The Coalition for Vaccine Safety has called for creation of an independent vaccine safety agency according to a news report by the Biloxi Sun Herald.

Clinical trial for dengue fever vaccine to begin

by Ted Purlain on May 21, 2010

Dengue

Dengue Fever

The Fort Collins Coloradoan reports that a biotech company located in Fort Collins, Colo., is beginning its first clinical trials of a vaccine for dengue fever.

Newborns vulnerable to measles as early as two months

by Daniel Purt on May 21, 2010

Measles

Measles

A U.S. News & World Report article states that babies can become vulnerable to measles as early as two to three months after they are born.

Tuberculosis most deadly of neglected diseases

by Ashton Daigle on May 21, 2010

Tuberculosis

Tuberculosis

Greater than nine out of ten cases of tuberculosis could be avoided by 2050 through better testing, medicine and vaccines, according to a recently published review in the medical journal The Lancet.

Gender can affect immune system response

by Ted Purlain on May 20, 2010

Immunesystem

The immune system at work

A new study reports that gender can play a role in how an immune system responds to certain vaccines and their side effects.

Tajikistan polio outbreak expected to stall

by Daniel Purt on May 20, 2010

Polio

Polio

The Eurasia Review reports that Tajikistan is expected to see a sharp decrease in polio cases thanks to a nationwide immunization effort.

Smallpox vaccine may have slowed spread of AIDS

by Tina Redlup on May 20, 2010

Smallpox_vaccine

Smallpox vaccine

The discontinuation of the smallpox vaccine may have been a factor in the spread of AIDS , according to the results of a study recently published in BMC Immunology.

Vaccine body supports WHO action on pneumonia

by Ashton Daigle on May 20, 2010

Who

World Health Organization

The Global Alliance for Vaccines and Immunization hopes a resolution to increase efforts to combat pneumonia will be approved when they appear later this week before the World Health Organization, according to an Associated Press wire report.

South Africa takes flu precautions prior to World Cup

by Ted Purlain on May 19, 2010

Flu_vaccine

Flu vaccine

Extra precautions are being put in place in South Africa to prevent a potential flu outbreak during next month's World Cup, FT.com reports.

Bavarian Nordic begins Imvamune deliveries

by Daniel Purt on May 19, 2010

Smallpox-virus-ns

Smallpox

Danish biopharmaceuticals group Bavarian Nordic began deliveries of its Imvamune smallpox vaccine to the U.S. Strategic National Stockpile on Monday, the 30 year anniversary of the eradication of smallpox.

Drug resistant child staph infection cases on the rise

by Tina Redlup on May 19, 2010

Mrsa

MRSA

Drug resistant child staph infection cases are on the rise according to a study involving 25 children’s hospitals across the nation, the Associated Press reports.

Xcellerex announces successful production of swine flu H1 Hemagglutinin

by Ashton Daigle on May 19, 2010

1ru7_bio_r_500

H1 Hemagglutinin

Xcellerex officials announced this week that they have successfully produced swine flu H1 Hemagglutinin, California strain.

FDA says vaccines containing pig virus are safe for use

by Daniel Purt on May 18, 2010

Rotavirus

Rotavirus

The U.S. Food and Drug Administration says two vaccines created to combat rotavirus are safe to use despite the presence of a pig virus found in each.

Canada warns of second measles outbreak

by Tina Redlup on May 18, 2010

Measles

Measles

Five confirmed cases of measles in Alberta, Canada, have led to officials with Alberta Health Services requesting residents to get measles vaccines, according to iNews880.com.

Cancer vaccine breakthrough reported

by Ashton Daigle on May 17, 2010

20153-72

Metastatic melanoma cells

Cancer researchers in the U.K. say they have created a new vaccine that may ultimately offer a cure for certain types of cancer.

Powder-based oral vaccine to be part of AAPS conference

by Ted Purlain on May 15, 2010

Conference

The American Association of Pharmaceutical Scientists' National Biotechnology Conference will be held this weekend in the Hilton San Francisco Union Square starting this Sunday, May 16.

Former WHO flu head calls for development of pandemic flu vaccine

by Daniel Purt on May 15, 2010

Stohr

Dr. Klaus Stohr

CIDRAP News reports that the former head of the World Health Organization's flu program, Dr. Klaus Stohr, believes scientists should attempt to develop a prepandemic vaccine in an effort to "get the jump" on the next flu pandemic.

Sinovac submits clinical trial application for mumps vaccine

by Tina Redlup on May 15, 2010

Mumps

Mumps virus

China-based vaccine manufacturer Biotech Ltd. has submitted an application to the China State Food and Drug Administration to begin human clinical trials for a mumps vaccine, Medical News Today reports.

Novavax announces publication of H1N1 study

by Ashton Daigle on May 15, 2010

Novavax

Novavax, Inc.

Novavax, Inc., has published results of a pandemic H1N1 vaccine pre-clinical trial in the May 12 online edition of the journal Vaccine.

Merck announces agreement to distribute diphtheria and tetanus vaccine

by Daniel Purt on May 14, 2010

Merck

Merck & Co., Inc. announced in April that it has entered into an agreement that provides the company with exclusive rights to market and distribute a tetanus and diphtheria toxoids adsorbed vaccine produced by vaccine maker MassBiologics in 49 states.

Giardia parasite breakthrough could lead to malaria vaccine

by Daniel Purt on May 14, 2010

Picture_2

Giardia lamblia

A Howard Hughes Medical Institute international research scholar has reported in the journal Nature Medicine that advances have been made in creating a vaccine against the intestinal parasite Giardia lamblia.

Outbreak of Rift Valley Fever reported in World Cup host country

by Daniel Purt on May 14, 2010

Who

World Health Organization

The World Health Organization is not advising international travel restrictions to South Africa for those attending this summer's World Cup tournament despite a recently reported Rift Valley Fever outbreak.

New discovery could be boon to AIDS vaccine work

by Daniel Purt on May 14, 2010

Th_walker_large

Harvard Professor Bruce Walker

A study published in the online journal Nature says that a small percentage of people who are slow to progress to AIDS are helping researchers learn why some have a natural protection against HIV and may help in developing a vaccine for AIDS.

Booster doses can increase response in older adults againt pertussis

by Ted Purlain on May 14, 2010

Screen_shot_2010-05-06_at_4

Pertussis

Just one booster dose helped adults ages 55 and older respond well to a series of antigens that included diphtheria, tetanus and pertussis, Doctor's Guide Channels reports.

Measles outbreak in British Columbia

by Daniel Purt on May 14, 2010

Measles

Measles

Authorities in British Columbia confirmed 83 measles cases in the Canadian province, according to The Province, and said the high number is due in part to many in Western Canada who refuse to be vaccinated.

Zydus Cadila gets nod for H1N1 vaccine

by Tina Redlup on May 14, 2010

H1n1

H1N1

Zydus Cadilla, an Ahmedabad, India-based drug company, announced that it has become the first Indian firm to market the country’s first H1N1 flu vaccine, officials told LiveMint.com.

Crucell and NIH Burkina Faso malaria vaccine trial

by Ashton Daigle on May 14, 2010

Malaria

Malaria

Crucell N.V. announced Thursday that it has begun the first phase of a clinical study for irs AdVac-based malaria vaccine in Burkina Faso.

CDC expanding disease detection center program to protect against emerging diseases

by Nick Rees on May 13, 2010

Ray_r

Ray Arthur

"Global health security is only as strong as the weakest link," Ray Arthur, Associate Director for Global Health at CDC National Center for Infectious Diseases, said as part of a presentation on the CDC's Global Disease Protection Plan at last week's 2010

FDA determines rotovirus should not cause vaccine suspension

by Tina Redlup on May 13, 2010

Fda-logo

The Food and Drug Administration, with the help of a panel of experts, has determined that recent findings regarding rotovirus vaccines Rotateq, made by Merck and Co. Pharmaceuticals, and Rotateq, made by GlaxoSmithCline, should not lead to the continued

Second human safety study of ARCS vaccine underway

by Ted Purlain on May 13, 2010

Vaccine

According to a news release from MarketWire, a second human safety study of a Cleveland BioLabs, Inc., drug used to treat Acute Radiation Syndrome is underway.

New findings could help develop vaccines for respiratory infections

by Ashton Daigle on May 12, 2010

Flu_vaccine

Influenza vaccine

Researchers at the Trudeau Institute reported in the current Journal of Experimental Medicine that they have identified two signaling components that could potentially allow for cellular immunity against the influenza virus and lead to vaccines against re

FDA called on to raise vaccine safety testing standards

by Tina Redlup on May 12, 2010

Fda-logo

The National Vaccine Information Center formally called on the U.S. Food and Drug Administration this week to increase its labeling practices and legal vaccine safety testing.

Chickenpox outbreak in Florida

by Tina Redlup on May 12, 2010

Chickenpox

Chickenpox

Florida's Lee County has issued an outbreak warning for chickenpox after 41 confirmed cases of the disease have hit children since February.

Bill & Melinda Gates Foundation to fund vaccine research

by Rita Uplend on May 12, 2010

Bill_melinda_gates_f

The Bill & Melinda Gates Foundation announced backing for 78 science projects on Tuesday, including a vaccine triggered by human sweat and a laser vaccine.

Sanofi pasteur to pay for overpriced Canadian vaccines

by Daniel Purt on May 12, 2010

Pentacel-package

Pentacel

One of the world's largest vaccine producer's Canadian branch will pay more than $2.5 million after government regulators found the company overcharged for two vaccines that protect against childhood illnesses.

A/H1N1 continues to affect Brazil

by Daniel Purt on May 12, 2010

H1n1

The People's Daily Online reports that the A/H1N1 flu continues to affect Brazil.

Dengue outbreaks on the rise in Asia-Pacific

by Tina Redlup on May 11, 2010

Who

World Health Organization

World Health Officials announced last week that outbreaks of dengue fever have risen in the Asia Pacific region in the past year, killing three times more victims in 2008 than in recent years.

New malaria drug fights resistance

by Ashton Daigle on May 11, 2010

Malaria

Malaria

Researchers claim they have developed a new anti-malaria drug that can kill the parasite that causes the disease, according to an article published May 5 in the Journal Nature.

Immunizations for Phase 3 study of hepatitis B vaccine complete

by Ted Purlain on May 11, 2010

Hepb

Hepatitis B

Dynavax Technologies reports that it has completed immunizing over 2,000 subjects in a Phase 3 study of HEPLISAV, an adult hepatitis B vaccine.

Shingles vaccine not a risk for side effects

by Daniel Purt on May 11, 2010

Photo-16017

Zostavax

Merck & Co.'s shingles vaccine does not appear to have a risk of serious side effects, according to a new study.

New therapeutic TB vaccine could cut treatment time

by Ted Purlain on May 8, 2010

Tuberculosis

Tuberculosis

Archivel Farma, S.L. has announced at the 2010 BIO International Convention that its therapeutic TB vaccine, RUTI(R), can cut treatment time for the virus from nine months to one month when used with an antibiotic.

Pig virus DNA found in Merck's Rotateq vaccine

by Nick Rees on May 8, 2010

Rotavirus_vaccine

Rotateq vaccine

The U.S. Food and Drug Administration reported May 6 that fragments of two types of pig viruses were found in Merck & Co.'s Rotateq vaccine.

New clue to fighting Dengue fever

by Ashton Daigle on May 8, 2010

Dengue-mosquito

Dengue mosquito

Scientists may have discovered new clues as to how the body fights off the tropical disease Dengue fever, according to research published in the journal Science.

Whooping cough outbreak in San Luis Obispo

by Tina Redlup on May 7, 2010

Screen_shot_2010-05-06_at_4

Pertussis

Several confirmed cases of pertussis, also known as whooping cough, have resulted in a California county issuing a public alert warning of the disease.

Aradigm gets FDA approval for Cystic drug fibrosis clinical trial

by Nick Rees on May 7, 2010

About_lead_gonigo

Dr. Igor Gonda

Aradigm Corporation announced that it has received clearance from the U.S. Food and Drug Administration for its inhaled liposomal ciprofloxacin Investigational New Drug application.

E.coli vaccine becoming more of a possibility

by Tina Redlup on May 6, 2010

Ecoli

E.coli vaccine

Novartis scientists say they are getting closer to creating a universal E.coli vaccine.

Child vaccine refusals on the rise in the U.S.

by Nick Rees on May 6, 2010

More U.S. parents are refusing or delaying vaccinations for their children, a study presented May 4 at the annual meeting of the Pediatric Academic Societies in Vancouver has revealed.

GlycoVaxyn receives NIH grant for Staphylococcus aureus vaccine study

by Ashton Daigle on May 6, 2010

Staph_aureus

Staphylococcus

GlycoVaxyn AG and Professor Jean Lee, principal investigator at the Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, announced on May 4 that they received a $ 3.4 million U.S. Food and Drug Administration NIH grant to finance pre

Lawsuit filed over side effects of HPV vaccine

by Tina Redlup on May 6, 2010

Picture_4

Gardasil

The Associated Press reports that, on behalf of her teenage daughter, an Albuquerque, N.M., woman has sued the producer of a vaccine that is supposed to protect women from cervical cancer.

Anti-polio drive near Afghanistan halted, raising epidemic fears

by Rita Uplend on May 5, 2010

Polio

Polio

As a result of the continuing threat posed by militants in North Waziristan, a planned three day anti-polio drive had to be canceled, leaving experts worried that the country stands on the brink of a polio epidemic.

Advaxis advances clinical development of prostate cancer vaccine

by Nick Rees on May 5, 2010

7020-guha_chandan

Dr. Chandan Guha

Advaxis, Inc., a biotechnology company that develops proprietary, live, attenuated Listeria monocytogenes immunotherapeutics that deliver engineered tumor antigens, which are used to fight cancer, announced that it is advancing the clinical development of

Emergent BioSolutions V.P. to present at conference

by Nick Rees on May 4, 2010

Jackson

W. James Jackson, Ph.D.

W. James Jackson, Ph.D., the senior vice president and chief scientific officer at Emergent BioSolutions, Inc., will speak this week on a panel titled "Vaccines for the 21st Century."

BioSante to begin tests on prostate cancer vaccine

by Tina Redlup on May 4, 2010

Testing of an experimental prostate cancer drug begun almost two years after the research was stopped will soon restart, BioSante Pharmaceuticals, Inc. said on Monday.

Possible link between complications and H1N1 vaccine investigated

by Nick Rees on May 4, 2010

Guthriebirkhead_2

Guthrie S. Birkhead

Stressing that concerns are most likely a false alarm, federal health officials have begun investigating the possibility that there could be significant complications from H1N1 vaccine.

Whooping cough on the rise in Fresno

by Pat Dulnier on May 4, 2010

The number of whooping cough cases in Fresno, California, is on the rise, health officials have said, adding that a Fresno County infant died from the disease recently.

Outbreak of polio in Europe investigated

by Pat Dulnier on May 1, 2010

Technical experts have been sent by the World Health Organization to Tajikistan to investigate an outbreak of seven polio cases in the country.

Major vaccination campaign to start in Haiti

by Ted Purlain on May 1, 2010

108mnun165142

UNICEF in Haiti

A major immunization campaign will begin on Saturday in Haiti to give life-saving vaccinations to an estimated 60,000 Haitian children, the United Nations Children's Fund has announced.

Flu vaccinations hit record levels last year

by Tina Redlup on May 1, 2010

Cdc

CDC

A record 40 percent of adults and children, fearing swine flu, received the ordinary seasonal flu last year, federal health officials said this week.

Recall and destruction recommended for Shan5 vaccines

by Nick Rees on May 1, 2010

Who

A recall and destruction for all of the lots of Shantha Biotechnics pentavalent Shan5 vaccines has been recommended by the World Health Organization as a precautionary measure following the discovery of undissolved white sediments in the vaccine.

Sabin Vaccine Institute appoints new CEO

by Nick Rees on April 30, 2010

Michael_marine2

Michael W. Marine

The Sabin Vaccine Institute has announced that Michael W. Marine, the former U.S. Ambassador to the Socialist Republic of Vietnam, has been appointed as the institute's new chief executive officer.

ImuXen vaccines receive positive test results

by Pat Dulnier on April 30, 2010

Picture_1

liposomes

Positive results have been received by the biopharmaceutical Lipoxen for two of its ImuXen proprietary candidates for influenza vaccine and malaria vaccine.

H1N1 vaccine doses expiring nationwide

by Ted Purlain on April 30, 2010

Picture_2

H1N1

Thousands of doses of the H1N1 flu vaccine in Florida are on the verge of expiration or have already expired following a dip in demand for the vaccine.

India admits errors in drug testing that lead to six deaths

by Daniel Purt on April 30, 2010

00000267

V. M. Katoch

Proper guidelines for trials of an HPV vaccine among young girls in India were not followed, the Union Health Ministry admitted this week.

Needles may be more effective than tablets, study says

by Daniel Purt on April 29, 2010

45e311a8c

Dr. Markus Mohrs

Researchers at the Trudeau Institute have made a new discovery that may allow for the delivery of more effective vaccines to prevent chronic parasitic worm infections.

Human clinical trials to start on Dynavax's flu vaccine

by Pat Dulnier on April 29, 2010

Picture_5

influenza

Drug developer Dynavax has announced that human clinical trials will begin soon for its vaccine that is intended to protect against several flu strains.

Cubans vaccinated against A/H1N1

by Rita Uplend on April 29, 2010

Picture_4

A/H1N1

As of Sunday, more than one million Cubans have been vaccinated against A/H1N1 flu as part of the first stage of a vaccination campaign, Cuba's government announced on Tuesday.

Australian flu vaccine maker denies bad batch cause for illnesses

by Nick Rees on April 29, 2010

Picture_3

FLUVAX

A Melbourne-based pharmaceutical company that made the flu vaccine being implicated in a rash of Western Australia children falling ill and one death has denied that a bad batch of vaccine is the result.

Vaccine clinical research center opens in China

by Ted Purlain on April 28, 2010

Ppd_hq

PPD U.S. headquarters

A vaccine clinical research center has been opened by PPD, Inc., in Taizhou, China, one of the country's major regions for conducting vaccine studies.

Malaria vaccine enters third phase of testing

by Ted Purlain on April 28, 2010

Mosquito

The third phase of testing for the world's most clinically advanced malaria vaccine candidate began last year and researchers at the Kenya Medical Research Institutes and Centers of Disease Control believe it could lead to the nation's first malaria vacci

Australian biotech firm to begin testing Alzheimer's vaccine

by Daniel Purt on April 28, 2010

Dna

Alzheimer's

Testing is expected to begin soon on a new vaccine developed by Affiris, an Austrian biotechnology firm, to fight Alzheimer's.

Promising signs reported for vaccine to stop smoking

by Nick Rees on April 27, 2010

Picture_3

Nabi Biopharmaceuticals has reported promising signs in the early clinical trials for its vaccine to aid people in stopping smoking.

Seattle co. waiting FDA approval of cancer treatment vaccine

by Rita Uplend on April 26, 2010

Fda-logo

Dendreon, a Seattle biotech company, is awaiting a decision due this week by the U.S. Food and Drug Administration to bring the nation's first cancer treatment vaccine to market.

2010 World Vaccines Congress hands out awards

by Tina Redlup on April 26, 2010

Sanofi_pasteur_ceo

Wayne Pisano

The 2010 World Vaccines Congress met last week just outside Washington D.C., with attendees discussing the latest news in the vaccine world.

WHO flu expert says vaccines not to blame for Australian sicknesses

by Daniel Purt on April 26, 2010

Who

World Health Organization

An expert on influenza with the World Health Organization has said that it is unlikely that the bad reactions seen in western Australian children are the result of a bad batch of seasonal flu vaccine.

Salmonella vaccine link found

by Rita Uplend on April 26, 2010

Picture_2

salmonella

A link has been found between salmonella, which causes food poisoning, and HIV, leading scientists to believe that the discovery could lead to a salmonella vaccine.

UN urges Chinese parents to vaccinate children

by Pat Dulnier on April 24, 2010

Screen_shot_2010-04-23_at_3

measles

Parents in China are being urged by the United Nations health agency to get their children vaccinated against measles and hepatitis B to protect their children against premature death and long-term liver problems.

Scientists create patch for vaccine delivery

by Nick Rees on April 24, 2010

Screen_shot_2010-04-23_at_3

nanopatch

Scientists at the University of Queensland have developed a patch the size of a postage stamp that they claim can be used in delivering cheap, needle-free vaccines with much smaller doses while achieving the same results of a traditional needle.

AIDS vaccine collaboration announced

by Pat Dulnier on April 24, 2010

Screen_shot_2010-04-23_at_4

Lentigen

A collaboration has been announced between the International AIDS Vaccine Initiative and Lentigen to design a preventive AIDS vaccine based on Lentigen's technology.

Australian children fall ill after flu vaccine administered

by Tina Redlup on April 24, 2010

Article-hames-420x0

Kim Hames

The West Australian Health Minister has announced that more than 60 West Australian children may have had adverse reactions to a flu vaccine.

Health Protection Agency finalizing Strategic Plan for 2010-15

by Rita Uplend on April 23, 2010

The board of The Health Protection Agency has begun finalizing its Strategic Plan for 2010-15, making the draft plan available to the public for the first time.

Merck gains exclusive rights for tetanus and diphtheria vaccine

by Ted Purlain on April 23, 2010

Screen_shot_2010-04-22_at_3

diphtheria

An agreement has been announced between MassBiologics of the University of Massachusetts Medical School and Merck & Co., Inc., that provides the exclusive rights to market and distribute MBL's tetanus and diphtheria toxoids adsorbed vaccine in the United

HHS says doctors and minorities mistrust vaccines

by Nick Rees on April 23, 2010

Screen_shot_2010-04-22_at_3

HHS Secretary Sebelius

The recent H1N1 swine flu pandemic has revealed a dangerous mistrust of vaccines in doctors and minorities, U.S. Health and Human Services Secretary Kathleen Sebelius announced on Monday.

Euorpean volcano ash slows West African vaccinations

by Pat Dulnier on April 23, 2010

Screen_shot_2010-04-22_at_3

World Health Organization

At least 15 million doses of polio vaccine destined for a West Africa vaccination campaign have been delayed at airports in Germany and France as a result of the volcanic ash cloud, a U.N. official has revealed.

UK's HPA to hold London vaccine symposium

by Rita Uplend on April 22, 2010

Screen_shot_2010-04-21_at_4

Health Protection Agency

The Centre for Infections in Colindale, London, has announced a symposium on scientific issues in immunization to be held May 12.

NanoBio announces development of intranasal hepatitis B vaccine

by Nick Rees on April 22, 2010

Screen_shot_2010-04-21_at_3

hepatitis B

An initiative has been announced by NanoBio Corporation to develop an intranasal vaccine for the treatment of hepatitis B.

Study on pneumonia virus raises hope for vaccine

by Pat Dulnier on April 22, 2010

Lenney_photo

Prof. Warren Lenney

In a study published in The Lancet, scientists have revealed that a virus responsible for wheezing and pneumonia claims the lives of as many as 200,000 children worldwide each year.

Chickenpox outbreak reported in Delaware

by Rita Uplend on April 22, 2010

Screen_shot_2010-04-21_at_3

Chicken pox virus

An outbreak of chickenpox has been confirmed in Delmar, Del., affecting children with the highly contagious disease at Delmar Middle and High School.

Boston Univ. professor receives grant to fight streptococcus pneumonia

by Tina Redlup on April 21, 2010

Screen_shot_2010-04-21_at_12

streptococcus pneumonia

The Boston University School of Medicine's Richard Goldstein, a professor of pediatrics, has been awarded a three-year, $300,000 grant to aid in his research to create a more effective pneumonia vaccine.

New use of proteins in genetic material could help in cancer fight

by Ted Purlain on April 21, 2010

A new study in mice has shown that a transcription factor normally found in male germ cells could become a target for cancer vaccines, according to a report by HealthDay News.

HPV vaccine may prevent other types of cancer

by Tina Redlup on April 20, 2010

Bauman_small

Dr. Glenn Bauman

The human papilloma vaccine, which is intended to prevent cervical cancer, is now believed by cancer doctors to prevent other cancers in both men and women.

Antibodies from hen eggs may fight H5N1

by Nick Rees on April 20, 2010

Huanhuunguyen

Dr. Huan Huu Nguyen

Antibodies found in common eggs laid by hens vaccinated against the H5N1 virus can possibly prevent an H5N1 pandemic, new research has shown.

HPV virus trial suspended in India

by Tina Redlup on April 20, 2010

Screen_shot_2010-04-20_at_9

HPV virus

Following the deaths of six children who had been administered the controversial Human Papilloma Virus vaccines in India, a phase-3 trial of the vaccines has been canceled by the nation's government.

Five countries still infected with bird flu identified

by Nick Rees on April 20, 2010

Screen_shot_2010-04-20_at_9

H5N1 virus

Fears of 2006's bird flu epidemic have been raised again as five countries have been identified as potentially still being infected with the disease, which poses a global threat to human and animal health

WHO warns H1N1 to continue through 2011

by Nick Rees on April 20, 2010

Margaret_chan_bio

Margaret Chan

The head of the World Health Organization has warned that the H1N1 flu pandemic might not be conquered until 2011 and that continued vigilant is necessary against the mutating virus.

NIH gives $3M grant for malaria vaccine

by Pat Dulnier on April 20, 2010

Screen_shot_2010-04-19_at_4

Plasmodium vivax malaria

Support from the National Institute of Allergy and Infectious Disease of the NIH has given Protein Potential, LLC support in its research for a vaccine to prevent malaria caused by the Plasmodium vivax parasite.

Inovio, universities receive grant to develop hepatitis C vaccine

by Ted Purlain on April 20, 2010

Hepatitis-c2

hepatitis C

PHILADELPHIA — Inovio Biomedical Corp. and its university research partners were awarded a $2.8 million Pennsylvania state grant to develop a DNA vaccine to treat hepatitis C, the Philadelphia Business Journal reported April 9.

"Nanovaccine" reverses diabetes in mice, researchers say

by Tina Redlup on April 20, 2010

Pipette_0

Dr. Pere Santamaria

A new study, published online April 8 by Cell Press in the journal Immunity, describes a therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease.

Sanofi-Aventis, Navy to test traveler's diarrhea vaccine

by Paul Tinder on April 16, 2010

379_sanofi-aventis-logo

NEW YORK — French drugmaker Sanofi-Aventis said April 12 that it will work with the U.S. Naval Medical Research Center to develop and test a vaccine for traveler's diarrhea, The Associated Press reported.

UK vaccine makes strides in melanoma treatment

by Mary J. Lewis on April 15, 2010

Howard_kaufman

Dr. Kaufman

LONDON — A vaccine being tested in the United Kingdom has helped been shown to help some patients fully recover from melanoma, even in its advanced stages, The Telegraph of London reported April 11.

Study of HIV antibodies may aid vaccine development

by Rita Uplend on April 5, 2010

Hiv

HIV

Researchers report that they've gained more insight into how the body fights off HIV, a finding that offers a possible new avenue toward a vaccine against the virus, which causes AIDS.

Flu shot safe for most egg allergic children, study says

by Tina Redlup on April 5, 2010

Flu_vaccine

NEW YORK — The flu shot is safe for most kids with egg allergies, according to a new report in Pediatrics released April 5.

CDC updates advice for travelers

by Paul Tinder on April 5, 2010

Cdc

The Centers for Disease Control and Prevention reports that the 2009 H1N1 flu viruses are expected to circulate throughout 2010, including during the Southern Hemisphere flu season.

Peregrine says study shows anti-HIV potential of antibodies

by Tina Redlup on April 5, 2010

Hiv

HIV

Peregrine Pharmaceuticals Inc. announced April 5 the publication of data showing phosphatidylserine (PS)-targeting antibodies can block one of the key ways the AIDS virus gains entry into certain blood cells.

Measles outbreak spreads in New Zealand

by Rita Uplend on April 2, 2010

Measles

Measles

New Zealand health officials fear an outbreak of measles in a small community in the Far North has made its way to Wellington.

Resurgence of mumps seen in males in Ireland

by Pat Dulnier on April 2, 2010

Mumps

Mumps

Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI.

Small molecules have big impact for TB bacteria

by Ted Purlain on April 2, 2010

Tuberculosis

TB

Mycobacterium tuberculosis (Mtb) possesses extraordinary survival ability by masking itself from the host immune system and persisting for decades inside the host.

Canada cuts off funding to international AIDS vaccine project

by Tina Redlup on April 2, 2010

Canada-flag

OTTAWA — Canada has pulled the plug on funding to one of the largest AIDS vaccine development agencies in the world, the Winnipeg Free Press reported March 31.

GlaxoSmithKline launches free vaccine program

by Pat Dulnier on April 1, 2010

Vaccine

NEW YORK — British drugmaker GlaxoSmithKline PLC said March 20 that it is launching a program in the United States to provide free vaccines to adults who don't have health insurance.

Millions of H1N1 vaccine doses may have to be discarded

by Paul Tinder on April 1, 2010

H1n1

H1N1

Despite months of dire warnings and millions in taxpayer dollars, less than half of the 229 million doses of H1N1 vaccine the government bought to fight the pandemic have been administered.

Measles alert issued after dozen cases diagnosed

by Ted Purlain on April 1, 2010

Measles

Measles

The British Columbia Centre for Disease Control is warning health care professionals and the public to be on the alert for measles after nearly a dozen people in Vancouver were diagnosed recently with the disease, Canwest News Service reported.

Basketball superstars urge teens to stay in the game

by Pat Dulnier on April 1, 2010

Basketball

DETROIT — Detroit Pistons forward Jonas Jerebko and NBA legend Bob Lanier teamed up with NBA Cares and the Society for Adolescent Medicine on March 29 to bring Vaccines for Teens to the Metro Detroit community.

U.S. has record drop in TB rates

by Pat Dulnier on March 31, 2010

Tuberculosis

Tuberculosis

Tuberculosis rates in the United States dropped more than 10 percent last year compared with 2008, the sharpest decrease ever recorded in a single year, the Centers for Disease Control and Prevention reported March 31.

CDC reports states’ H1N1 flu inoculation rates vary widely

by Ted Purlain on March 31, 2010

Cdc

The Centers for Disease Control and Prevention reported that the vaccination rates for the pandemic H1N1 influenza virus are different around the country. New England has the highest rates while the South is having the lowest.

Selecta raises $15 million to advance potential vaccine

by on March 31, 2010

Fda-logo

A Massachusetts startup that uses nanotechnology to engineer safer and more effective vaccines is expected to say April 5 that it has raised another $15 million in venture capital to finance the further development of its products according to the Boston

Emergent BioSolutions among 2010 tech awards finalists

by Ted Purlain on March 31, 2010

Techcouncilmd

ROCKVILLE, Md. — The Tech Council of Maryland has selected finalists for its awards that recognize individuals and organizations for innovation, dedication and outstanding service to Maryland's technology community.

Cuba to vaccinate more than 1.1 million

by Tina Redlup on March 30, 2010

Who

World Health Organization

Cuba will begin vaccinating nearly 10 percent of its citizens against swine flu this week, reversing its previous skepticism about the high cost and effectiveness of immunization to combat the virus, The Associated Press reported March 26.

State ends mercury-limit suspension for H1N1 flu vaccine

by Paul Tinder on March 30, 2010

H1n1

H1N1

OLYMPIA, Wash. — Washington’s limit on the amount of mercury allowed in H1N1 flu vaccines for certain people is ending, the state’s Department of Health announced March 23.

Q fever vaccine urged for at-risk group

by Pat Dulnier on March 30, 2010

Q_fever

Q-fever

Doctors in the Netherlands have urged the country’s caretaker health minister, Ab Klink, to order a batch of Q fever vaccines for people at risk of developing complications from the goat and sheep disease, DutchNews.nl reported March 29.

Experts to review WHO’s H1N1 flu response

by Ted Purlain on March 30, 2010

Who

World Health Organization

A group of outside experts will scrutinize the WHO's response to the H1N1flu outbreak and likely examine whether the global body could have been clearer when it declared a pandemic of what has turned out to be a relatively mild disease.

CDC sees sustained H1N1 activity in Southeast

by Pat Dulnier on March 30, 2010

Cdc

Flu indicators are showing signs of increased and sustained pandemic flu activity in some Southeastern states, though rates remain steady at the national level, the U.S. Centers for Disease Control and Prevention said March 26.

Latin America braces for deadly dengue epidemic

by Rita Uplend on March 30, 2010

Dengue

Dengue

Health officials in Latin America report an earlier than usual outbreak of potentially deadly dengue fever, and are bracing this year for a particularly virulent outbreak of the mosquito-borne tropical disease, Agence France Presse reported March 24.

Rapid development of drug-resistant H1N1 flu reported in 2 cases

by Tina Redlup on March 30, 2010

H1n1

H1N1

Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, doctors from the National Institute of Allergy and Infectious Diseases reported March 26.

2 pandemic flu viruses’ lack of sugar could aid vaccine design

by Ted Purlain on March 30, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

The influenza viruses responsible for the pandemics of 1918 and 2009 share a structural detail that makes both susceptible to neutralization by the same antibodies, according to research by the NIAID.

Suspected smallpox in Uganda most likely chickenpox

by Rita Uplend on March 26, 2010

Who

World Health Organization

The World Health Organization is investigating reports of a potential smallpox outbreak in Uganda but says the cases likely involve chickenpox instead.

Study finds H1N1 flu in pregnancy is critical risk

by Rita Uplend on March 26, 2010

H1n1

H1N1

LONDON — Pregnant women in Australia and New Zealand who had pandemic H1N1 flu were 13 times more likely to become critically ill and be admitted to hospital, researchers said March 19.

BioSante's leukemia vaccine gets orphan drug status

by Paul Tinder on March 26, 2010

Leukemia

Leukemia

BioSante Pharmaceuticals Inc.'s treatment for acute myeloid leukemia received orphan-drug designation from the Food and Drug Administration on March 23 as the vaccine led to increased remission rates in a Phase II study.

Novavax cites positive H1N1 flu vaccine data

by Tina Redlup on March 26, 2010

H1n1

H1N1

ROCKVILLE, Md. — Novavax Inc. confirmed March 24 that its potential H1N1 flu vaccine prompted an immune response in patients during a midstage study.

Merck KGaA suspends Stimuvax cancer vaccine trials

by Ted Purlain on March 25, 2010

Fda-logo

FRANKFURT, Germany — German drugmaker Merck KGaA put on hold all testing on humans of its experimental cancer vaccine Stimuvax after a Phase II trial participant contracted encephalitis.

Joint venture fights TB with vaccine candidate

by Daniel Purt on March 25, 2010

Lockhart

Dr. Stephen Lockhart

When researchers at Oxford University took their development of a vaccine candidate against tuberculosis as far as they could, they found a commercial partner in Emergent BioSolutions.

U.S. not immune to TB threat, policy consultant says

by Ted Purlain on March 25, 2010

Troy_tevi

Tevi Troy

There is relatively little interest about tuberculosis in the United States because there is a perception that this is just a developing world issue, says Tevi Troy, a writer and consultant on health care and domestic policy

80-year-old vaccine not enough to fight TB, researcher says

by on March 25, 2010

Helen-mcshane

Dr. Helen McShane

Although tuberculosis remains a global threat and a strengthening foe, the most effective vaccine against it is more than 80 years old.

European partnership helps accelerate innovation against tuberculosis

by Tina Redlup on March 25, 2010

Worldtbday

This year's World TB Day theme, "On the move against tuberculosis: Innovate to accelerate action," addresses a critical aspect of the core business and values of the European & Developing Countries Clinical Trials Partnership.

CDC marks World TB Day 2010

by Ted Purlain on March 25, 2010

Cdc

World TB Day is March 24. This annual event commemorates the date in 1882 when Dr. Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacteria that cause tuberculosis.

Clinton urges renewed commitment to battling TB

by Tina Redlup on March 25, 2010

Tuberculosis

Tuberculosis

In remarks March 24, World Tuberculosis Day, Secretary of State Hillary Rodham Clinton urged everyone to "reaffirm our commitment to tackle this deadly disease together."

Aeras participates in events around the world on TB Day

by Paul Tinder on March 25, 2010

Aeras

On March 24, Aeras Global TB Vaccine Foundation recommitted itself to developing new and better TB vaccines and observed World TB Day 2010 by participating in events on three continents, the group said in a press release.

NASA, cruise line got H1N1 shots early on, AP reveals

by Pat Dulnier on March 24, 2010

Cdc

Last fall, as H1N1 flu cases mounted and parents desperately sought to protect their kids, the hard-to-get vaccine was handed out in some surprising places.

Dynavax says Heplisav as safe as Glaxo's hepatitis B vaccine

by Rita Uplend on March 24, 2010

Fda-logo

Dynavax Technologies Corp. said March 23 that the safety profile of its experimental hepatitis B vaccine Heplisav was comparable with GlaxoSmithKline’s hepatitis B vaccine Engerix-B, which recently got a regulatory approval.

Pfizer, Glaxo sign 10-year vaccine deal for poor

by Ted Purlain on March 24, 2010

Pneumococcal

Pneumococcal

LONDON — Pfizer and GlaxoSmithKline signed a landmark 10-year deal March 23 to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations.

FDA says to temporarily stop using GSK's Rotarix

by Tina Redlup on March 24, 2010

Fda-logo

Officials from the Food and Drug Administration are advising that doctors should temporarily stop using the vaccine against a diarrhea-causing virus because the vaccine is contaminated with an apparently harmless pig virus.

TB rate down in U.S., but drug-resistant cases rise elsewhere

by Ted Purlain on March 22, 2010

Tuberculosis

TB

Even with tuberculosis cases falling sharply in the United States to historic lows, strains of drug-resistant disease are gaining ground elsewhere in the world, the Centers for Disease Control Prevention and the World Health Organization report.

3 studies show ways to increase health-care worker vaccination rates

by Tina Redlup on March 22, 2010

Cdc

Health care personnel influenza immunization rates have remained low, despite recommendations from the Centers for Disease Control and Prevention.

Meningococcal disease outbreak in Okla. kills 2 children

by Pat Dulnier on March 22, 2010

Meningitis

Meningitis

In the wake of an outbreak of meningococcal disease at Oologah-Talala Public Schools, state and local health officials offered free vaccinations to the school system's students and staff, according to the Tulsa World.

Inventor of vaccine that eliminated serious cattle disease dies

by Daniel Purt on March 22, 2010

Walter-plowright

Walter Plowright

Walter Plowright, the British veterinarian often called one of the "heroes of the 20th century" because of his invention of a vaccine that has almost totally eliminated the cattle disease rinderpest, died recently in London. He was 86.

EU approves Novartis’ Menveo for meningococcal disease

by Pat Dulnier on March 19, 2010

Meningitis

Meningococcal

BASEL, Switzerland — Novartis announced March 18 that the European Commission granted a marketing authorization for its vaccines against meningococcal disease.

Poorer girls not getting HPV vaccine for cervical cancer

by Rita Uplend on March 19, 2010

Hpv

HPV

A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.

Mosquitoes turned ‘flying vaccinators’ unlikely to bite anytime soon

by Ted Purlain on March 19, 2010

Dengue-mosquito

Experts in Japan developed a mosquito that spreads vaccine rather than disease when it bites humans, it emerged March 19.

Genocea Biosciences signs deal for pneumonia antigens

by Pat Dulnier on March 19, 2010

Strep-pneumoniae

Streptococcus Pneumoniae

A vaccine discovery and development company on March 18 announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston.

China accused of selling bad vaccines

by Rita Uplend on March 18, 2010

China-flag

BEIJING — China's Health Ministry is investigating the safety of inoculations in a northern province after a report that defective vaccines possibly killed four children and seriously sickened dozens.

TB booster shot promising, study says

by Daniel Purt on March 18, 2010

Tuberculosis

Tuberculosis

A booster shot has shown promise in improving tuberculosis resistance in previously vaccinated adults, according to new research in South Africa.

WHO suspends Shan5 combination vaccine

by Rita Uplend on March 18, 2010

Who

World Health Organization

GENEVA — The World Health Organization said March 18 that it was suspending the use of the Indian-developed Shan5 combination vaccine, which is used against infections such as diphtheria, tetanus and hepatitis B.

Workers get flu shot if co-workers do, study says

by Tina Redlup on March 18, 2010

Flu_vaccine

IOWA CITY, Iowa — Increasing vaccination rates of health care personnel substantially improves patient safety, lowering flu deaths by 40 percent, researchers suggest.

Chickenpox outbreak increases hospital admissions

by Tina Redlup on March 17, 2010

Chickenpox

Chickenpox

HANOI, Vietnam — An outbreak of chickenpox is hitting Ho Chi Minh City and Hanoi as the number of infected children admitted to hospitals in big cities has increased significantly, the Voice of Vietnam reported March 15.

Biovest set to unveil its personalized lymphoma vaccine

by Tina Redlup on March 17, 2010

Fda-logo

TAMPA, Fla. and MINNEAPOLIS — Biovest International Inc. announced March 17 that it will present information about its personalized cancer vaccine, BiovaxID, at the following upcoming conferences:

Bavarian says FDA approves Imvamune production in U.S.

by Pat Dulnier on March 17, 2010

Fda-logo

Bavarian Nordic A/S announced that it has received notification that the U.S. FDA has accepted all the actions taken by the company to address the observations made during its inspection of the manufacturing facilities in 2009.

Medical care for chickenpox down since vaccine’s introduction

by Ted Purlain on March 17, 2010

Chickenpox

Chickenpox

Since the varicella vaccine was introduced in the mid-1990s, the number of people receiving medical care for chickenpox in the U.S. has decreased sharply — particularly among children.

8 million Afghan children to benefit from UN polio vaccination drive

by Paul Tinder on March 16, 2010

Who

World Health Organization

U.N. agencies and the Afghan health ministry are conducting a three-day campaign aimed at vaccinating an estimated 7.7 million children under the age of 5 against polio, which can leave patients totally paralyzed.

HHS preparing to handle claims of harm from H1N1 vaccine

by Rita Uplend on March 16, 2010

H1n1

H1N1

While the pandemic H1N1 influenza vaccine seems to be just as safe as seasonal flu vaccines, the federal government has been getting some letters from people saying they plan to seek compensation for injuries caused by the injection.

BioSante cancer vaccine gets 'orphan drug' status

by Tina Redlup on March 16, 2010

Fda-logo

LINCOLNSHIRE, Ill. — BioSante Pharmaceuticals received orphan drug status for its potential pancreatic cancer treatment, the company announced March 15.

Dynavax says auditors concerned about its finances

by Ted Purlain on March 16, 2010

Hepb

Hepatitis B

Dynavax Technologies Corp. said March 16 that its auditors have expressed doubts about the company's ability to continue as a going concern as a result of the company's current financial position, according to Reuters.

85 million African children to get polio shot during campaign

by Pat Dulnier on March 16, 2010

Polio

Polio

GENEVA— The World Health Organization says more than 85 million children under 5 in west and central Africa will be vaccinated against polio.

GAVI Alliance to ask donors for $4.3 billion

by Rita Uplend on March 16, 2010

Who

World Health Organization

LONDON — An additional $4.3 billion is needed if a global vaccines alliance is to meet its goal of supplying life-saving immunizations to millions of children in poor countries by 2015, the organization said March 15.

Vaccinating children against flu helps everyone, study says

by Ted Purlain on March 16, 2010

Cdc

A new study shows that when children get vaccinated against seasonal influenza, the entire community can benefit.

Vaccines don't cause autism, federal court rules

by Tina Redlup on March 16, 2010

Flu_vaccine

WASHINGTON — The United States’ "vaccine court" has once again concluded that vaccines don't cause autism.

Glioblastoma vaccine shows promise in animal study

by Paul Tinder on March 13, 2010

Dendrritic-cell

Dendritic Cell

LOS ANGELES — ImmunoCellular Therapeutics Ltd. announced March 10 that its dendritic cell-based vaccination with cancer stem cells demonstrated a statistically significant survival benefit in a preclinical animal model of glioblastoma.

H1N1 flu spreads slower than seasonal flu, study says

by Pat Dulnier on March 13, 2010

Cdc

The H1N1 flu appears to spread more slowly than "regular" seasonal flu in a household setting, but when it does spread it's more likely to affect children, a new study suggests.

Autism study researcher suspected of misappropriating $2 million

by Paul Tinder on March 12, 2010

Cdc

A Danish scientist involved in two major studies that debunked any linkage of vaccines to autism is suspected of misappropriating $2 million in U.S. grants at his university in Denmark, the Philadelphia Inquirer reported March 12.

GlaxoSmithKline makes vaccine executive changes

by Ted Purlain on March 12, 2010

Glaxosmithkline

GlaxoSmithKline

LONDON — British pharmaceutical company GlaxoSmithKline PLC on March 12 announced two changes in the executive lineup of its vaccines business.

Emergent BioSolutions’ CEO recognized as outstanding international business leader

by Tina Redlup on March 12, 2010

El-hibri_fuad

Fuad El-Hibri

ROCKVILLE, Md. — The World Trade Center Institute announced March 11 that Emergent BioSolutions Inc.’s chairman and CEO has been named as one of Maryland’s outstanding international business leade

India likely to start H1N1 flu vaccination next week

by Rita Uplend on March 12, 2010

H1n1

H1N1

NEW DELHI — India is “most likely” to administer imported swine flu vaccine to the high-risk groups from next week, a senior health ministry official said March 10.

Baxter presents results from Phase III study of Preflucel

by Tina Redlup on March 12, 2010

Flu_vaccine

DEERFIELD, Ill. — Baxter International Inc., in conjunction with DynPort Vaccine Co., announced Phase III study data measuring the clinical efficacy for its trivalent seasonal influenza candidate vaccine on March 11 in Miami.

Battelle, IBM, Merck join university in plan for vaccine factory

by Pat Dulnier on March 11, 2010

Upmc

An ambitious plan to build a vaccine factory in the Pittsburgh area is gaining momentum with the announcement March 11 of three new partners in the University of Pittsburgh Medical Center project, the Pittsburgh Business Times reported.

BioSante says small leukemia vaccine trial successful

by Rita Uplend on March 11, 2010

Leukemia

Leukemia

BioSante Pharmaceuticals Inc. announced positive results of a human clinical study that show that its GVAX leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients.

W.Va. medical center recognized for mandatory flu vaccine program

by Rita Uplend on March 11, 2010

Flu_vaccine

Charleston Area Medical Center has been recognized by a state group for "going above and beyond the call of duty" in getting the flu vaccine to employees and preventing the potential spread of the disease, The Charleston Gazette reported March 11.

Drugmakers agree on vaccines deal for developing nations

by Ted Purlain on March 11, 2010

Pneumococcal

Pneumococcal

LONDON — Several drug companies have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.

Transgene sells option on cancer vaccine to Novartis

by Paul Tinder on March 10, 2010

Fda-logo

STRASBOURG, France — Transgene SA, a French biotechnology company, sold Novartis AG an option on rights to the experimental TG4010 lung cancer vaccine in a deal that may fetch as much as $960 million, Bloomberg reported.

Doctors should help increase immunizations in adults, report says

by Ted Purlain on March 10, 2010

Vaccine

Up to 50,000 U.S. adults die each year from vaccine preventable diseases, and the direct health care burden of vaccine preventable diseases in American adults is $10 billion a year.

Vaccination, prevention beating back hepatitis, report says

by Tina Redlup on March 10, 2010

Cdc

Decades of vaccination and prevention efforts may have the hepatitis viruses on the run, according to a new report from the U.S. Centers for Disease Control and Prevention released March 10.

Novel strategies may vaccines’ increase stability, professor says

by Pat Dulnier on March 10, 2010

Fda-logo

Cell-based vaccines are at the forefront of influenza vaccine development, according to findings presented March 10 at the 14th International Congress on Infectious Diseases in Miami and reported by Pediatric SuperSite.

Nabi closes license deal for smoking vaccine candidate

by Daniel Purt on March 10, 2010

Nicvax

NicVax

ROCKVILLE, Md. — Nabi Pharmaceuticals said March 8 that it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline, the Associated Press reported.

CDC study finds U.S. herpes rates remain high

by Pat Dulnier on March 10, 2010

Hsv2

HSV-2

Approximately 1 in 6 Americans (16.2 percent) between the ages of 14 and 49 is infected with herpes simplex virus type 2, according to a national health survey released March 9 by the Centers for Disease Control and Prevention.

Novavax completes enrollment of flu vaccine trial in Mexico

by Rita Uplend on March 10, 2010

Who

ROCKVILLE, Md. — Novavax Inc. announced March 8 that more than 3,500 volunteers ages 18 to 64 in Mexico have been enrolled in Stage B of its 2009 H1N1 virus-like-particle pandemic influenza vaccine study.

Students urged to get H1N1 shot before spring break

by Tina Redlup on March 10, 2010

Cdc

With spring break coming up and large numbers of students expected to travel both domestically and internationally, getting vaccinated against 2009 H1N1 influenza is especially important.

Baby given overdose of TB vaccine

by Ted Purlain on March 10, 2010

Vaccine

LONDON — An investigation is under way after a newborn baby was given 10 times the normal dose of a tuberculosis vaccine at a hospital in North Lincolnshire, England.

Crucell appoints new chief medical officer

by Pat Dulnier on March 9, 2010

Vaccine

LEIDEN, Netherlands — Dutch biopharmaceutical company Crucell announced March 8 that Jerald C. Sadoff was appointed chief medical officer will be a member of its management committee.

Scientists find why vitamin D is crucial to immune systems

by Rita Uplend on March 9, 2010

Vitamin-d

Vitamin D

LONDON — Vitamin D is vital in activating human defenses and low levels suffered by around half the world's population may mean their immune systems' killer T cells are poor at fighting infection, scientists said March 7.

Meningitis at OU now 'outbreak'

by Rita Uplend on March 9, 2010

Meningitis

Meningitis

COLUMBUS, Ohio — The seven bacterial meningitis cases at Ohio University the past two years have been declared an outbreak by the U.S. Centers for Disease Control and Prevention, The Columbus Dispatch reported March 7.

1 in 5 at-risk babies in U.S. doesn't get hepatitis B vaccine

by Ted Purlain on March 9, 2010

Hepb

Hepatits B

About one in five babies born to mothers with hepatitis B aren't getting treatments that have been shown to prevent the infection in newborns, a study whose findings were released online March 8 in advance of the April print issue of Pediatrics.

Supreme Court to decide if vaccine makers can be sued

by Tina Redlup on March 9, 2010

Cdc

WASHINGTON — The Supreme Court announced March 8 that it would decide whether a federal law protects vaccine manufacturers from lawsuits in state court seeking damages for alleged design defects.

Pneumococcal conjugate vaccine beneficial in HIV, report says

by Tina Redlup on March 6, 2010

Hiv

HIV

A seven-valent pneumococcal conjugate vaccine can protect adults with HIV against recurrent pneumococcal infection, according to research published in the March 4 issue of the New England Journal of Medicine.

CDC awards contracts to evaluate effectiveness of H1N1 vaccine

by Tina Redlup on March 6, 2010

Flu_vaccine

The Centers for Disease Control and Prevention has awarded Abt Associates two new contracts to evaluate the effectiveness of the H1N1 vaccine among health care workers and children younger than 18, the company announced March 5.

U.S. H1N1 vaccine campaign challenging, speakers say

by Ted Purlain on March 6, 2010

H1n1

H1N1

WASHINGTON — First, people were clamoring for H1N1 vaccines, but there were not enough to go around. By the time vaccines were available in any quantity, most of the public had lost interest.

FDA sees no public hearing for experimental cancer vaccine

by Rita Uplend on March 6, 2010

Fda-logo

WASHINGTON — The U.S. Food and Drug Administration is not planning to seek advice from its outside advisers over Dendreon Corp.'s experimental prostate cancer vaccine, Reuters reported March 5.

CDC monitors malaria cases in Haiti

by Tina Redlup on March 6, 2010

Malaria

The U.S. Centers for Disease Control and Prevention has received reports of several cases of malaria in Haiti since a 7.0 magnitude earthquake struck the country Jan. 12.

Vaccine for asbestos-related cancer shows promise

by Pat Dulnier on March 4, 2010

Mesothelioma

Mesothelioma

An investigational vaccine for the asbestos-related cancer mesothelioma is safe, according to a new study cited in a press release March 4 from the American Thoracic Society.

85 million children to be immunized across 19 countries

by Ted Purlain on March 4, 2010

Polio

Polio

More than 85 million children under five years old will be immunized against polio in 19 countries across West and Central Africa in a massive cooperation aimed at stopping a year-long polio epidemic the World Health Organization announced.

Indian H1N1 vaccine to be out mid-May

by Paul Tinder on March 4, 2010

H1n1

H1N1

NEW DELHI — The country's first indigenously produced vaccine against H1N1 virus will be ready for use from mid-May, The Times of India reported March 4.

Findings confirm H1N1 flu's toll on pregnant women

by Ted Purlain on March 4, 2010

H1n1

H1N1

NEW YORK — New research from Australia confirms that the HIN1 flu hits pregnant women particularly hard — especially if they have asthma, obesity or diabetes.

'Painless' vaccine needle invented in Japan

by Tina Redlup on March 4, 2010

Flu_vaccine

Kanji Takada, a professor of pharmacokinetics, has developed a round vaccine "chip" measuring 1.5 centimeters in diameter that contains as many as 300 micro needles.

Patient trials of genital herpes vaccine begin in London

by Pat Dulnier on March 4, 2010

Hsv2

HSV2

LONDON — A new vaccine designed to prevent people with genital herpes from passing the virus on to their sexual partners has begun its first patient trials at a hospital in England.

Experimental vaccine protects monkeys from chikungunya

by Paul Tinder on March 4, 2010

Chikungunya-virus

Chikungunya

GALVESTON, Texas — The mosquito-borne virus chikungunya has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy.

Coalition for Vaccine Safety calls for congressional hearings

by Ted Purlain on March 4, 2010

Cdc

A new coalition is calling for hearings to investigate HHS, the Centers for Disease Control and Prevention and other government agencies for what it describes as a failure to fully address issues of vaccine safety.

Advisory committee silent on high-dose flu vaccine for elderly

by Tina Redlup on March 4, 2010

Cdc

The U.S. Advisory Committee on Immunization Practices last week heard a report about the high-dose influenza vaccine that was recently approved for people 65 and older but voiced no preference for its use in that age group.

Meningitis outbreak kills 250 in Burkina Faso

by Rita Uplend on March 3, 2010

Malaria_mosquito

Health officials in the west African country of Burkina Faso are worried about an increase in deaths from meningitis which has killed about 250 people so far this year, up from 203 in the same period last year.

Panacea Biotec signs H1N1 flu vaccine deal

by Pat Dulnier on March 3, 2010

H1n1

H1N1

MUMBAI — Panacea Biotec announced March 3 that it has signed an advance market agreement with the government of India to manufacture Pandyflu, the company's H1N1 flu vaccine.

Puerto Rico declares epidemic of dengue fever

by Paul Tinder on March 3, 2010

Dengue

Dengue Fever

SAN JUAN, Puerto Rico — Health officials in Puerto Rico have declared an epidemic of dengue fever, The Associated Press reported.

Inovio Biomedical given OK for H5N1 flu vaccine trials

by Rita Uplend on March 3, 2010

H5n1

H5N1

Inovio Biomedical announced March 3 that it got the go-ahead to begin human trials of a preventive vaccine for H5N1 avian flu in Korea.

Egg allergy no bar to flu shot, researchers say

by Ted Purlain on March 3, 2010

Flu_vaccine

NEW ORLEANS — Most children with egg protein allergies who received influenza vaccinations had no adverse reactions, researchers said at the annual meeting of American Academy of Allergy, Asthma & Immunology, according to MedPage Today.

Scientists use Olympics to study spread of infectious diseases

by Tina Redlup on March 3, 2010

Vancouver-olympics

As an international crowd of athletes and supporters gathered en masse in Vancouver, some scientists used the Olympics as their virtual test tube to find out how to prevent the outbreak of diseases spread by air travel.

Medicago, McGill University receive grant to research VLPs

by Paul Tinder on March 2, 2010

Vlps

Virus-like Particles

Medicago Inc., and the Research Institute of the McGill University Health Centre have been awarded a $288,000 research grant to study plant-made virus-like particles with a focus on immune response induced.

New inhaled drug protects from flu in 1 dose

by Pat Dulnier on March 2, 2010

Daiichi_sankyo

WASHINGTON — A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported Feb. 26, and can also protect against infection.

Single-dose H5N1 vaccine effective in adults, elderly

by Rita Uplend on March 2, 2010

H5n1

H5N1

Researchers from Hungary and the United Kingdom have developed a single-dose H5N1 influenza vaccine that induces a protective level of immunity against infection in healthy adult and elderly volunteers.

WHO official sees promise from India cholera vaccine

by Ted Purlain on March 2, 2010

Cholera

Cholera

GENEVA — Because deadly cholera infections are still on the rise, producing oral cholera vaccines in poor countries could help boost the immunity of those most vulnerable to the water-borne disease, a World Health Organization official said March 1.

Vaccine advice outweighs fear of autism, study finds

by Tina Redlup on March 1, 2010

Cdc

CHICAGO — One in four U.S. parents believes some vaccines cause autism in healthy children, but even many of those worried about vaccine risks think their children should be vaccinated, The Associated Press reported March 1.

Cyto Pulse, Karolinska Institutet get clinical trial approval

by Paul Tinder on February 27, 2010

Dna

DNA

Cyto Pulse Sciences announced approval from the Swedish Medical Products Agency to conduct a phase I clinical trial evaluating an HIV/DNA vaccine in collaboration with the Karolinska Institutet and the Swedish Institute for Infectious Disease Control.

NasVax, Novartis sign vaccine research deal

by Daniel Purt on February 27, 2010

Vaccine

TEL AVIV — Israel's said Feb. 21 it had signed an agreement with Novartis to jointly investigate the feasibility of developing vaccines using its VaxiSome technology, including an improved flu vaccine, Reuters reported Feb. 21.

Australian trial begins on investigational staph vaccine

by Rita Uplend on February 27, 2010

Staph_aureus

S. Aureus

PERTH, Australia — Researchers here are calling for volunteers to help test an investigational vaccine against Staphylococcus aureus.

NIH, FDA announce initiative to fast-track innovations to public

by Ted Purlain on February 27, 2010

Nih

The U.S. Food and Drug Administration and the National Institutes of Health unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.

WHO says pandemic at less severe end of spectrum: WHO

by Tina Redlup on February 27, 2010

Who

World Health Organization

GENEVA — The current H1N1 swine flu pandemic is relatively less severe than some other influenza outbreaks, the World Health Organization said Feb. 24

Dynavax selects clinical candidate in universal flu vaccine program

by Pat Dulnier on February 26, 2010

Fda-logo

BERKELEY, Calif. — Dynavax Technologies Corp. announced Feb. 25 that it has selected a clinical vaccine candidate for its novel Universal Flu program and completed key preclinical studies.

Single-dose HIV DNA vaccine induces strong immune response in monkeys

by Paul Tinder on February 26, 2010

Hiv

HIV

For the first time researchers from the U.S. and abroad have shown that a single-dose HIV DNA vaccine can induce a long-lasting HIV-specific immune response in nonhuman primates.

Pfizer factory in N.C. to help make new vaccine

by Rita Uplend on February 26, 2010

Pfizer

CHARLOTTE, N.C. — A new version of the Prevnar childhood vaccine that federal regulators approved Feb. 24 will be partly produced at the company's drug factory in Sanford.

Older women not likely to benefit from cervical cancer vaccine

by Ted Purlain on February 26, 2010

Hpv

HPV

Women older than 40 are unlikely to get much benefit from the vaccine for the virus that causes cervical cancer, a new study reports.

Dutch find no link between infant deaths, vaccine

by Tina Redlup on February 26, 2010

Pfizer

AMSTERDAM — The Dutch health authority RIVM said Feb. 23 the deaths of three infants last year were not related to a vaccine produced by U.S. pharmaceutical company Wyeth, now part of Pfizer.

CEL-SCI study shows vaccine blocks progression of rheumatoid arthritis

by Paul Tinder on February 25, 2010

Vaccine

VIENNA, Va. — CEL-SCI Corp. and its scientific collaborators announced Feb. 22 that the company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis in a mouse model.

Novartis receives FDA approval of Menveo

by Paul Tinder on February 25, 2010

Fda-logo

BASEL, Switzerland — The U.S. Food and Drug Administration approved Novartis’ Menveo to prevent meningococcal disease, which infects more than 500,000 people each year, leading to more than 50,000 deaths globally.

Publication of Vical's H5N1 results paves way for H1N1 clinical trial

by Rita Uplend on February 25, 2010

H5n1

H5N1

SAN DIEGO — Vical Inc. announced Feb. 24 the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of its Vaxfectin-adjuvanted DNA vaccines for H5N1 (avian-origin) influenza.

2009 H1N1 flu strain will be in next season flu vaccine

by Ted Purlain on February 25, 2010

Cdc

The 2009 H1N1 flu virus, which has sickened millions and killed at least 15,000 people worldwide, will be included in the United States’ next seasonal flu vaccine when it becomes available in the fall, government health experts decided.

Texas university gets $40 million grant to make tobacco-based vaccine

by Tina Redlup on February 25, 2010

Dod

The Texas A&M University System and a Texas company have been awarded a $40 million grant from the U.S. Department of Defense to develop vaccines made from tobacco rather than the antiquated egg-based technology.

Genocea Biosciences licenses herpes simplex virus patent estate from university

by Pat Dulnier on February 24, 2010

Hsv2

HSV-2

Genocea Biosciences, a vaccine discovery and development company, announced that it has licensed an extensive patent estate for 25 pending and issued patents related to herpes simplex virus type 2 antigens.

Inovio Biomedical to present at DNA Vaccines 2010 Conference

by Paul Tinder on February 24, 2010

Dna

DNA

SAN DIEGO — Inovio Biomedical Corp. announced Feb. 23 that representatives and associates of the company will make multiple presentations at the DNA Vaccines 2010 conference March 2 through 4 in New Orleans.

Flightless mosquitoes may curb dengue, researchers say

by Rita Uplend on February 24, 2010

Malaria_mosquito

WASHINGTON — Genetically altered mosquitoes that cannot fly may help slow the spread of dengue fever and could be a harmless alternative to chemical insecticides, U.S. and British scientists said Feb. 22.

Researchers' group slams decision to cancel HIV-vaccination facility

by Ted Purlain on February 24, 2010

Hiv

HIV

The head of an association that represents Canada's HIV researchers is criticizing a federal government decision to scrap plans for an $83.5 million facility that would manufacture potential vaccines.

Young kids should get new Prevnar, U.S. experts say

by Tina Redlup on February 24, 2010

Pneumococcal

Pneumococcal

Children younger than 5 who already got four doses of Pfizer Inc.'s Prevnar 13 vaccine should get a fifth booster dose of the new version that covers more strains of pneumonia-causing bacteria.

European agency recommends Sanofi Pasteur’s Humenza

by Pat Dulnier on February 22, 2010

Humenza

Humenza

LYON, France — Sanofi Pasteur announced Feb. 19 that its adjuvanted H1N1 influenza vaccine Humenza has received a positive opinion from the scientific committee of the European Medicines Agency.

AltraVax acquires technology platform for vaccine development

by Paul Tinder on February 22, 2010

Hepb

Hepetitis B

AltraVax Inc. has acquired a vaccine development technology package that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

Indiana fund invests in vaccine research

by Rita Uplend on February 22, 2010

Vaccine

INDIANAPOLIS — BioCrossroads' Indiana Seed Fund has invested in Bioscience Vaccines Inc. to accelerate the development of biologic materials, which may boost the effectiveness of a wide range of life-saving vaccines.

UNICEF backs measles vaccination campaign in Bangladesh

by Ted Purlain on February 22, 2010

Measles

Measles

More than 20 million Bangladeshi children will be vaccinated against measles over the next two weeks as part of a campaign backed by UNICEF to try to eradicate the deadly disease in the South Asian nation, the UN News Service reported Feb. 15.

South African officials say H1N1 outbreak threatens World Cup

by Tina Redlup on February 22, 2010

World-cup

CAPE TOWN, South Africa — South Africa faces a possible health crisis if an H1N1 flu outbreak strikes during the soccer World Cup this year, the country’s health minister told parliament Feb. 15, Reuters reported.

Ireland’s children hardest hit in new measles outbreak

by Paul Tinder on February 20, 2010

Measles

Measles

Children younger than 5 have been the main victims of a measles outbreak sweeping Ireland that has hospitalized one in three of those affected, The Irish Independent reported Feb. 13.

Vaccination campaign begins in Haiti

by Rita Uplend on February 20, 2010

Unicef

BOGOTA, Colombia — An intensive effort is under way in Haiti to immunize approximately 1.5 million Haitians amid concerns of increased risks of disease outbreaks after last month's catastrophic earthquake, AlertNet reported Feb. 18.

Virxsys researches using AIDS to fight AIDS

by Ted Purlain on February 20, 2010

Hiv

HIV

WASHINGTON — A company using genetically engineered versions of the AIDS virus says its unusual approach is getting some results, both for treating and perhaps as a vaccine against HIV.

AIDS vaccine effects may wear off, researchers say

by Tina Redlup on February 20, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — An AIDS vaccine that appears to have worked at least partly in Thailand may only temporarily protect patients, with the effects starting to wane after a year or so, researchers reported Feb. 18.

Sebelius: Pandemic uncovered technology’s weaknesses

by Pat Dulnier on February 20, 2010

Sebelius_kathleen

Kathleen Sebelius

U.S. Health and Human Services Secretary Kathleen Sebelius spoke at the 2010 Public Health Preparedness Summit about the lessons learned so far from the response to the H1N1 flu pandemic and efforts to strengthen health preparedness.

Parents urged to keep records rather than rely on doctors

by Pat Dulnier on February 19, 2010

Vaccine

NEW YORK — Taking charge of your toddler's vaccination record may be the best way to ensure he or she doesn't miss any shots, a new study suggests.

Fridge-free vaccine hopes raised

by Paul Tinder on February 19, 2010

Who

World Health Organization

Scientists at England’s Oxford University have found a way of keeping vaccines stable without refrigeration, BBC News reported Feb. 19.

WHO recommends adding H1N1 strain to regular flu vaccine

by Rita Uplend on February 19, 2010

H1n1

H1N1

LONDON — The World Health Organization is recommending that swine flu be added to regular flu vaccines next season, The Associated Press reported Feb. 18.

MMR vaccine doctor Andrew Wakefield quits autism centre

by Ted Purlain on February 19, 2010

Wakefield-andrew

Andrew Wakefield

Andrew Wakefield, the British doctor whose research triggered a health scare over the measles, mumps and rubella vaccine, has resigned from the autism center he founded in Texas, The Guardian reported Feb. 18.

Study shows how viruses altered evolution

by Tina Redlup on February 19, 2010

Poli-di-milano

Politecnico di Milano

LONDON — Italian scientists said Feb. 19 that they had found evidence of how viruses helped change the course of human evolution and said their discovery could help in the design of better drugs and vaccines.

Tests show King Tut died from malaria, study says

by Pat Dulnier on February 16, 2010

Tut

King Tutankhamen

CHICAGO — King Tutankhamen, the teenaged pharaoh whose Egyptian tomb yielded dazzling treasures, limped around on tender bones and a clubfoot and probably died from malaria, researchers said Feb. 16.

Researchers find ‘secret weapon’ of cancer-causing retroviruses

by Paul Tinder on February 16, 2010

Thierry-heidmann

Thierry Heidmann

Oncogenic retroviruses are a particular family of viruses that can cause some types of cancer.

Qatar to cancel further imports of H1N1 vaccine

by Rita Uplend on February 16, 2010

Flu_vaccine

DOHA, Qatar — Qatar's Supreme Council of Health has decided to cancel imports of the H1N1 vaccine, after a drop in the number of H1N1 influenza cases in the country, The Peninsula reported Feb. 10.

Senegal confirms H1N1 outbreak

by Ted Purlain on February 16, 2010

H1n1

H1N1

DAKAR, Senegal — Modou Diagne Fada, Senegal’s minister of health and preventive medicine, confirmed that the country had been hit by the epidemic H1N1 influenza, AfricaNews reported Feb. 9

Measles outbreak spreading in South Africa

by Tina Redlup on February 16, 2010

Who

World Health Organization

The cause of a measles outbreak sweeping South Africa has not as yet been determined, but initial suspicions point to religious objections and unfounded fears that immunizations against the disease increase the risk of autism in children.

Inovio Biomedical vaccine for cervical cancer generates response

by Pat Dulnier on February 16, 2010

Hpv

HPV

SAN DIEGO — Inovio Biomedical Corp. announced Feb. 8 additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine trial

Dynavax starts hepatitis B trial

by Paul Tinder on February 16, 2010

Hepb

Hepetitis B

BERKELEY, Calif. — Dynavax Technologies Corp. will start a 2,000-patient trial of its investigational adult hepatitis B vaccine, aiming for data in the first half of 2011, the San Francisco Business Times reported Feb. 8.

Direct-injection vaccine combination tested for pancreas cancer

by Rita Uplend on February 16, 2010

Amer-cancer-soc

Researchers at the Cancer Institute of New Jersey are investigating the development of a series of vaccine injections to see if they will produce an immune response against pancreatic cancer, the institute said

Measles continues to spread in Zimbabwe

by Ted Purlain on February 16, 2010

Measles

Measles

HARARE, Zimbabwe — Measles continues to spread in Zimbabwe despite intensified efforts by the government and its partners to contain the outbreak, which has affected more than 1,200 people since October, The Herald reported Feb. 10.

WHO to decide whether worst over in H1N1 pandemic

by Tina Redlup on February 16, 2010

Who

World Health Organization

GENEVA — The World Health Organization will convene its emergency committee later this month to examine whether the H1N1 flu pandemic has peaked, its top influenza expert said Feb. 11.

40 dead, 2,000 infected in country's first cholera outbreak in 50 years

by Pat Dulnier on February 13, 2010

Cholera

Cholera

SYDNEY — At least 40 people are dead and 2,000 infected as Papua New Guinea struggles to contain its first cholera outbreak in 50 years, The Associated Press reported Feb. 1

Scientists prove hypothesis on the mystery of dengue virus infection

by Paul Tinder on February 13, 2010

Who

World Health Organization

An immunology research institute has validated the long-held and controversial hypothesis that antibodies — usually the "good guys" in the body's fight against viruses — instead contribute to severe dengue virus-induced disease.

Circassia reports positive trial results for ragweed allergy vaccine

by Rita Uplend on February 13, 2010

Ragweed

Ragweed

OXFORD, England — Circassia Ltd. announced Feb. 12 that its ToleroMune ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial.

Vaccine not fail-safe in ongoing mumps outbreak

by Ted Purlain on February 13, 2010

Mumps

Mumps

In a recent mumps outbreak occurring in the eastern United States, even some of those who were vaccinated against the infectious illness got sick, health officials report according to HealthDay News.

Voluntary system of H1N1 vaccinations works, research shows

by Tina Redlup on February 13, 2010

Vaccine

Social interaction between neighbors, work colleagues and other communities and social groups makes voluntary vaccination programs for epidemics such as H1N1 flu, SARS or avian flu a surprisingly effective method of disease control.

Cervarix vaccine approved in Canada

by Daniel Purt on February 12, 2010

Hpv

HPV

A second vaccine to protect against human papillomavirus, or HPV, has been approved for use in Canada, CBC News reported Feb. 9.

Vaccine firm secures $3 million in funding

by Paul Tinder on February 12, 2010

Hepb

Hepatitis B

A Scottish life science firm has secured an additional $3.1 million in funding to develop new vaccines, BBC News reported.

Whooping cough vaccine may need to change, researchers say

by Rita Uplend on February 12, 2010

Whoopingcough

Whooping Cough

The bacteria that causes whooping cough in Australia has mutated, scientists have warned, eroding the protection provided by the vaccine now given to children, the Australian Associated Press reported Feb. 10.

Preteen vaccine campaign has a Native American spokesperson

by Ted Purlain on February 12, 2010

Vaccine

The Centers for Disease Control and Prevention is partnering with the Indian Health Service to launch a campaign informing American Indian and Alaska Native parents about the importance of a preteen medical check-up and preteen vaccines.

CDC answers questions about vaccine selection for 2010-11 flu season

by Tina Redlup on February 12, 2010

Cdc

The Centers for Disease Control and Prevention recently addressed questions about the vaccine for the 2010-11 flu season on its Web site.

Israel moves to stop delivery of more H1N1 flu vaccines

by Daniel Purt on February 10, 2010

Israel_flag

JERUSALEM —There are currently 4.6 million doses in the country as only 700,000 have been used, The Jerusalem Post reported Feb. 9.

Novavax reports positive data from its VLP vaccine study

by Pat Dulnier on February 10, 2010

Novavax-vlp-vaccine

Novavax's VLP Vaccine

Novavax Inc. announced Feb. 9 new data from a clinical study that began in May among healthy adults 18 to 49 years old with Novavax's trivalent seasonal influenza virus-like particle (VLP) vaccine.

Vaccine tests on Romanian children spark controversy

by Rita Uplend on February 10, 2010

H1n1

H1N1

Growing concern in Romania about the opaque circumstances in which a vaccine against H1N1 flu is being tested on children has forced health authorities to postpone the launch of the vaccination campaign by at least one month.

Global Tamiflu-resistant H1N1 cases reach 225

by Ted Purlain on February 10, 2010

Who

World Health Organization

The World Health Organization reported that 225 cases of H1N1 flu with resistance to oseltamivir (Tamiflu) have been found worldwide, and resistant viruses have spread from person to person in several clusters but have not spilled into the community.

New York City urges some to get mumps vaccine

by Tina Redlup on February 10, 2010

Mumps

Mumps

NEW YORK — New York City health officials are encouraging young adults, especially males, in the Jewish communities in Brooklyn to get vaccinated for mumps, UPI reported Feb. 9.

H1N1 flu vaccine safe, California and CDC data show

by Paul Tinder on February 10, 2010

H1n1

H1N1

At the height of fears over H1N1 flu this fall, some vaccination foes claimed it was safer to get illness than to be inoculated against it.

Third of anti-malarial medicines in 3 African nations substandard, study finds

by Rita Uplend on February 10, 2010

Malaria

Malaria

The first results from a study of key anti-malarial medicines reveal that a high percentage of medicines circulating on national markets are of substandard quality and may contribute to the growth of drug-resistant strains of malaria.

H1N1 flu still out there, officials caution

by Ted Purlain on February 10, 2010

Cdc

WASHINGTON — H1N1 flu is still circulating around the world and still killing people, although it is on the decline everywhere, global health officials said Feb. 5.

More than 1,000 get mumps in New York, New Jersey since August

by Pat Dulnier on February 10, 2010

Mumps

Mumps

NEW YORK — More than 1,000 people in New Jersey and New York, many of them adolescent Orthodox Jews, have been sickened with mumps since August, health authorities said Feb 8.

Nearly half of Americans believe H1N1 outbreak is over, poll finds

by Tina Redlup on February 10, 2010

H1n1

H1N1

BOSTON – The latest poll from researchers at the Harvard School of Public Health shows that 44 percent of Americans believe the H1N1 flu outbreak is over, and levels of concern about getting sick with the virus continue to decline.

Infection persists, despite vaccine, analysis finds

by Daniel Purt on February 8, 2010

Fda-logo

A vaccine introduced in 2000 has been highly effective in reducing the number of severe lung, blood and brain infections in infants and children. But at the same time, a serious and sometimes fatal complication has become more common.

Nabi Biopharmaceuticals completes PentaStaph milestone

by Rita Uplend on February 8, 2010

Nicvax

NicVAX

ROCKVILLE, Md. — Nabi Biopharmaceuticals announced Feb. 8 that it has completed the manufacture and transfer of specified materials associated with the sale of the PentaStaph vaccine candidate to GlaxoSmithKline Biologicals.

Bivalent polio vaccine introduced in Delhi, U.P.

by Ted Purlain on February 8, 2010

Polio

Polio

NEW DELHI — Union Health and Family Welfare Minister Ghulam Nabi Azad on Feb. 7 launched the bivalent oral vaccine against polio in Delhi and Uttar Pradesh states to mark India’s national immunization day, The Hindu reported.

For obese people, vaccine needle size matters

by Paul Tinder on February 8, 2010

Hepb

Hepatitis B

NEW YORK — Our expanding waistlines may have outgrown doctors’ needles, researchers report in the March issue of Pediatrics.

Novavax, Rovi end flu vaccine development plan

by Tina Redlup on February 8, 2010

Novavax-vlp-vaccine

Novavax's viruslike particle vaccines

TEL AVIV, Israel — Novavax Inc. announced Feb. 8 that it ended talks aimed at a collaboration with Rovi Pharmaceuticals of Madrid to develop Novavax's viruslike particle vaccines against influenza in Spain.

Researchers synthesize protein of maternal malaria

by Pat Dulnier on February 5, 2010

Malaria

Malaria

Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children, ScienceDaily reported Feb. 5.

Efforts needed to boost adult immunizations, study says

by Paul Tinder on February 5, 2010

Flu_vaccine

Adult Immunization

According to a national report, millions of adult Americans are vulnerable to diseases that can be forestalled by vaccines, CIDRAP News reported Feb. 4.

Prostate cancer vaccine using DNA progress

by Rita Uplend on February 5, 2010

Prostatecancer

Prostate Cancer

Researchers in Cork, Ireland, have developed a vaccine that enables a person’s immune system to attack cancer cells directly, The Irish Times reported Feb. 5.

25 percent of Americans get H1N1 vaccine, CDC director says

by Ted Purlain on February 5, 2010

Cdc

More than 75 million Americans, or close to 25 percent of the population, have been vaccinated against the pandemic H1N1 virus, the director of the Centers for Disease Control and Prevention estimated Feb. 4.

Researchers uncover genome of malaria parasite

by Tina Redlup on February 5, 2010

Malaria

Malaria

Research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria, ScienceDaily reported Feb. 5.

President’s budget boosts funds for tropical diseases

by Ted Purlain on February 4, 2010

Flu_vaccine

WASHINGTON — President Barack Obama's budget proposes a unique new initiative — battling some tropical diseases not just to improve health but as a national security strategy, Reuters reported Feb. 2.

Researchers say dengue fever cases surge in Central, Latin America

by Ted Purlain on February 4, 2010

Dengue-mosquito

SANTIAGO, Chile — Dengue cases in Central and Latin America have increased almost five-fold in incidence in the last 30 years, researchers have found.

Progress is slow on moving surplus H1N1 flu vaccine to countries in need

by Tina Redlup on February 4, 2010

Who

World Health Organization

There is now so much unused H1N1 pandemic flu vaccine in the world that rich nations, including the United States, are trying to get rid of their surpluses.

New malaria vaccine shows promise in early study

by Rita Uplend on February 4, 2010

Malaria

Malaria

A new vaccine tested in 100 West African children triggers the immune system to produce antibodies against the malaria parasite at levels normally seen only in adults who have strong resistance to the disease.

Study investigates who is most likely to take precautions during a pandemic

by Pat Dulnier on February 4, 2010

Sars

SARS

LONDON — A study that looked at how people behave during pandemics has identified key demographic and psychological factors that may predict protective behaviors.

Bharat Biotech releases 1 billionth dose of vaccine

by Daniel Purt on February 3, 2010

India-flag

Manufacturer Bharat Biotech on Feb. 3 delivered its billionth vaccine dose and announced plans to invest Rs. 250 crore in two years to carry forward clinical trials in different disciplines, the India Gazette announced Feb.

More H1N1 vaccines recalled in Connecticut

by Paul Tinder on February 3, 2010

H1n1

H1N1

HARTFORD, Conn. — More than 11,000 doses of H1N1 vaccine distributed in Connecticut have been recalled because of decreased potency, the third such recall in two months, The Hartford Courant reported Feb. 3.

Mandatory policy boosts vaccination rate among health care workers

by Rita Uplend on February 3, 2010

Vaccine

A mandatory influenza vaccination policy improves immunization rates among health care workers, according to a recent study of a large health care organization.

Trial nicotine vaccine may help prevent smoking addiction, relapse

by Ted Purlain on February 3, 2010

Nicvax

NicVAX

Oregon Health & Science University is participating in a Phase III clinical trial to determine whether a new investigational smoking cessation aid called NicVAX is safe, effective and capable of stimulating an immune response, the school announced Feb. 3.

Biotech companies find progress in vaccine market

by Tina Redlup on February 3, 2010

Flu_vaccine

When it comes to vaccines, everyone now wants to get in on the action.

NanoBio Awarded Key Patent Covering Vaccine and Anti-Infective Product Platforms

by Pat Dulnier on February 3, 2010

Flu_vaccine

Flu Vaccine

NanoBio Corp. announced Feb. 2 that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

Some viruses use fats to penetrate a cell

by Tina Redlup on February 3, 2010

Sv40

SV40

SV40 viruses use an amazing means of communication, in order to be able to penetrate into a cell: fats, whose structure must fit like a key in a lock, ScienceDaily reported Jan. 29.

PATH paying FDA for work on a pneumococcal disease vaccine

by Paul Tinder on February 3, 2010

Fda-logo

A nonprofit organization is paying the Food and Drug Administration to help develop a better vaccine against pneumococcal disease in poor countries, The New York Times reported Feb. 1.

VLP vaccine protects monkeys from chikungunya virus

by Pat Dulnier on February 3, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

An experimental vaccine developed using non-infectious virus-like particles has protected macaques and mice against chikungunya virus, researchers at the National Institutes of Health have found.

The Lancet retracts study linking autism to vaccine

by Ted Purlain on February 3, 2010

Mmr

LONDON — The Lancet medical journal formally retracted a paper that caused a 12-year international battle over links between the three-in-one childhood measles, mumps and rubella vaccine and autism.

MSF says it is responding to rise in malaria infections in Burundi

by Tina Redlup on February 2, 2010

Malaria

Malaria

Médecins Sans Frontières teams in Burundi's Kayanza province assessing and treating patients in the midst of a rise in the incidence of malaria, the organization also known as Doctors Without Borders reported Jan. 29.

Vaccine 'could cut HIV TB deaths'

by Daniel Purt on February 2, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

A vaccine could cut tuberculosis cases among HIV-positive Africans by almost two-fifths, a U.S. study suggests.

Cadila Pharmaceuticals’ H1N1 vaccine faces technical hurdle

by Rita Uplend on February 2, 2010

India-flag

NEW DELHI — Cadila Pharmaceuticals’ plans to manufacture H1N1 flu vaccines has hit a roadblock as the drug regulator has expressed concerns over the technology to be used.

Gates: $10 billion vaccine program could save 8.7 million lives

by Ted Purlain on February 2, 2010

Gates-bill

Bill Gates

DAVOS, Switzerland — Bill and Melinda Gates announced plans Jan. 29 to invest $10 billion in the fight against a number of illnesses including AIDS and said the record donation could save nearly nine million lives.

Partnership to support vaccine formulation across PATH projects

by Tina Redlup on February 2, 2010

Pneumococcal

Pneumococcal

PATH, an international nonprofit global health organization, recently signed an agreement with the University of Kansas Center for Research to support the advancement of vaccine candidates across its vaccine development portfolio.

Bacterial diarrhea vaccine shows promise, TD Vaccines says

by Rita Uplend on January 29, 2010

Ecoli

E. coli

TD Vaccines A/S announced Jan. 25 the early results of a preliminary vaccine to combat a leading cause of bacterial diarrhea that afflicts millions of international travelers as well as children in the developing world.

New vaccine method is cheaper more effective, researchers say

by Tina Redlup on January 29, 2010

Nih

Traditional vaccines can be ineffective and expensive. Now, an interdisciplinary team of Cornell researchers has devised a new way to make vaccines that promises to prevent diseases much more cheaply, the university announced Jan. 25.

3.7 million in England get H1N1 flu shots

by Pat Dulnier on January 29, 2010

Who

World Health Organization

LONDON — Approximately 3.7 million people in England have been vaccinated against H1N1 flu, health authorities announced, and urged anyone in priority groups to have the shot now to ward off the virus in 2010, reported Jan. 21.

New work offers hope for effective salmonella vaccine

by Tina Redlup on January 29, 2010

Salmonella

Salmonella

Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of salmonella.

PATH, NIAID to conduct Phase 1 trial of adjuvant

by Paul Tinder on January 29, 2010

Niaid_logo

National Institutes of Allergy and Infectious Diseases

PATH signed an agreement with the Division of Microbiology and Infectious Diseases at the NIAID in Bethesda, Md., to conduct a Phase 1 clinical trial of the double mutant heat-labile toxin (dmLT) vaccine/adjuvant.

Bill Gates stresses importance of vaccines in annual foundation letter

by Rita Uplend on January 28, 2010

Gates-bill

Bill Gates

Bill Gates, founder of Microsoft and co-chairman of the Bill and Melinda Gates Foundation released an open letter that addresses what he called the “miracle of vaccines.”

Guidance from CDC for relief workers going to Haiti

by Rita Uplend on January 28, 2010

Cdc

The U.S. Centers for Disease Control and Prevention has released updated guides for relief workers and others traveling to Haiti in the aftermath of the Jan. 12 earthquake that decimated the country.

Open letter to the American people about the H1N1 flu vaccine

by Tina Redlup on January 28, 2010

Flu_vaccine

More than 30 health providers and organizations released an open letter advising people to get vaccinated. Below is the text of that letter.

Vaccine approach extends life of prostate cancer patients, trial shows

by Tina Redlup on January 28, 2010

Prostatecancer

Prostate Cancer Cells

In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses lived substantially longer than patients who received a placebo vaccine.

BARDA funding to support flu vaccine production in Vietnam

by Paul Tinder on January 28, 2010

Who

World Health Organization

PATH has received an award from the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services to support the enhancement of sustainable influenza vaccine production in Vietnam.

Burkina Faso site begins vaccinations in RTS,S Phase 3 trial

by Pat Dulnier on January 27, 2010

Malaria_mosquito

Malaria

NANORO, Burkina Faso — The Phase 3 trial of GlaxoSmithKline Biologicals' RTS,S, a malaria vaccine candidate, is on track.

Mich. county’s chicken pox cases increase

by Paul Tinder on January 27, 2010

Chickenpox

Chicken Pox

Health Department officials in Oakland County, Michigan, say they are seeing more children than expected being diagnosed with chicken pox for this time of year.

Vaccine could be lethal weapon against malaria, cholera

by Rita Uplend on January 27, 2010

Malaria

Malaria

A biomedical researcher at the University of Central Florida has developed what promises to be the first low-cost dual vaccine against malaria and cholera, school officials announced Jan. 26.

Canada gives WHO 5 million doses of H1N1 vaccine

by Ted Purlain on January 27, 2010

H1n1

H1N1

TORONTO — Canada has revealed what it will do with a portion of the country's large H1N1 vaccine surplus, announcing Jan. 28 that it is giving 5 million doses to the World Health Organization.

Rotavirus vaccine 'could save millions of­­ lives'

by Tina Redlup on January 27, 2010

Rotavirus

Rotavirus

WASHINGTON — A vaccination campaign to combat rotavirus in the world's poorest countries could save the lives of hundreds of thousands of children, according to a pair of studies published this week.

Iowa senator wants more details about victims of epidemics

by Rita Uplend on January 27, 2010

H1n1

H1N1

An Iowa legislator said she wants state health officials to disclose more details about people who die in epidemics, in part to raise more awareness than ad campaigns can.

Irish officials warn parents about measles outbreak

by Paul Tinder on January 27, 2010

Measles

Measles

Parents in the south of Ireland have been urged to ensure their children are protected against measles following a recent outbreak of the disease, the Irish Times reported Jan. 26.

Vical to present vaccine development programs

by Ted Purlain on January 27, 2010

Phacilitate-2010

Vical Inc. announced that it would present an overview of its DNA vaccine and adjuvant technologies and an update on its clinical-stage vaccine development programs at the Phacilitate Vaccine Forum in Washington.

Malaria vaccine 3 years off,' Gates says

by Pat Dulnier on January 27, 2010

Malaria

Malaria

Microsoft founder Bill Gates has told the BBC that a vaccine for malaria could be just three years away.

WHO addresses allegations of faking pandemic

by Tina Redlup on January 27, 2010

Who

The World Health Organization released a statement Jan. 22 addressing allegations of a conflict of interest and a fake pandemic meant to aid the pharmaceutical industry.

Novavax to present at Phacilitate's North American Vaccine Forum

by Ted Purlain on January 26, 2010

Phacilitate-2010

ROCKVILLE, Md.--Two officials from Novavax Inc. announced Jan. 25 that they will be presenting at Phacilitate's eighth annual Vaccine Forum Washington 2010.

Gastric ulcer bacteria turn immune defense inward, researchers say

by Tina Redlup on January 25, 2010

Helicobacter

Helicobacter Pylori

Despite a strong response from our immune defense, the body is unable to rid itself of the bacterium Helicobacter pylori.

WHO says 13 districts in Afghanistan critical for polio eradication

by Pat Dulnier on January 25, 2010

Who

World Health Organization

Successful anti-polio action depends on vaccinators being able to reach and immunize every child under 5 years old in 13 volatile districts in the southern provinces of Kandahar, Helmand and Farah.

South African vaccine maker boosts its continental reach

by Pat Dulnier on January 25, 2010

Biovac

South African vaccine maker Biovac Institute, in partnership with major pharmaceutical firms, is on track to boost annual capacity sevenfold to 35 million doses by 2013, its deputy chief executive said.

Venezuela to U.S.: Send Haiti vaccine, not troops

by Tina Redlup on January 25, 2010

Haiti_flag

Venezuelan President Hugo Chavez has called on Washington to send medication to the quake-stricken Haiti rather than troops.

U.N., WHO assess Haiti’s health risks, needs after earthquake

by Daniel Purt on January 23, 2010

Who

World Health Organization

United Nations officials have stressed the need for a strongly coordinated effort to bring vital assistance to the roughly 3 million people affected by last week’s earthquake in Haiti.

Saudi Arabian university gives $300,000 grant toward breast cancer vaccine research

by Rita Uplend on January 23, 2010

Rittenhouse-olsen

Kate Rittenhouse-Olson

BUFFALO, N.Y. — A University at Buffalo cancer researcher has received a $300,000 grant from King Saud University to continue her work with a Saudi researcher on a vaccine for breast cancer, the schools announced Jan. 21.

Post-licensure data confirm benefits of rotavirus vaccine, study shows

by Paul Tinder on January 22, 2010

Rotavirus

Rotavirus

A complete three-dose series of pentavalent rotavirus vaccine was 85 percent to 89 percent effective against rotavirus gastroenteritis severe enough to cause emergency room visits or hospital admission in children aged 15 days through 23 months.

Nigerian officials say H1N1 flu vaccine ‘not available’

by Ted Purlain on January 22, 2010

H1n1

H1N1

Two weeks after A/H1N1 killed a 38-year-old woman and eight others subsequently tested positive, Lagos state government disclosed that Nigeria currently "has no vaccine to treat the flu virus in stock," AllAfrica.com reported Jan. 20

Novartis flu adjuvant boosts wide protection, FDA study says

by Tina Redlup on January 22, 2010

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — A vaccine additive made by Novartis and used in its European influenza shots can boost the body's immune response to a wide range of viruses, U.S. researchers reported Jan. 20 according to Reuters.

Australia’s rate of childhood vaccinations at 7-year low

by Rita Uplend on January 21, 2010

Vaccine

SYDNEY — Australians face the risk of catching diseases not seen in wide circulation for decades as childhood vaccination rates slip into serious decline, AAP reported Jan. 21.

London nurses' H1N1 vaccinations 'at 33 percent,' NHS says

by Pat Dulnier on January 21, 2010

Flu_vaccine

H1N1 Flu Vaccine

LONDON — Just one in three nurses in London has been vaccinated against the H1N1 flu, the National Health Service has admitted.

Australians find antigens that could lead to malaria vaccine

by Paul Tinder on January 21, 2010

Malaria

Malaria

SYDNEY — Researchers in Australia say a group of proteins produced in the human immune system when it is infected with malaria could help lead to the creation of a malaria vaccine, Voice of America reported Jan. 20.

Most H1N1 vaccine reactions are sore arms, FDA says

by Rita Uplend on January 21, 2010

Cdc

WASHINGTON — Most of the adverse effects to the H1N1 flu vaccine are "non-serious," according to the commissioner of the U.S. Food and Drug Administration, UPI reported Jan. 20.

Heisman winner urges Ohioans to get vaccines

by Tina Redlup on January 21, 2010

Archie_griffin

Archie Griffin

COLUMBUS, Ohio — The Ohio Department of Health partnered with Archie Griffin, a two-time Heisman Trophy winner and Ohio State University alumnus, to encourage Ohioans to tackle H1N1 by getting a flu vaccine.

FDA advisory committee to discuss 2010-11 flu vaccine

by Rita Uplend on January 20, 2010

Fda-logo

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet Feb. 22 to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccine for the 2010-11 season.

New measles outbreak in Zimbabwe

by Ted Purlain on January 20, 2010

Measles

Measles

BIKITA, Zimbabwe — Ten infants have died of measles in the past five days, health authorities here told Radio VOP on Jan. 20.

Gorillas carry malignant malaria parasite, study reports

by Tina Redlup on January 20, 2010

Malaria

Malaria

The parasite that causes malignant malaria in humans has been detected in gorillas, according to a study co-authored by biologist Francisco Ayala of the University of California, Irvine.

GlaxoSmithKline's flu vaccine Arepanrix approved In Japan

by Pat Dulnier on January 20, 2010

Arepanrixh1n1

Arepanrix H1N1

TOKYO — GlaxoSmithKline PLC's Japanese unit said Jan. 20 that it has received approval from the Japanese government for its influenza vaccine Arepanrix H1N1.

Generex’s vaccine technology platform described at PepTalk 2010

by Daniel Purt on January 20, 2010

Hofe-eric-von_

Dr. Eric von Hofe

WORCESTER, Mass. — Generex Biotechnology Corp. announced Jan. 19 the presentation of the immuno-therapeutics vaccine technology platform and product pipeline of its wholly owned subsidiary, Antigen Express Inc.

India's Ranbaxy acquires Bangalore vaccine company

by Pat Dulnier on January 19, 2010

Ranbaxy-laboratories

Ranbaxy Laboratories

MUMBAI, India — Indian drugmaker Ranbaxy Laboratories on Jan. 19 signed an agreement to acquire product rights and manufacturing facility of Bangalore-based Biovel Lifesciences Pvt. Ltd., for an undisclosed sum, Reuters reported.

A case of novel H3N2 flu virus reported in Iowa, CDC says

by Paul Tinder on January 19, 2010

H3n2

H3N2

One case of human infection with a novel influenza A virus was reported by the Iowa Department of Public Health, according to FluView, a report from the Centers for Disease Control and Prevention for the week ending Jan. 9.

GSK offers to share data to help fight malaria fight

by Rita Uplend on January 19, 2010

Malaria

Malaria

LONDON — The chief executive of the world's second biggest pharmaceutical company will announce Jan. 20 that he is putting into the public domain thousands of potential drugs that might cure malaria, The Guardian reported.

Swiss warn on flu vaccine with autoimmune disease

by Ted Purlain on January 19, 2010

Flu_vaccine

ZURICH — Switzerland's medical regulator recommended that patients with serious autoimmune diseases should not use an H1N1 flu vaccine from Novartis, saying there were no studies assessing the inoculation in that segment of the population.

Cervical cancer vaccine will cut cases by two thirds, experts calculate

by Tina Redlup on January 19, 2010

Hpv

HPV

The number of women under 30 diagnosed with cervical cancer will fall nearly two thirds by 2025 thanks to the vaccine against human papillomavirus, researchers say.

Thousands of high-risk kids missing 2nd H1N1 flu doses, USA Today finds

by Pat Dulnier on January 18, 2010

Flu_vaccine

Hundreds of thousands of children are overdue for a second dose of H1N1 vaccine that's needed to fully protect them from swine flu, a USA Today review of data from 10 states shows.

Immune response better with skin scratch vaccination, study says

by Paul Tinder on January 18, 2010

Smallpox-virus-ns

Smallpox

Giving a vaccine through a scratch on the skin triggers a stronger immune response than injected vaccines and requires 100 times less vaccine to prompt an immune response, HealthDay News reported Jan. 17.

First steps taken toward development of a malaria transmission-blocking vaccine

by Rita Uplend on January 18, 2010

Malaria

Malaria

BETHESDA, Md. — The PATH Malaria Vaccine Initiative announced a new collaboration Jan. 15 to initiate development toward a vaccine that may eventually help eliminate and eradicate malaria.

1 in 5 Americans got swine flu vaccine, CDC reports

by Tina Redlup on January 18, 2010

Cdc

ATLANTA — About one in five Americans has been vaccinated against H1N1 flu, according to the government's first detailed estimates of vaccination rates against the pandemic, the Washington Post reported Jan. 16.

GlaxoSmithKline’s quarterly sales of H1N1 vaccine lower than forecast

by Ted Purlain on January 18, 2010

Who

World Health Organization

LONDON — GlaxoSmithKline confirmed Jan. 15 that approximately 130 million doses of its pandemic H1N1 adjuvanted vaccine were shipped to governments in the fourth quarter of 2009.

Enjoy a safe and healthy Lunar New Year

by Rita Uplend on January 15, 2010

Tiger

Many travelers are expected to visit Asia in the upcoming weeks to celebrate the beginning of the Year of the Tiger when it begins Feb. 14.

Dynavax Technologies names 2 senior executives

by Paul Tinder on January 15, 2010

Hepb

Hepatitis B

Dynavax Technologies Corp. announced Jan. 12 the addition of two new senior executives to direct key commercial and clinical activities prior to the launch of Heplisav, an investigational adult hepatitis B vaccine.

Foundation reaches milestone in rotavirus vaccine trial

by Pat Dulnier on January 15, 2010

Rotavirus

Rotavirus

Rotavirus is responsible for the deaths of more than 1,500 infants and children daily, mainly in developing countries. The International Medica Foundation is sponsoring a Phase II clinical trial of its oral rotavirus vaccine, RotaShield.

Merck submits Gardasil data for women 27 to 45

by Ted Purlain on January 15, 2010

Fda-logo

NEW YORK — Merck & Co on Jan. 13 said it had provided U.S. regulators with new information needed for approval to market its Gardasil cervical cancer vaccine to women between the ages of 27 to 45, Reuters reported.

Poland refuses H1N1 flu vaccines

by Tina Redlup on January 15, 2010

Who

World Health Organization

WARSAW, Poland — The government here refused to import H1N1 flu vaccines amid worldwide warnings of a spreading epidemic.

Who's afraid of the HPV vaccine?

by Rita Uplend on January 14, 2010

Cdc

A new study may explain the intense disagreement about proposals to vaccinate elementary-school girls against human papillomavirus, ScienceDaily reported Jan. 14.

Inhibitex says recruitment begins for staph vaccine study

by Pat Dulnier on January 14, 2010

Staph_aureus

Staphylococcus Aureus

Pfizer Inc. has initiated patient recruitment for 408-patient, randomized, double-blind Phase I clinical trial to evaluate three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine in healthy adults.

Zadaxin when used with Novartis vaccine raises immunity, SciClone says

by Paul Tinder on January 14, 2010

Flu_vaccine

BANGALORE, India — SciClone Pharmaceuticals Inc. said its adjuvant, Zadaxin, in combination with Novartis' H1N1 vaccine increased immune response, Reuters reported Jan. 12.

Most young adults in new sexual relationships infected with HPV, study finds

by Rita Uplend on January 14, 2010

Hpv

HPV

A new study of new couples found that 56 percent of young adults in a new sexual relationship were infected with human papillomavirus, ScienceDaily reported Jan. 14.

Singer shows how 'quick and easy' H1N1 vaccination can be

by Tina Redlup on January 14, 2010

Derulo

Jason Derülo

“Whatcha Say” singer Jason Derülo had a stellar 2009 — a No. 1 Billboard Hot 100 single, an opening spot on Lady Gaga's Monster Ball Tour — and he knows that if he wants to step it up in 2010, he's going to have to stay healthy.

VaxInnate licenses H1N1 flu vaccine to India’s Biological E. Ltd.

by Rita Uplend on January 14, 2010

H1n1

H1N1

VaxInnate Corp. has granted Indian biopharmaceutical company Biological E. Ltd. a license to its recombinant H1N1 flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

Phase II study starts for intranasal, seasonal influenza vaccine deltaFLU

by Tina Redlup on January 14, 2010

H1n1

HiN1

VIENNA — AVIR Green Hills Biotechnology, based in Austria, announced Jan. 13 that it is embarking on the first clinical phase II study for the seasonal vaccine deltaFLU

Sinovac obtains 5th H1N1 vaccine order from Chinese government

by Paul Tinder on January 14, 2010

China-flag

BEIJING — Sinovac Biotech Ltd. announced Jan. 13 that it has received its fifth purchase order for its H1N1 vaccine, Panflu.1, from China's Ministry of Industry and Information Technology for the national purchase plan.

Novavax reports positive results for respiratory syncytial virus vaccine candidate

by Pat Dulnier on January 14, 2010

Rsv

RSV

ROCKVILLE, Md. — Novavax Inc. announced Jan. 12 that it has completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats.

Hospital workers fired after refusing flu vaccine

by Tina Redlup on January 14, 2010

Flu_vaccine

CHARLESTON, W.Va. — Charleston Area Medical Center plans to terminate two employees for refusing to take a seasonal flu vaccine, the Charleston Daily Mail reported Jan. 13.

Sanofi’s vaccine for mosquito virus protects adults, study shows

by Rita Uplend on January 13, 2010

Dengue-mosquito

Dengue Virus

Sanofi-Aventis’ experimental vaccine against dengue protected healthy volunteers against all four strains, bringing the drugmaker closer to providing the first vaccine against a disease that threatens 40 percent of the world’s population.

Emergent BioSolutions says CFO to join board of MdBio Foundation

by Paul Tinder on January 13, 2010

Elsey_don

R. Don Elsey

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced Jan. 11 that its chief financial officer and senior vice president of finance and administration has joined the board of directors of the MdBio Foundation.

Sanofi says there are no changes in its H1N1 U.S. contracts

by Rita Uplend on January 13, 2010

H1n1

H1N1

LONDON — Sanofi-Aventis is meeting all its U.S. contracts for sales of H1N1 flu vaccine, despite Washington's decision to cut supplies from rival drugmaker CSL, a company spokesman told Reuters on Jan. 11.

Glaxo reduces Germany’s H1N1 vaccine shipment by $193 million

by Tina Redlup on January 13, 2010

Flu_vaccine

LONDON — GlaxoSmithKline Plc agreed to reduce Germany’s order of Pandemrix H1N1 flu vaccine by $193 million on Jan. 12 after health officials decided they need fewer doses, the country’s Health Ministry said.

Vaccine drive set as yellow fever strikes in Guinea

by Ted Purlain on January 12, 2010

Yellow_fever

Yellow Fever

DAKAR, Senegal — Guinean health officials plan this month to vaccinate more than 250,000 people in the northeast against yellow fever after one confirmed and several suspected cases emerged in the region.

WHO to review its handling of H1N1 flu pandemic

by Paul Tinder on January 12, 2010

Who

World Health Organization

GENEVA — The World Health Organization is to examine its handling of the H1N1 pandemic, the group said Jan. 12, after accusations by some politicians that it exaggerated the dangers of the virus under pressure from drug companies.

Academy recommends steps to tackle hepatitis B and C

by Pat Dulnier on January 12, 2010

Hepb

Hepatitis B

WASHINGTON — Stepped-up vaccination requirements, a boost in resources for prevention and treatment, and a public awareness campaign are needed to curb the health threats posed by hepatitis B and hepatitis C.

U.S. officials wary of another wave of H1N1 flu

by Ted Purlain on January 12, 2010

H1n1

H1N1

Citing mistakes made in the 1957 flu pandemic, federal officials on Jan. 7 urged hesitant Americans to get vaccinated now against H1N1 flu to prevent any possibility of another wave of illness and deaths.

President, HHS announces national influenza vaccination week

by Tina Redlup on January 12, 2010

Cdc

President Barack Obama, the U.S. Department of Health and Human Services and its Centers for Disease Control and Prevention announced a nationwide effort to encourage H1N1 flu vaccination during National Influenza Vaccination Week from Jan. 10–16.

Hawaii Biotech completes dosing of Phase 1 trial for dengue virus vaccine

by Daniel Purt on January 9, 2010

Dengue-mosquito

Dengue Transmission

HONOLULU — Hawaii Biotech Inc. announced Jan. 7 that it has completed recruitment and dosing in a multiple dose Phase 1 clinical study of its dengue virus monovalent vaccine.

Cambodia records more cases of malaria and dengue fever in 2009

by Tina Redlup on January 9, 2010

Malaria_mosquito

Malaria

PHNOM PENH, Cambodia — Cambodia has seen a rise in reported cases of dengue fever and malaria in 2009, local media reported Jan. 5, citing health officials here.

Researchers say vaccine might 'mop up' leukemia cells Gleevec leaves behind

by Rita Uplend on January 9, 2010

Nih

Preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Imatinib mesylate (Gleevec).

France cancels H1N1 flu vaccines ordered from Novartis

by Daniel Purt on January 9, 2010

Flu_vaccine

Flu Vaccine

Swiss pharmaceutical company Novartis AG announced Jan. 8 that France canceled 7 million of the 16 million ordered doses of H1N1 pandemic flu vaccine.

SII, Zydus Cadila get approval for H1N1 vaccine trials

by Pat Dulnier on January 9, 2010

H1n1

H1N1

NEW DELHI — Pune-based Serum Institute of India, the largest vaccine maker in the country, has received approval from India’s drugs controller to conduct clinical trials of its H1N1 vaccine, the company announced Jan. 6.

FDA grants orphan drug status for personalized lymphoma vaccine

by Rita Uplend on January 8, 2010

Fda-logo

TAMPA, Fla. — Biovest International Inc. announced Jan. 7 that the U.S. Food and Drug Administration has granted orphan drug designation to BiovaxID, Biovest’s personalized lymphoma vaccine.

SFBR receives contract to test vaccines for Ebola, Marburg viruses

by Paul Tinder on January 8, 2010

Marburg

Marburg

SAN ANTONIO — The Southwest Foundation for Biomedical Research announced Jan. 6 that it has received a contract from the Dutch pharmaceutical firm Crucell to test a vaccine against Ebola and Marburg viruses, which cause hemorrhagic fevers.

Canada to bridge Mexico’s H1N1 flu vaccine requirements

by Pat Dulnier on January 8, 2010

H1n1

H1N1

OTTAWA — Canada’s health minister has announced the country will provide 5 million doses of H1N1 flu vaccine to Mexico to help bridge that country’s immediate pandemic vaccine requirements.

Flu vaccine’s effects reduced in arthritis patients treated with rituximab

by Tina Redlup on January 8, 2010

Flu_vaccine

Flu Vaccine

Flu shots do not protect arthritis patients who are being treated with the intravenous drug rituximab, according to a new study by Dutch researchers, The New York Times and Los Angeles Times reported Jan. 7.

No U.S. decision on H1N1 vaccine orders, CDC director says

by Daniel Purt on January 8, 2010

Cdc

WASHINGTON — The United States has not made a decision on whether to cancel or sell any of its orders for the H1N1 vaccine, unlike some countries in Europe, a federal health official said Jan. 7.

Countries reassess orders for H1N1 vaccine, need for donations

by Rita Uplend on January 7, 2010

Who

As the number of H1N1 flu cases in some regions of the world continues to fall, developing countries scheduled to receive donated H1N1 vaccines from the World Health Organization are reassessing just how many vaccines their countries need.

CDC addresses safety of thimerosal in vaccines against H1N1 flu

by Tina Redlup on January 7, 2010

H1n1

H1N1

The Centers for Disease Control and Prevention posted this “fact sheet” about thimerosal in H1N1 vaccines on its Web site Jan. 4.

Gaps in U.S. children's vaccine coverage shrinking

by on January 7, 2010

Cdc

More American children are fully immunized against common childhood illnesses, and disparities in vaccine coverage among socioeconomic groups are shrinking, according to a new study from the Centers for Disease Control and Prevention.

Cepheid receives FDA emergency use authorization for its flu panel test

by Pat Dulnier on January 7, 2010

Fda-logo

SUNNYVALE, Calif. — Cepheid announced Jan. 4 that it has been granted emergency use authorization from the U.S. Food and Drug Administration for its Xpert Flu A Panel test.

GeoVax Labs appoints vice president for research, development

by Paul Tinder on January 7, 2010

Hiv

HIV

ATLANTA — GeoVax Labs, a biopharmaceutical company that develops vaccines for diseases caused by HIV and other infectious agents, announced the appointment of a vice president of research and development.

CDC adds HPV to adult immunization schedule

by Rita Uplend on January 5, 2010

Cdc

The CDC's adult immunization guidelines includes a new recommendation that women 19 to 26 be immunized with either the quadrivalent human papillomavirus (HPV) vaccine or the recently approved bivalent HPV vaccine to reduce their risk of cervical cancer.

Insect cells provide the key to alternative H1N1 flu vaccination

by Daniel Purt on January 5, 2010

H1n1

H1N1

Scientists in Vienna have developed a new technique for producing vaccines for H1N1 based on insect cells, according to a report by ScienceDaily on Jan. 4.

3 H1N1 vaccine studies confirm safety, weigh dosing

by Pat Dulnier on January 5, 2010

Who

World Health Organization

Large trials in the United States, Hungary and China recently confirmed the safety and efficacy of H1N1 vaccines, yielding new insights on how to best use vaccines in a pandemic setting, CIDRAP News reported Jan. 4.

Refusing chickenpox vaccine associated with increased risk of disease, report finds

by Rita Uplend on January 5, 2010

Chickenpox

Chicken Pox

Children whose parents refuse the varicella (chickenpox) vaccine appear more likely to develop the disease, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

H1N1 response shows need for better medical emergency plans

by Daniel Purt on January 5, 2010

Bob-graham-jim-talent

Bob Graham and Jim Talent

This commentary was written by Bob Graham and Jim Talent ?and published in The Washington Post on Jan. 4.

Rise in mumps cases blamed on youngsters missing out on MMR jabs

by Paul Tinder on January 4, 2010

Mumps

Mumps

Cases of mumps in Scotland have increased by almost 50 per cent in the past year, figures revealed Dec. 23.

China says H1N1 flu spreading into the countryside

by Pat Dulnier on January 4, 2010

China-flag

BEIJING — The H1N1 strain of flu is rapidly spreading into China's vast countryside and there could be a spike in cases around the Lunar New Year period when millions head back to their home towns.

Health care provider groups encourage Americans to get the H1N1 vaccine

by Rita Uplend on January 4, 2010

H1n1

H1N1

More than 30 health care provider groups sent an open letter Dec. 30 to the American people emphasizing that the H1N1 vaccine is safe, effective and the best way to protect against the flu.

Leukemia vaccine being developed

by Ted Purlain on January 4, 2010

Leukemia

Leukemia

LONDON — A vaccine for leukemia is about to be tested on human patients for the first time, in a breakthrough that could offer hope to thousands of people, the Telegraph reported Jan. 4.

Another study finds no link between vaccine, autism

by Tina Redlup on January 4, 2010

Vaccine

NEW YORK — A new study provides further evidence that the measles-mumps-rubella vaccine is not associated with an increased risk of autism, Reuters Health reported Jan. 4.

CDC Flu Wrap

by Tina Redlup on January 2, 2010

Cdc

The Center for Disease Control has reported only four cases of flu-related pediatric mortality across seven states during the week ending January 2.

Sharks killed for oil used in H1N1 flu vaccine

by Tina Redlup on January 1, 2010

Squalene

Squalene

Vaccines being made to protect people from H1N1 flu may not be so healthy for threatened species of sharks, National Geographic News reported Dec. 29.

Trudeau Institute to receive $1.6 million more for vaccine program

by Paul Tinder on December 31, 2009

Flu_vaccine

Influenza Vaccine

SARANAC LAKE, N.Y. — The Trudeau Institute will receive an additional $1.6 million for its work with the U.S. Navy to research the impact and efficacy of combining influenza vaccinations with antiviral drugs.

Pfizer updates FDA on Prevnar 13 vaccine

by Rita Uplend on December 31, 2009

Who

World Health Organization

NEW YORK — Pfizer Inc. announced Dec. 30 that the U.S. Food and Drug Administration has not yet completed its review of the biologics license application for Prevnar 13, its candidate pneumococcal conjugate vaccine.

MTV’s Alexa Chung spreads the word about H1N1

by Rita Uplend on December 31, 2009

Mtv_logo

MTV is making sure the general public is up to date on the basics of the H1N1 virus.

Short-term school closings doesn’t block flu outbreaks, researchers say

by Ted Purlain on December 31, 2009

Cdc

Short-term school closings are not an effective way to block the spread of influenza viruses, and may even be counterproductive, Pennsylvania researchers have found.

Swedish research might point to stomach cancer vaccine

by Tina Redlup on December 31, 2009

Stomach-cancer

Stomach Cancer

GOTHENBURG, Sweden — New research at Sahlgrenska Academy might be an important step toward creating a vaccine against ulcers and stomach cancer, The Local reported Dec. 30.

Extremely drug-resistant TB found in U.S.; weaker form spreads globally

by Rita Uplend on December 29, 2009

Tuberculosis

TB

Public health officials are concerned about the implications of the first U.S. case of extremely drug-resistant tuberculosis, diagnosed in a 19-year-old Peruvian who is visiting here to study English, Homeland Security Today reported Dec. 29.

It may take a year to conquer H1N1 flu pandemic, WHO official says

by Paul Tinder on December 29, 2009

Who

World Health Organization

GENEVA — The H1N1 flu pandemic may not be conquered until 2011 and continued vigilance is required against the virus, which can still mutate, the head of the World Health Organization said Dec. 29.

Sinovac seeks to conduct trial for vaccine against hand, foot, and mouth disease

by Pat Dulnier on December 29, 2009

Foot-mouth

HFMD

BEIJING — Sinovac Biotech Ltd. announced Dec. 28 that it has applied to China's State Food and Drug Administration to begin a human clinical trial for its vaccine against the virus that causes hand, foot, and mouth disease (HFMD).

TB figures continue to increase in the United Kingdom

by Ted Purlain on December 29, 2009

Tuberculosis

TB

The number of people developing tuberculosis continues to increase despite earlier signs of stabilizing, according to a report released Dec. 2 by the United Kingdom’s Health Protection Agency.

Free Mexican holidays offered to diarrhea vaccine guinea pigs

by Daniel Purt on December 29, 2009

Patch-vaccine

Needle-free Vaccine

Intercell is offering free flights and hotel accommodation to 900 volunteers being recruited in the UK and Germany who are prepared to test a remedy for travelers’ diarrhea.

Distributor BDI Pharma launches online ordering site for vaccines

by Pat Dulnier on December 29, 2009

Vaccine

BDI Pharma Inc., a national distributor of biotech therapies, unveiled an online supply solution for health care workers to acquire a wide variety of vaccines.

Vical reports benefits of DNA technology platform with vaccine for H1N1 flu

by Paul Tinder on December 29, 2009

Dna

DNA

SAN DIEGO — Vical Inc. announced the publication of data documenting the successful pilot lot production and initiation of animal immunogenicity testing of a Vaxfectin-adjuvanted DNA vaccine for H1N1 influenza.

H1N1 reveals gaps in nation’s emergency health preparedness efforts, report says

by Rita Uplend on December 29, 2009

H1n1

H1N1

WASHINGTON — The H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health.

Measles kill 22 in Zimbabwe

by Ted Purlain on December 29, 2009

Measles

Measles

Measles primarily affects children younger than 5 and can lead to blindness, inflammation of the middle ear, brain damage and death.

WHO chief yet to be vaccinated against H1N1

by Tina Redlup on December 29, 2009

Who

World Health Organization

GENEVA — World Health Organization chief Margaret Chan revealed that she has yet to be vaccinated against the H1N1 flu virus, which has killed more than 11,500 people worldwide.

CDC Flu Wrap

by Pat Dulnier on December 26, 2009

Cdc

The Center for Disease Control has reported only four cases of flu-related pediatric mortality across seven states during the week ending December 26.

Genocea Biosciences awarded grant to develop of Chlamydia vaccine

by Pat Dulnier on December 26, 2009

Chlamydia-trachomatis

Chlamydia Trachomatis

Cambridge, Mass. – Genocea Biosciences has been awarded a grant from the University of Pittsburgh Medical Center’s Sexually Transmitted Infections Cooperative Research Center for the development of vaccines for Chlamydia trachomatis.

Canadian officials discuss fate of surplus H1N1 vaccine doses

by Ted Purlain on December 26, 2009

Who

World Health Organization

TORONTO — Canada is in discussions with pandemic vaccine maker GlaxoSmithKline and with the World Health Organization about what to do with the country's expected surplus of H1N1 vaccine, the head of the Public Health Agency of Canada said Dec. 9.

England made progress against tuberculosis, but more needs done, report says

by Tina Redlup on December 26, 2009

Tuberculosis

TB

National Health Service efforts to tackle tuberculosis in England are improving, but worryingly nearly 18 percent TB hot spot areas, and 60 percent of all areas, still don't have a strategy in place to tackle the disease.

Immunovaccine to proceed with trial for its cancer vaccine

by Paul Tinder on December 26, 2009

Fda-logo

HALIFAX, NOVA SCOTIA — Immunovaccine Inc. announced Dec. 9 that its Investigational New Drug (IND) application for its therapeutic cancer vaccine, DPX-0907, has been cleared by the U.S. Food and Drug Administration.

India’s health ministry to initiate impact study on pneumococcal conjugate vaccine

by Daniel Purt on December 26, 2009

Strep-pneumoniae

Streptococcus Pneumoniae

Along with rolling out the (five-in-one vaccine to check pneumonia as planned, the union health ministry will launch an impact study in one high-mortality state before deciding on introducing pneumococcal conjugate vaccine as part of the India’s national

Research reveals further progress toward AIDS vaccine

by Pat Dulnier on December 24, 2009

Hiv

HIV

PHILADELPHIA — Researchers from Thomas Jefferson University are one step closer to developing a vaccine against AIDS, the school announced Dec. 14.

As H1N1 flu wanes, so does public's fear?, CDC director says

by Paul Tinder on December 24, 2009

H1n1

H1N1

The good news on the H1N1 swine flu front is that the number of cases of infection continues to decrease and the vaccine supply is now plentiful, HealthDay News reported.

Obamas receive H1N1 vaccinations at White House

by Rita Uplend on December 24, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON — The White House confirms that President Obama and First Lady Michelle Obama have each received the H1N1 shot.

Flu pandemic may change U.S. flu approach forever, officials say

by Ted Purlain on December 24, 2009

Cdc

WASHINGTON — The swine flu pandemic may have changed the U.S. approach to handling influenza forever, and for the better, U.S. officials said Dec. 17 according to Reuters.

FDA approves a high dose flu influenza vaccine intended for seniors

by Tina Redlup on December 24, 2009

Fda-logo

SILVER SPRING, Md. — The U.S. Food and Drug Administration approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

Vical, University of Washington receive patent for herpes simplex DNA vaccine

by Daniel Purt on December 23, 2009

Vical

SAN DIEGO -- Vical Inc. announced Dec. 22 that it and the University of Washington received U.S. Patent No. 7,628,993 covering DNA vaccines for herpes simplex virus type 2 (HSV-2).

Sinovac named among China's top 10 most competitive companies

by Daniel Purt on December 23, 2009

Sinovac

Sinovac Biotech Ltd. was recently selected by China Business Media as one of China's Top 10 most competitive companies listed overseas for 2009.

WHO prequalifies 3 Novartis H1N1 flu vaccines for use in developing world

by Pat Dulnier on December 23, 2009

Who

Basel, Switzerland -- Novartis announced Dec. 21 that the World Health Organization has granted prequalification for all three of its influenza A (H1N1) 2009 monovalent vaccines for supply to United Nations agencies.

Most parents who tried were able to get H1N1 shots for children, poll finds

by Paul Tinder on December 23, 2009

Cdc

Boston -- A new poll by researchers at the Harvard School of Public Health shows the shortage of H1N1 vaccine for children is easing, according to a press release dated Dec. 22.

Nasal swine flu vaccine recalled over potency

by Tina Redlup on December 23, 2009

Fda-logo

WASHINGTON -- Drugmaker MedImmune is recalling nearly 5 million doses of H1N1 flu vaccine because the nasal spray appears to lose strength over time, federal health officials announced Dec. 22.

Dengue fever outbreak recorded in Australia

by Rita Uplend on December 22, 2009

Who

Australian health authorities are fighting dengue fever on two fronts and are fearful that hot summer weather will intensify the chances of more outbreaks, The Courier-Mail reported Dec. 18.

NIH awards institute $18.8 million for major infectious disease study

by Daniel Purt on December 22, 2009

Nih

SAN DIEGO — Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases — tuberculosis, malaria and dengue virus.

New nasal vaccine blocks parasite transmission to mosquitoes

by Pat Dulnier on December 22, 2009

Malaria

Malaria

An experimental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria, ScienceDaily reported Dec. 20.

Swiss plan to donate, sell on swine flu vaccines

by Paul Tinder on December 22, 2009

H1n1

H1N1

ZURICH — Switzerland plans to donate or sell approximately 4.5 million excess doses of the H1N1 flu vaccine because of the low uptake of shots, the government said, according to a Reuters report Dec. 18.

Medicago reports positive trial results for its avian flu pandemic vaccine

by Tina Redlup on December 22, 2009

H5n1

H5N1

QUEBEC CITY — Medicago Inc., a biotechnology company focused on developing vaccines based on proprietary manufacturing technologies and virus-like particles.

Sanofi-aventis to acquire Chattem, broaden consumer health care bas

by Paul Tinder on December 22, 2009

Sanofi-aventis_logo

Sanofi-aventis

Sanofi-aventis and Chattem Inc. announced Dec. 21 that they have entered into an agreement under which sanofi-aventis is to acquire 100 percent of the outstanding shares of Chattem in a cash tender offer for approximately $1.9 billion.

Mumps outbreak hits N.Y. Jewish community

by Pat Dulnier on December 22, 2009

Mumps

Mumps

NEW YORK — The largest U.S. outbreak of mumps is sweeping New York, WPIX-TV reported Dec. 20.

States with widespread pandemic flu drop to 11

by Rita Uplend on December 22, 2009

H1n1

H1N1

The second wave of the H1N1 influenza pandemic continued to fade last week, as the number of states with widespread cases dropped to 11 and reported deaths in children also declined.

Study suggests 1 H1N1 shot may protect kids; CDC disagrees

by Tina Redlup on December 22, 2009

Cdc

Can young children get by with just one dose of the H1N1 swine flu vaccine?

Former CDC director named president of Merck Vaccines

by Ted Purlain on December 22, 2009

Gerberding-julie

Dr. Julie Gerberding

WHITEHOUSE STATION, N.J. — Merck & Co. Inc. announced that a former director of the Centers for Disease Control and Prevention has been named president of Merck Vaccines, effective Jan.

CDC Flu Wrap

by Rita Uplend on December 19, 2009

Cdc

The Center for Disease Control has reported only nine cases of flu-related pediatric mortality across seven states during the week ending December 19.

H1N1 deaths worldwide top 10,000, WHO says

by Ted Purlain on December 18, 2009

Who

World Health Organization

There have been more than 10,000 swine flu deaths worldwide since April, the World Health Organization said Dec. 18.

EU agency recommends Novartis meningitis vaccine

by Tina Redlup on December 18, 2009

Fda-logo

ZURICH — Europe's drugs watchdog has recommended approving a meningitis vaccine made by Switzerland's Novartis, according to Reuters.

Scientists spot source of hurdle to AIDS vaccine

by Pat Dulnier on December 18, 2009

Hiv

HIV

Researchers have identified the cause of a major hurdle in efforts to develop an AIDS vaccine, according to a report Dec. 18 in HealthDay News.

Vaccine availability opens up as doses approach 100 million

by Pat Dulnier on December 18, 2009

Sebelius_kathleen

Kathleen Sebelius

The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it.

3 Asian countries top list to get donated H1N1 vaccine

by Daniel Purt on December 18, 2009

Who

World Health Organization

Afghanistan, Azerbaijan, and Mongolia will be the first three countries to receive donated supplies of pandemic H1N1 vaccine funneled through the World Health Organization.

Germany, Spain seek to cut H1N1 vaccine orders

by Pat Dulnier on December 17, 2009

Who

World Health Organization

LONDON — Germany and Spain want to reduce deliveries of swine flu vaccine and potentially return excess supplies to manufacturers, because of low demand for the shots.

Women shy away from HIV vaccine trials, researchers say

by Paul Tinder on December 17, 2009

Hiv

HIV

Kampala, Uganda — Fewer women compared to men are willing to participate in trials for a potential HIV/Aids vaccine, researchers revealed Dec. 15.

MMR vaccinations in Wales 'highest in 12 years'

by Rita Uplend on December 17, 2009

Mmr

MMR Vaccine

The uptake of the MMR vaccine in Wales has reached its highest level in 12 years but health officials warn that the target rate has still not been reached, BBC News reported Dec. 17.

Study shows adjuvant boosts response to H1N1 vaccine

by Ted Purlain on December 17, 2009

Mf59

MF59

Novartis's pandemic H1N1 flu vaccine generated stronger immune responses when it was combined with an adjuvant than when used alone, though both formulations yielded good results, according to a report published by the New England Journal of Medicine.

Sanofi aims to double vaccine sales by 2013

by Tina Redlup on December 17, 2009

H1n1

H1N1

PARIS — French drugmaker Sanofi-Aventis SA aims to double sales at its Sanofi Pasteur vaccines business by 2013, compared to the 2008 level, and reiterated it could make acquisitions in this fast-growing area.

Researchers work on vaccine to improve immune system in newborns

by Ted Purlain on December 17, 2009

Newborn

As soon as babies are born, they are susceptible to diseases and infections, such as jaundice and E. coli. For up to a month, their immune systems aren't adequately developed to fight diseases.

Pneumonia shots not going to all who need them, authorities say

by Tina Redlup on December 17, 2009

Flu_vaccine

Pneumococcal vaccine

While a nationwide push for vaccination against H1N1 and seasonal flu has led to long lines for shots, another vaccine against a common and deadly flu complication — pneumonia — hasn't gotten nearly as much attention.

2 sign deal to develop, license MRSA vaccine worldwide

by Rita Uplend on December 17, 2009

Mrsa

MRSA

ST. PAUL, Minn. — Syntiron announced Dec. 16 that it has granted Sanofi Pasteur an exclusive worldwide license to its human vaccine against Staphylococcus aureus.

Study of vaccine against Clostridium difficile expands into the U.S.

by Pat Dulnier on December 17, 2009

C-difficile

C. Difficile

Lyon, France and Swiftwater, Pa. — Sanofi Pasteur announced Dec. 15 that it is expanding its phase II clinical study of a vaccine against Clostridium difficile infection into the United States.

800,000 doses of pediatric H1N1 vaccine recalled because of potency, CDC says

by Daniel Purt on December 17, 2009

Cdc

WASHINGTON — Vaccine maker Sanofi Pasteur is recalling 800,000 doses of its pediatric H1N1 swine flu vaccine because it is not as potent as it should be, U.S. officials said Dec. 15.

Afghanistan first in world to use new vaccine against polio

by Rita Uplend on December 16, 2009

Polio

Polio

KABUL — A new vaccine against polio will be used for the first time Dec. 15 in polio immunization campaigns in Afghanistan, according to the World Health Organization.

Crucell may add polio to protect vaccine sales, Reuters reports

by Paul Tinder on December 16, 2009

Who

World Health Organization

AMSTERDAM — Dutch biotech firm Crucell NV will likely look to add a sixth antigen to its portfolio of childhood vaccines as part of expected product add-ons after a stake sale to Johnson & Johnson, Reuters reported Dec. 15.

Several serious illnesses missing from U.S. vaccination plan, report says

by Pat Dulnier on December 16, 2009

Nih

National Institutes of Health

While vaccines help prevent many diseases in the United States, the nation lacks immunization protection against several serious illnesses, according a new report from the Institute of Medicine.

Fast method for preparing flu vaccine developed

by Ted Purlain on December 16, 2009

Cox-manon

Manon Cox

Someday, effective vaccines might be produced two to four times the speed of vaccines manufactured in fertilized chicken eggs, according to a researcher in the Netherlands.

Israel says it will send more H1N1 vaccine to Gaza, where 2 more die

by Daniel Purt on December 16, 2009

Who

World Health Organization

GAZA CITY, Gaza Strip — Two more people died of H1N1 flu in the Gaza Strip on Dec. 13, bringing to 10 the total number of Gazans who have been killed by the disease, according to the Hamas-run health ministry.

Experimental TB vaccine to be tested in Uganda

by Rita Uplend on December 15, 2009

Tuberculosis

TB

Health experts will in the coming weeks converge in Mayuge and Iganga districts for a clinical trial, to test the world's first experimental tuberculosis vaccine in nearly a century, allAfrica.com reported Dec. 9.

Hospitalizations, deaths higher among indigenous people, MMWR reports

by Pat Dulnier on December 15, 2009

H1n1

H1N1

Indigenous populations from Australia, Canada and New Zealand have been found to have a three to eight times higher rate of hospitalization and death associated with infection with the 2009 pandemic H1N1 influenza virus.

Stem cells can be engineered to kill HIV, scientists show

by Ted Purlain on December 15, 2009

Hiv

HIV

Researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

Vaccine to treat gum disease may be on the way, companies say

by Daniel Purt on December 15, 2009

Gumdisease

Gum Disease

A vaccine to treat severe gum disease is being developed in a new collaboration announced Dec. 10 between Sanofi Pasteur and CSL Limited.

Vaccination key to stemming rotavirus, experts say

by Tina Redlup on December 15, 2009

Who

World Health Organization

DAKAR, Senegal — Health experts in Africa are calling on governments to vaccinate children against rotavirus, to end an “unacceptable” yet preventable situation in which the virus kills some 1,400 children in developing countries daily

CDC Flu Wrap

by Tina Redlup on December 14, 2009

Cdc

The Centers for Disease Control has reported 16 flu-related deaths among children across nine states during the week ending December 5.

Oncothyreon's cancer vaccine trial starts in Asia

by on December 12, 2009

Merck

SEATTLE — Oncothyreon Inc. announced Dec. 10 that its development partner Merck KGaA started a late-stage trial of its cancer vaccine in patients in Asia with advanced non-small cell lung cancer.

GSK, Intercell enter deal to develop needle-free, patch-based vaccines

by Pat Dulnier on December 12, 2009

Patch-vaccine

Patch-based Vaccine

LONDON and VIENNA — GlaxoSmithKline Biologicals and Intercell on Dec. 11 announced an agreement to form a strategic alliance to accelerate the development and commercialization of needle-free, patch-based vaccines.

Pfizer wins Europe approval for new vaccine

by Paul Tinder on December 12, 2009

Strep-pneumoniae

Streptococcus pneumoniae

NEW YORK — The European Commission has granted Pfizer Inc. a European marketing authorization for a more protective form of its vaccine Prevnar 13, which protects against pneumonia, the company announced Dec. 11.

NIAID testing candidate DNA vaccine for 2009 H1N1 influenza

by Pat Dulnier on December 12, 2009

Niaid_logo

National Institute of Allergy and Infectious Diseases

WASHINGTON — The National Institute of Allergy and Infectious Diseases has completed enrollment in a small clinical trial testing a candidate DNA vaccine for 2009 H1N1 influenza, the agency announced Dec. 11.

China worries swine flu vaccine campaign faltering

by Tina Redlup on December 12, 2009

H1n1

H1N1

BEIJING (Reuters) - China's vaccination campaign against the H1N1 flu strain is not proceeding as fast as it should be partly because people are needlessly worried about the vaccine’s safety, officials said Dec. 11.

CDC Flu Wrap

by Tina Redlup on December 11, 2009

Cdc

Centers for Disease Control

The Centers for Disease Control has reported only nine cases of flu-related pediatric mortality across seven states during the week ending December 12. This the lowest number reported by the CDC so far this quarter.

Hepatitis E outbreak kills 12, infects 210 in Uganda, according to reports

by Rita Uplend on December 10, 2009

Hepe

Hepatitis E

KAABONG, Uganda — An outbreak of Hepatitis E has killed 12 people out of 210 infected in Uganda’s northeastern region of Karamoja, The New Vision Web site reported, citing Michael Lochiyo, the health educator of Kaabong district in the region.

Human trial for spoon-fed vaccines to begin

by Ted Purlain on December 10, 2009

Helicobacter

Helicobacter

Human trials are soon to begin on an Australian-pioneered technique that could revolutionize the way we vaccinate — by replacing the syringe with the spoon, the Australian Associated Press reported Dec. 8.

Health experts say more funds needed for TB tests, drugs, vaccines

by Tina Redlup on December 10, 2009

Tuberculosis

Tuberculosis

CANCUN, Mexico — Health experts called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year.

NIAID trial of 2009 H1N1 influenza vaccine enrolling HIV-positive adults

by Paul Tinder on December 10, 2009

Niaid_logo

National Institute of Allergy and Infectious Diseases

HIV-infected adults are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine, the National Institutes of Health announced Dec. 10.

North Korea accepts South Korea’s offer of H1N1 flu medication

by Daniel Purt on December 10, 2009

Who

World Health Organization

SEOUL, South Korea — North Korea has accepted South Korea's offer of drugs to stem an outbreak of H1N1 influenza, in what will be the first direct government aid since relations soured last year.

Sanofi Pasteur expands global dengue vaccine clinical program in Latin America

by Paul Tinder on December 10, 2009

Dengue-mosquito

Dengue Fever

MEXICO CITY — Sanofi Pasteur announced Dec. 9 that it is expanding its dengue vaccine clinical program in Latin America with a new multicenter study in children and adolescents in Mexico, Colombia, Honduras and Puerto Rico.

Dynavax gets go-ahead to produce of hepatitis B vaccine component

by Pat Dulnier on December 10, 2009

Hepb

Hepatitis B

Dynavax Technologies Corp. announced Dec. 9 that its manufacturing facility in Dusseldorf, Germany, has been approved for the commercial production of hepatitis B surface antigen.

Flu pandemics could affect blood supplies, German study says

by Daniel Purt on December 10, 2009

Blood-donate

Blood Collection

A German research team has discovered that a severe pandemic scenario could quickly lead to a deficit of up to 96,000 red blood cell (RBC) transfusion units in Germany alone, creating potentially fatal outcomes.

N.Y. autopsies show 2009 H1N1 influenza virus damages entire airway

by Ted Purlain on December 10, 2009

H1n1

H1N1

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics.

Stanford fellow argues for better vaccines for the next pandemic

by Tina Redlup on December 10, 2009

Cdc

The H1N1 swine flu has sickened at least 22 million and killed almost 4,000 in the United States since April, according to the Centers for Disease Control and Prevention.

Geron says interim data shows cancer vaccine meets goals

by Pat Dulnier on December 9, 2009

Vac1

GRNVAC1

MENLO PARK, Calif. — Geron Corp. announced Dec. 8 the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine, in patients with acute myelogenous leukemia at the 51st Annual Meeting of the American Society of

Germany considers selling extra H1N1 flu vaccine

by Rita Uplend on December 9, 2009

Hartmut_schubert

Hartmut Schubert

Six weeks after Germany began vaccinating against swine flu, only about five percent of the population has gotten the shots.

Skepticism on H1N1 flu’s danger limits European vaccine demand

by Ted Purlain on December 9, 2009

Flu_vaccine

H1N1 Vaccine

Fewer Europeans are getting pandemic flu vaccine than typically get seasonal flu shots, as safety concerns and lower-than-expected death rates have damped demand, Bloomberg reported Dec. 8.

Developing nations’ vaccine shortage may threaten security, former WHO official says

by Pat Dulnier on December 9, 2009

Who

Flu vaccine shortages in developing nations may destabilize global security should the H1N1 virus become more deadly, said David Heymann, a former deputy head of the World Health Organization.

Study confirms low mortality for H1N1 flu, but CDC director says threat isn’t over

by Daniel Purt on December 9, 2009

H1n1

h1N1

WASHINGTON — One of the most systematic looks yet at the H1N1 flu pandemic confirms that it is at worst only a little more serious than an average flu season and could well be a good deal milder, researchers said.

Web system will track outbreaks of disease

by Paul Tinder on December 7, 2009

Uae-flag

United Arab Emirates

ABU DHABI, United Arab Emirates — A new electronic system for reporting infectious diseases in the capital has been launched by the Health Authority-Abu Dhabi, The National reported Dec. 6.

NanoBio says vaccine adjuvant also effective by injection

by Paul Tinder on December 7, 2009

Fda-logo

ANN ARBOR, Mich. — NanoBio Corp. announced Dec. 7 that its recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine elevated immune responses when administered via injections.

Universal flu vaccine trial a success, BiondVax Pharmaceuticals says

by Rita Uplend on December 7, 2009

Vaccine

Universal Flu Vaccine

RECHOVOT, Israel — BiondVax Pharmaceuticals Ltd. announced the success of the Phase I/II clinical trial of its Multimeric-001 universal flu vaccine on Dec. 7.

Union takes hospital to arbitration over workers’ refusal to get vaccination

by Ted Purlain on December 7, 2009

Child-hosp-phil

Children's Hospital of Philadelphia

PHILADELPHIA — A union is taking the Children's Hospital of Philadelphia to arbitration because five people who refused to get the seasonal flu vaccine said they were fired.

Medical countermeasure development should be priority, BARDA director says

by Tina Redlup on December 7, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON — Congress, the Obama administration and taxpayers need to accept that drugmakers are not going to pursue discovery and development of emergency medical countermeasures out of the kindness of their hearts.

Shanghai calls for blood in swine-flu war

by Paul Tinder on December 5, 2009

108335-main_thumb

Donating Blood

SHANGHAI — City health authorities launched their latest drive in the fight against swine flu, calling on people who have been vaccinated against the virus to donate blood for emergency-treatment storage.

Health leaders fear minorities are avoiding H1N1 vaccine

by Paul Tinder on December 5, 2009

H1n1

H1N1

DETROIT — Whether it's mistrust of the government or confusion in the message, minorities aren't lining up to get vaccinated against H1N1 as they should.

Cervarix effective against HPV for more than 6 years, study finds

by Rita Uplend on December 5, 2009

277161177_0a810dfcd2

Human Papillomavirus

The human papillomavirus (HPV) vaccine Cervarix protects women from infection for longer than six years, new research has found, HealthDay News reported Dec. 2.

Chicken pox vaccine may also reduce risk of shingles among children

by Pat Dulnier on December 5, 2009

Large_shingles04_r

Herpes Zoster

OAKLAND, Calif. — Herpes zoster, also known as shingles, is very rare among children who have been vaccinated against chicken pox, according to a Kaiser Permanente study in the December issue of the Pediatric Infectious Diseases Journal.

European agency advises of fever risk in children following Pandemrix vaccination

by Daniel Purt on December 5, 2009

Flu_vaccine

Pandemrix Vaccine

LONDON — The European Medicines Agency warned Dec. 4 that young children might experience fever after their second dose of the pandemic influenza vaccine Pandemrix.

Maryland's first reported cases of Tamiflu-resistant H1N1 flu confirmed

by Rita Uplend on December 3, 2009

Who

world health organization

Two recently treated patients at the Johns Hopkins Hospital had drug-resistant forms of the 2009 H1N1 flu virus, according to the U.S. Centers for Disease Control and Prevention and the Maryland Department of Health and Mental Hygiene.

Americans speak out on why they got the flu vaccine in new video

by Paul Tinder on December 3, 2009

Ud-dept-hhs

U.S. Department of Health and Human Services

Americans Speak Out: Why We Got the Flu Vaccine, a video that the U.S. Department of Health and Human Services, features Americans talking about why they chose to get vaccinated against the 2009 H1N1 flu virus.

Vaccination, antivirals, social distancing may blunt H1N1's impact, study suggests

by Pat Dulnier on December 3, 2009

H1n1

H1N1

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help lessen the final impact of the virus.

Scientists reveal malaria parasites' tactics for outwitting our immune systems

by Daniel Purt on December 3, 2009

Malaria

Malaria

Malaria parasites are able to disguise themselves to avoid the host's immune system, according to research funded by the Wellcome Trust and published Dec. 1 in the journal Proceedings of the National Academy of Sciences.

Measles deaths drop by 78 percent but resurgence feared

by Tina Redlup on December 3, 2009

Measles

Measles

LONDON -- Global deaths from measles fell by 78 percent between 2000 and 2008 thanks largely to mass childhood vaccination campaigns, but experts say death rates may rise again if complacency allows immunization efforts to lag.

Make cancer vaccine more affordable, Nobel laureate says

by Ted Purlain on December 2, 2009

Harald-zur-hausen_420

Harald zur Hausen

CALCUTTA, India — Cervical cancer vaccines should cost less to be more effective in lowering the death rate caused by the disease a Nobel laureate said, according to a report in The Times of India on Dec. 3.

H1N1 vaccine supply continues to grow

by Rita Uplend on December 2, 2009

Cdc

Since the national voluntary H1N1 vaccination campaign began in early October, more than 70 million doses of vaccine have been allocated by the federal government to all 50 states, U.S. territories, and the District of Columbia.

CDC sees opportunity as flu wanes, vaccine supply grows

by Paul Tinder on December 2, 2009

Frieden_dr

Thomas Frieden

Decreasing pandemic flu activity and growing supplies of vaccine offer a window of opportunity for people to protect themselves from the virus, especially if the nation experiences a third wave of infections.

Aspirin, Tylenol may decrease effectiveness of vaccines, researchers say

by Pat Dulnier on December 2, 2009

Pbb_protein_cox1_image

COX-1

With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. However, researchers suggest that over-the-counter drugs may lessen their effect, ScienceDaily reported Dec. 2.

Hackers spread virus with swine flu vaccine offer; CDC addresses rumors

by Daniel Purt on December 2, 2009

Computer

Computer Virus

BOSTON — Hackers are spreading a vicious computer virus through spam e-mail messages that urge recipients to visit a bogus Web site offering vaccinations to protect them against another virus — the one that causes swine flu, Reuters reported Dec. 1.

New report shows 97 medicines and vaccines in development for HIV/AIDS

by Pat Dulnier on December 2, 2009

Fauci_anthony

Anthony Fauci

WASHINGTON, D.C. — America’s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions.

CDC: Flu activity eases, but child deaths still climb

by Tina Redlup on December 2, 2009

H1n1

H1N1

The number of states with widespread pandemic flu activity dropped for the third week in a row, but the virus continued to take a heavy toll on children, with at least 27 more pediatric deaths reported the week of Nov 15 to 21.

Ohio authorities order more H1N1 flu vaccine doses

by Paul Tinder on December 2, 2009

Flu_vaccine

H1N1 Flu Vaccine

COLUMBUS, Ohio — The Ohio Department of Health submitted an order for 259,800 doses of H1N1 flu vaccine to the Centers for Disease Control and Prevention on Nov. 25.

Bavarian Nordic will file for market approval for Imvamune in Canada

by Tina Redlup on December 2, 2009

Hedegaard_anders

Anders Hedegaard

KVISTGARD, Denmark — Bavarian Nordic A/S announced Nov. 30 that it expects to file a new drug submission for its third-generation smallpox vaccine, Imvamune with Health Canada in the second half of 2010.

WHO prequalifies GlaxoSmithKline’s H1N1 pandemic vaccine

by Ted Purlain on December 2, 2009

Who

LONDON — GlaxoSmithKline announced Dec. 1 that the World Health Organization has awarded prequalification for global use of Arepanrix, its adjuvanted H1N1 pandemic vaccine manufactured in Canada.

CDC Flu Wrap

by Paul Tinder on November 30, 2009

Cdc

The Center for Disease Control has reported 35 flu-related pediatric deaths across 19 states during the week ending November 21, which brings the total to 301 cases so far in 2009. There were 90 in 2008, 77 in 2007, 43 in 2006 and 45 in 2005.

Inovio partner announces completion of Phase I DNA vaccine study

by Pat Dulnier on November 30, 2009

Josephkim

J. Joseph Kim

SAN DIEGO — Inovio Biomedical Corp. announced Nov. 30 that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio's electroporation technology.

Novavax completes enrollment in study of seasonal flu vaccine in older adults

by Paul Tinder on November 30, 2009

Flu_vaccine

Flu Vaccine

ROCKVILLE, Md. — Novavax announced Nov. 30 that it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza virus-like particle vaccine candidate in healthy adults 60 years of age or older.

FDA approves Agriflu seasonal influenza vaccine

by Rita Uplend on November 30, 2009

Fda-logo

The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

Children under 10 need 2 doses of H1N1 vaccine, parents reminded

by Ted Purlain on November 30, 2009

Flu_vaccine

H1N1 Vaccine

COLUMBUS, Ohio – The Ohio Department of Health reminded parents and health care providers Nov. 30 that children younger than 10 should receive two doses of H1N1 flu vaccine in order to achieve optimal protection against pandemic flu.

GSK files Rotarix for prevention of rotavirus in Japan

by Tina Redlup on November 30, 2009

Who

GlaxoSmithKline announced Nov. 30 that it has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in several countries outside of Japan).

New case of avian flu confirmed in Egypt

by Tina Redlup on November 28, 2009

Avian_flu

Avian flu

The Ministry of Health of Egypt has reported a new confirmed human case of avian influenza A (H5N1), the World Health Organization said Nov. 27.

Unknown disease affects more than 100 people, causes 3 deaths in Congo

by Pat Dulnier on November 28, 2009

Who

BRAZZAVILLE, Republic of Congo — An unknown epidemic caused three deaths and affected more than 100 people in the last few days in the Republic of Congo.

WHO donates 9 million flu shots to Philippines, 14 million to Nigeria

by Ted Purlain on November 28, 2009

MANILA, Philippines — The World Health Organization promised on Nov. 26 to donate 9 million H1N1 flu shots to the Philippines, and assured the country the vaccines were safe, Reuters reported.

But critics say more should be done.

by Rita Uplend on November 28, 2009

Larsen-2

"America needs to produce vaccines and therapeutics faster and less expensively than we have been because we might not have six months of advance warning for the next pandemic."

Baxter hopes to build U.S. cell-based vaccine manufacturing plant

by Ted Purlain on November 28, 2009

Baxter-international

DEERFIELD, Ill. — Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines, the Chicago Tribune reported Nov. 26

Drug-resistant H1N1 no major change in virus, WHO says

by Tina Redlup on November 27, 2009

H1n1

H1N1

GENEVA — Tamiflu resistance in some H1N1 patients with badly weakened immune systems does not seem to reflect a major change in the virus' susceptibility to the frontline drug, the World Health Organization said Nov. 26.

Sinovac establishes joint venture to expand vaccine development, manufacturing

by Pat Dulnier on November 27, 2009

Yin_weidong

Weidong Yin

BEIJING — Sinovac Biotech Ltd. announced Nov. 25 that it executed a joint venture agreement to establish Sinovac (Dalian) Vaccine Technology Co. Ltd. to research, develop, produce and commercialize human-use vaccines.

Researcher studies why some vaccines may require a booster

by Daniel Purt on November 27, 2009

Pichichero_m

Michael Pichichero

ROCHESTER, N.Y. — Do all vaccines boost immunity for the same period of time? And, if not, when are additional “booster shots” needed to keep immunity strong? One researcher is looking for answers, the Rochester General Health System announced Nov. 27.

World AIDS Day set for Dec. 1

by Tina Redlup on November 27, 2009

Hiv

HIV

World AIDS Day on Dec. 1 is intended to draw together people from around the world to raise awareness about HIV/AIDS and demonstrate international solidarity in the face of the pandemic, according to the World Health Organization.

New HIV infections reduced by 17 percent over 8 years

by Ted Purlain on November 27, 2009

Who

GENEVA and SHANGHAI — According to new data in the 2009 AIDS epidemic update, new HIV infections have been reduced by 17 percent over the past eight years, the World Health Organization and United Nations Program on HIV/AIDS announced Nov. 24.

H1N1 linked to rise in bacterial pneumonia cases

by Rita Uplend on November 27, 2009

Cdc

ATLANTA, Ga. — The Centers for Disease Control issued a warning Nov. 25 that catching the H1N1 virus can put patients at risk, not only of developing complications, but also serious bacterial pneumonia.

Calif. fills orders for more than 5 million doses of H1N1 vaccine

by Pat Dulnier on November 25, 2009

Horton-markjpg

Mark Horton

SACRAMENTO, Calif. -- The California Department of Public Health announced the tally for filling H1N1 vaccine orders stands at nearly 5.2 million doses.

Ohio's health department orders 438,900 additional H1N1 flu vaccine doses

by Paul Tinder on November 25, 2009

Flu_vaccine

H1N1 Vaccine

COLUMBUS, Ohio -- The Ohio Department of Health submitted an order for 438,900 doses of H1N1 flu vaccine to the Centers for Disease Control and Prevention on Nov. 20.

Small batch of H1N1 flu vaccines pulled in Canada

by Rita Uplend on November 25, 2009

Kettner_joel

Joel Kettner

LONDON -- Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients.

British, Welsh agencies investigate possible Tamiflu-resistant H1N1 cases

by Paul Tinder on November 25, 2009

H1n1

H1N1

LONDON -- Britain's Health Protection Agency is working with colleagues from the Public Health Service of Wales to investigate several possible cases of person-to-person transmission of oseltamivir-resistant H1N1 flu, the agency reported Nov. 20.

Vermont's EMTs and paramedics authorized to give flu shots

by Daniel Purt on November 25, 2009

Vaccine

H1N1 Vaccine

BURLINGTON, Vt. -- More than 700 of Vermont's licensed emergency medical technicians and paramedics are now eligible to serve as vaccinators at public and school clinics across the state.

GlaxoSmithKline says trial shows Pandemrix has strong response

by Pat Dulnier on November 24, 2009

Stephenne

Jean Stephenne

LONDON -- GlaxoSmithKline announced Nov. 23 that more than 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programs.

CDC kicks off national travelers' health public awareness campaign

by Paul Tinder on November 24, 2009

Schuchat_anne

Anne Schuchat

Every holiday season, millions of Americans travel through the nation's airports, seaports, and train stations to spend time with loved ones.

Next-generation flu vaccine plant to open in North Carolina

by Rita Uplend on November 24, 2009

Flu_vaccine

Flu Vaccine

WASHINGTON -- Novartis will officially open the first next-generation flu vaccine plant in the United States on Nov. 24, but it will be years before it makes its first vaccine.

H1N1 mutations detected in Norway

by Ted Purlain on November 24, 2009

Who

GENEVA -- The Norwegian Institute of Public Health has informed the World Health Organization of a mutation detected in three H1N1 viruses.

CDC confirms 4 new cases of Tamiflu-resistant H1N1

by Tina Redlup on November 24, 2009

Cdc

DURHAM, N.C. -- Tests have confirmed that samples from four patients with H1N1 influenza were found to be resistant to oseltamivir, known by the brand name Tamiflu.

4 million deaths averted in 2009 through its efforts, GAVI Alliance says

by Pat Dulnier on November 23, 2009

Mafubelu_daisy

Daisy Mafubelu

New data, released by the GAVI Alliance this week, shows that by the end of 2009 more than 4 million premature deaths caused by pertussis, Haemophilus influenzae type b (Hib) and hepatitis B will be prevented through GAVI support.

GAVI Alliance says immunizations reduced child deaths in Vietnam

by Tina Redlup on November 23, 2009

Gavi_logo

HANOI, Vietnam — Through its commitment to immunization and other child health interventions, Vietnam has drastically reduced its child deaths, the GAVI Alliance announced Nov. 20 during its partner forum.

Even Santas have to be careful this season

by Paul Tinder on November 23, 2009

Santa

Santa-America

Santa-America, a service charity, recommends that all Kris Kringles get their jolly old selves vaccinated against H1N1 influenza and pneumonia.

Senate committee members fault H1N1 vaccination strategy

by Rita Uplend on November 23, 2009

Cdc

Leaders of the U.S. Senate Homeland Security Committee sharply critiqued the federal government's H1N1 vaccination strategy saying health officials should have recommended targeting only the highest-risk groups as soon as the vaccine delays came.

Its impact on vaccine market is bringing down prices, GAVI says

by Paul Tinder on November 23, 2009

Vaccine

Pentavalent Vaccine

HANOI, Vietnam — Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably.

Md. governor praises Emergent BioSolutions

by Daniel Purt on November 20, 2009

Omalley_martin

Gov. Martin O’Malley

ANAPOLIS, Md. — Maryland Gov. Martin O’Malley praised Emergent BioSolutions for its upcoming expansion in East Baltimore during his online economic update released Nov. 19.

Fighting tuberculosis should be priority, Fauci says

by Tina Redlup on November 20, 2009

Fauci_anthony

Dr. Anthony Fauci

Dr. Anthony Fauci wrote this commentary, posted Nov. 17, for msnbc.com. He is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

2 House committees investigate pandemic vaccine decisions

by Pat Dulnier on November 20, 2009

Schuchat_anne

Anne Schuchat

WASHINGTON, D.C. — Federal officials, along with representatives from four vaccine companies, appeared before two U.S. House of Representatives committees to answer questions about why the nation hasn't stretched scarce pandemic vaccine supply.

Sid the Science Kid Flu takes shot at vaccination in new episode

by Pat Dulnier on November 20, 2009

Sid-science-kid

Sid the Science Kid

A special episode of PBS KIDS’ TV show, "Sid the Science Kid," where Sid explores the science behind flu vaccinations is now available for free download on flu.gov.

FDA advisory panel votes 11-6 against new bug-based flu vaccine

by Daniel Purt on November 20, 2009

Fda-logo

BETHESDA, Md. — More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said Nov. 19.

Hundreds of doses of H1N1 vaccine discarded in Canada because of 24-hour shelf life

by Daniel Purt on November 19, 2009

Flu_vaccine

H1N1 Vaccine

HALIFAX, Nova Scotia — Some health authorities across the country have tossed out hundreds of doses of the H1N1 flu vaccine because of miscalculations over how many of the time-sensitive dosages are needed at community clinics.

FDA panel backs Pfizer's enhanced vaccine for children

by Paul Tinder on November 19, 2009

Fda-logo

BETHESDA, Md. — Federal health experts said Nov. 17 that an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals.

Yellow fever vaccination campaign targeting 12 million people to start

by Paul Tinder on November 19, 2009

Yellow_fever

Yellow Fever

GENEVA and NEW YORK — The largest-ever yellow fever mass vaccination campaign is set to kick off next week across three African countries, the World Health Organization announced Nov. 17.

Researcher advocates avoiding panic in pandemics

by Daniel Purt on November 19, 2009

H1n1

H1N1

Public health officials walking a tightrope between massive demand for vaccines and intense public scrutiny of side effects now have a new standard for evaluating the safety of their vaccination programs.

BusinessWeek calls Genocea Biosciences 1 of world’s most intriguing startups

by Ted Purlain on November 19, 2009

Bakali_staph

Staph Leavenworth Bakali

Genocea Biosciences, a vaccine discovery and development company, announced Nov. 16 that it was named one of BusinessWeek’s “World’s Most Intriguing Startups” for 2009.

FDA wants panel to probe Pfizer vaccine efficacy

by Pat Dulnier on November 18, 2009

Emilio_emini

Dr. Emilio Emini

WASHINGTON — Pfizer Inc's next-generation Prevnar vaccine missed some of the main goals in a study testing its ability to protect against bacteria that cause ear infections, pneumonia and other diseases.

Novartis’ H1N1 flu vaccine effective at half the current antigen dose

by Rita Uplend on November 18, 2009

Oswald_andrin

Andrin Oswald

Novartis’ recently sanctioned unadjuvanted influenza H1N1 2009 monovalent vaccine may be effective at just half the dose currently stipulated under its FDA approval, according to interim data from ongoing clinical trials.

HIV vaccine failure probably caused by virus used, new research says

by Pat Dulnier on November 18, 2009

Hiv

HIV

The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus “shell” used to transmit the therapy around the body, according to research published Nov. 16 in the Proceedings of the National Academy of Sciences.

FDA approves 5th vaccine for 2009 H1N1 influenza virus

by Daniel Purt on November 18, 2009

Fda-logo

The U.S. Food and Drug Administration announced Nov. 16 that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.

Panenza, Sanofi Pasteur’s H1N1 vaccine, approved in France

by Tina Redlup on November 18, 2009

H1n1

H1N1

LYON, France — Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced that the French drug agency Afssaps has granted marketing authorization in France for Panenza, its non-adjuvanted Influenza H1N1 2009 monovalent vaccine.

Scientists create NICE solution to pneumonia vaccine testing problems

by Paul Tinder on November 18, 2009

Hwang_jeeseong

Jeeseong Hwang

Medical clinics could benefit from new software created at the National Institute of Standards and Technology, where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method.

Progress toward Alzheimer's vaccine, says Israeli researcher

by Pat Dulnier on November 17, 2009

Monsonego_alon

Alon Monsonego

JERUSALEM — An Israeli researcher working on a vaccine to combat Alzheimer's disease said Nov. 9 that he had made important progress following tests on gene-altered laboratory mice.

Kansas University receives $6 million contract for vaccine research

by Rita Uplend on November 17, 2009

Nih

Kansas University has been awarded a five-year, $6.85 million research contract with the goal of boosting the effectiveness and safety of vaccines that treat infectious diseases.

FDA expands approved use of H1N1 vaccines to include infants, children

by Rita Uplend on November 17, 2009

Fda-logo

The U.S. Food and Drug Administration has approved the use of the CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

GSK, Nabi announce agreement for vaccine for nicotine addiction

by Pat Dulnier on November 17, 2009

Stephenne

Jean Stephenne

LONDON and ROCKVILLE, Md. — GlaxoSmithKline Biologicals and Nabi Biopharmaceuticals have announced an exclusive worldwide option and licensing agreement for a vaccine for the treatment of nicotine addiction.

Former President Clinton: There'll be AIDS vaccine before a cure

by Paul Tinder on November 16, 2009

Clinton_bill

President Bill Clinton

CHICAGO — Former President Bill Clinton says he believes there's going to be a vaccine for AIDS found before anyone discovers a cure for the disease, WBBM Radio reported.

Canada shrugs off cost of flu vaccination campaign

by Ted Purlain on November 16, 2009

H1n1

H1N1

OTTAWA — Canada's top medical official defended the national H1N1 vaccination campaign on Nov. 12, and said the costs of doing nothing would be far higher than the money spent immunizing millions of people.

Temptime donates vaccine vial monitors to support WHO distribution of H1N1 vaccine

by Rita Uplend on November 16, 2009

Who

World Health Organization

MORRIS PLAINS, N.J. — Temptime Corp. announced that it will donate its vaccine vial monitors to the World Health Organization to monitor potential heat damage of H1N1 vaccines.

U.S. reports largest mumps outbreak in 3 years

by Tina Redlup on November 16, 2009

Mumps

Mumps Virus

ATLANTA — U.S. health officials say the largest U.S. outbreak of mumps in three years is occurring in New York and New Jersey, The Associated Press reports.

Emergent BioSolutions acquires manufacturing facility from MdBio

by Pat Dulnier on November 16, 2009

El-hibri_fuad

Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that it has completed the acquisition of a 55,000-square-foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the city of Baltimore.

CDC Flu Wrap

by Pat Dulnier on November 16, 2009

Cdc

The Center for Disease Control has reported 21 flu-related deaths among children across 15 states during the week ending November 14. The numbers went down from the previous 35 cases in 17 states.

Malaria outbreak in Virginia

by Ted Purlain on November 13, 2009

Malaria

Malaria

ATLANTA -- There were ten cases of malaria reported across the United States during the week ending October 10th, four of which occurred in Virginia.

Vical reports 3rd-quarter revenue up compared to 2008

by Daniel Purt on November 13, 2009

Vical

SAN DIEGO — Vical Inc. on Nov. 4 reported financial results for the quarter ended Sept. 30.

Vical official says DNA vaccine technology addresses challenges of emerging diseases

by Ted Purlain on November 13, 2009

Vical

GALVESTON, Texas — Vical Inc. reported Nov. 10 that it has a strong rationale advocating the use of DNA vaccine technology for emerging and/or pandemic infectious diseases.

Kineta, university partner on project to develop vaccine immune boosters

by Rita Uplend on November 13, 2009

Gale

Dr. Michael Gale Jr.

SEATTLE— Kineta Inc. has announced that it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases to develop novel vaccine adjuvants (agents that help boost the immune system).

Novavax begins study comparing VLP vaccine with Fluzone

by Paul Tinder on November 13, 2009

Singhvi_rahul

Dr. Rahul Singhvi

ROCKVILLE, Md. — Novavax Inc. has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults over age 60.

CDC Flu Wrap

by Paul Tinder on November 13, 2009

Cdc

The Center for Disease Control has reported 18 flu-related deaths among children that occurred in nine states during the week ending October 31.

'Anti-vaccine' attitude hampers H1N1 effort, Fauci says

by Daniel Purt on November 13, 2009

Fauci_anthony

Dr. Anthony Fauci

The head of the National Institute of Allergy and Infectious Diseases said the unpredictable H1N1 flu pandemic is not over and implored parents to get their children vaccinated.

GSK to donate 50 million doses of H1N1 vaccine for developing countries

by Paul Tinder on November 13, 2009

Witty

Andrew Witty

LONDON — GlaxoSmithKline on Nov. 10 announced that it has signed an agreement with the World Health Organization to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine for distribution to developing countries most in need.

GSK: Trial of 2 vaccines shows promise to treat H1N1, seasonal flu at same time

by Paul Tinder on November 12, 2009

Stephenne

Jean Stéphenne

LONDON — GlaxoSmithKline announced Nov. 9 the results from the clinical trial assessing Pandemrix, GSK’s adjuvanted H1N1 influenza vaccine, administered at the same time as the annual seasonal influenza vaccine, Fluarix.

FDA approves GlaxoSmithKline’s pandemic H1N1 vaccine

by Pat Dulnier on November 12, 2009

Fda-logo

LONDON and PHILADELPHIA — GlaxoSmithKline announced Nov. 10 that the Food and Drug Administration has approved a supplemental biologics license application for its unadjuvanted H1N1 influenza vaccine.

Letter from the commissioner to nation’s health care professionals on H1N1 vaccine

by Paul Tinder on November 11, 2009

Fda-logo

The following is an open letter dated Nov. 10 to health care professionals from Margaret A. Hamburg, commissioner of the Food and Drug Administration.

Study of key HIV antibodies could lead to new vaccine design

by Paul Tinder on November 11, 2009

Alam

S. Munir Alam

A study of how the most robust antibodies work to block HIV as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine, ScienceDaily reported Nov. 10.

Google teams up with U.S. agencies to pinpoint flu vaccine sites

by Rita Uplend on November 11, 2009

Google

Flu Finder

This year, it's especially important to have clear information on what you can do to prepare for the flu season.

Rare Ebola-like virus poses new threat to U.S. troops in Afghanistan

by Tina Redlup on November 11, 2009

Ebola

Ebola

KANDAHAR, Afghanistan — U.S. military officials sent a medical team to a remote outpost in southern Afghanistan this week to take blood samples from members of an Army unit after a soldier in the unit died from an Ebola-like virus.

National polio vaccinations under way in Chad

by Ted Purlain on November 11, 2009

Polio

Polio

GOZ BEIDA, Chad —A three-day nationwide polio vaccination campaign began Oct. 30 throughout Chad, including in the east where according to the World Health Organization the rate of routine immunizations is among the weakest nationwide, IRIN news reported.

WHO grants U.N. agencies access to GSK’s pneumococcal vaccine

by Rita Uplend on November 10, 2009

Stephenne_jean

Jean Stéphenne

BRUSSELS —The World Health Organization has endorsed for global use a vaccine against pneumonia, a life-threatening disease affecting many children younger than 5 in developing countries.

Intercell erases fiscal-year profit target on weak vaccine sales

by Pat Dulnier on November 10, 2009

Intercell_logo

VIENNA — Austrian biotech company Intercell scrapped its full-year profit target after third-quarter revenue for its Ixiaro vaccine against Japanese encephalitis fell short of expectations.

Immunovaccine works with Cato Research in cancer vaccine trial

by Daniel Purt on November 10, 2009

Chase_randal

Randal Chase

HALIFAX, Nova Scotia — Immunovaccine Inc. announced Nov. 2 that it entered into an agreement with Cato Research Canada Inc. to assist it in managing an upcoming Phase 1 clinical trial for DPX-0907.

Russia's health minister warns media against spreading flu panic

by Ted Purlain on November 10, 2009

Golikova_tatyana

Tatyana Golikova

MOSCOW — Russia's health minister warned the media against spreading panic over a swine and seasonal flu outbreak and said the situation was under control.

Experts offer advice on school preparedness for H1N1 outbreaks

by Paul Tinder on November 10, 2009

Griffin_arthur

Arthur Griffin Jr

NEW YORK — School district leaders planning for H1N1 pandemics should update emergency plans using a four-step process, according to the McGraw-Hill Education Urban Advisory Resource.

Kazakhstan to start testing domestic swine flu vaccine

by Rita Uplend on November 9, 2009

Kazakhstan_flag

Kazakhstan Flag

ASTANA, Kazakhstan — Kazakhstan will start testing a domestically produced H1N1 vaccine soon, the country's chief sanitary official Kenes Ospanov said Nov. 4.

Experimental vaccine cures pre-cancer vulvar growths

by Pat Dulnier on November 9, 2009

Kenter-dr

Dr. Gemma Kenter

BOSTON — An experimental vaccine cured nearly half of women with pre-cancerous growths on their genitals, producing major improvement in nearly four out of five, researchers in the Netherlands reported in a small study Nov. 4.

Beijing extends H1N1 flu vaccine inoculation to all residents

by Daniel Purt on November 9, 2009

Beijing

Beijing

BEIJING — Beijing health authorities said Nov. 6 that they would extend the H1N1 flu vaccine inoculation to all the city's 16

Novartis receives regulatory approval in Germany for Celtura

by Ted Purlain on November 9, 2009

Oswald_andrin

Andrin Oswald

BASEL, Switzerland — Novartis announced Nov. 5 that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza H1N1 2009 monovalent vaccine, Celtura.

Most people can’t find H1N1 vaccine yet, but will keep trying

by Paul Tinder on November 9, 2009

Blendon_robert

Robert J. Blendon

BOSTON — A new national poll from Harvard School of Public Health researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so.

CDC Flu Wrap

by Tina Redlup on November 9, 2009

Cdc

The Center for Disease Control has reported 35 flu-related pediatric deaths that occurred in 17 states during the week ending November 9. The previous week only reported 18 deaths in nine states.

New Merck begins operations after merger with Schering-Plough

by Rita Uplend on November 6, 2009

Clark_richard

Richard T. Clark

WHITEHOUSE STATION, N.J. — Merck & Co. Inc. outlined its global plans following the completion of Merck's merger with Schering-Plough Corp. announced Nov. 3.

489 dengue cases recorded in New Delhi

by Pat Dulnier on November 6, 2009

Dengue-mosquito

Dengue mosquito

NEW DELHI -- Twenty five new dengue cases were recorded in Delhi on Friday, taking the number of people affected by the vector-borne disease to 489, health officials told The Times of India on Nov. 6.

Agencies work to improve tracing of unsafe food products

by Daniel Purt on November 6, 2009

Fda-logo

A joint public meeting focused on improving the system for tracing food products and ingredients that are causing illness outbreaks or presenting other risks to the health of consumers is scheduled for Dec. 9 and 10 in Washington.

Deadly tropical disease hits south Sudan

by Ted Purlain on November 6, 2009

Msf

MALAKAL, Sudan — Southern Sudan is facing a "serious outbreak" of the deadly kala azar tropical disease, the aid agency Medecins Sans Frontieres, also known as Doctors Without Borders, warned Friday.

China adopts ‘malaria diplomacy’ as part of Africa push

by Paul Tinder on November 6, 2009

Sweet_wormwood

Sweet wormwood

HONG KONG — In a laboratory in China's southern city of Guangzhou, scientists are trying to enhance the rare sweet wormwood shrub, from which artemisinin — the best drug to fight malaria — is derived.

Emergent BioSolutions reports financial results for 3rd quarter

by Mary J. Lewis on November 5, 2009

Don_elsey

R. Don Elsey

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced Nov. 5 its financial results for the third quarter and nine months ended Sept. 30.

NYC health department asks providers to prioritize patients

by Pat Dulnier on November 5, 2009

Dr

Dr. Thomas Farley

New Yorkers have turned out in record numbers for seasonal flu shots this fall – depleting vaccine supplies and prompting the Health Department to issue new recommendations for vaccination.

Officials under fire after Wall Street firms get H1N1 flu vaccines

by Mary J. Lewis on November 5, 2009

Dr

Dr. Thomas Frieden

NEW YORK — Some of New York's biggest companies received doses of swine flu vaccine for at-risk employees, drawing criticism that the hard-to-find vaccine is going first to the privileged.

Suspect arrested in Milwaukee theft of flu vaccine

by Rita Uplend on November 5, 2009

Bevan_baker

Bevan Baker

MILWAUKEE — More than 900 doses of Milwaukee's allotted H1N1 flu vaccine will have to be returned to the manufacturer, officials said, after a truck used to transport the vaccine was stolen.

NIAID announces research awards to fight emerging infectious diseases

by Mary J. Lewis on November 5, 2009

Anthony_fauci

Anthony S. Fauci

The National Institute of Allergy and Infectious Diseases has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases.

Progress made on Group B streptococcus vaccine

by Mary J. Lewis on November 4, 2009

Sharon_hillier

Sharon Hillier

An early clinical study shows that a vaccine to prevent Group B Streptococcus infection is safe and modestly effective, according to findings presented Oct. 30 at the annual meeting of the Infectious Diseases Society of America.

How long does hepatitis B vaccine protection last?

by Ted Purlain on November 4, 2009

Dr_mcmahon

Dr. Brian J. McMahon

The hepatitis B vaccine – given to protect against infection by a virus that can cause severe liver damage and cancer — may protect for more than two decades, according to a new study.

Calmune, Crucell enter research, development deal

by Mary J. Lewis on November 4, 2009

Jaap_goudsmit

Jaap Goudsmit

Calmune Corp. announced Nov. 3 that it has entered an agreement with Crucell N.V. that will focus on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases.

XOMA signs antibody discovery collaboration with Kaketsuken

by Paul Tinder on November 4, 2009

Steven_engle

XOMA CEO Steven Engle

BERKELEY, Calif. — XOMA Ltd. and Kaketsuken have entered into a collaboration involving multiple proprietary XOMA antibody resea

Department of Defense receives first H1N1 vaccine shipments

by Mary J. Lewis on November 4, 2009

Ellen_embrey

WASHINGTON —The Defense Department has started receiving H1N1 vaccines and will begin distributing doses in the coming weeks, the American Forces Press Service reported Nov. 4.

Novavax reports positive data for seasonal flu vaccine candidate

by Mary J. Lewis on November 4, 2009

Rahul_singhvi

Dr. Rahul Singhvi

ROCKVILLE, Md. — Novavax, Inc. announced Nov. 2 that its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

Official writes vaccine makers, distributors about alleged price fixing

by Rita Uplend on November 4, 2009

Ag_blumenthal

Richard Blumenthal

Connecticut Attorney General Richard Blumenthal has written 13 makers and distributors of scarce seasonal flu vaccine regarding allegations of price fixing and preferential treatment for big retailers.

Emergent BioSolutions to webcast presentations

by Mary J. Lewis on November 4, 2009

Fuad_el-hibri

CEO Fuad El-Hibri

ROCKVILLE, Md. — Emergent BioSolutions Inc. will webcast its presentation at two investor conferences in November.

World’s largest malaria vaccine trial under way in Africa

by Pat Dulnier on November 4, 2009

Christian_loucq

Dr. Christian Loucq

NAIROBI, KENYA — A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is under way in seven African countries.

Work on pig genome may help with human medicine

by Mary J. Lewis on November 4, 2009

Roger_beachy

Dr. Roger Beachy

WASHINGTON — An international team of scientists has completed the first draft of the genome of a domesticated pig. This first draft sequence will spur advancements in swine production and human medicine.

Pregnant women have strong response to 1 dose of H1N1 vaccine

by Mary J. Lewis on November 3, 2009

Anthony_fauci

Anthony Fauci

Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial.

2nd dose of H1N1 vaccine elicits better response in youngest children

by Ted Purlain on November 3, 2009

Niaidlogo

NIAID

The National Institute of Allergy and Infectious Diseases announced interim trial results showing that children 9 years old and younger have improved immune response when given a second 15-microgram dose of 2009 H1N1 influenza vaccine.

Safety measures could minimize H1N1 transmission at 2009 Hajj

by Mary J. Lewis on November 3, 2009

Shahul_h

Shahul H. Ebrahim

The 2009 Hajj pilgrimage, expected to draw more than 2.5 million people from more than 160 countries to Muslim holy sites in Saudi Arabia, may present a serious public health challenge.

Global health organizations urge governments to fight pneumonia

by Paul Tinder on November 3, 2009

Bill_frist

Bill Frist

Nearly 100 leading global health organizations from around the world joined forces to recognize the first World Pneumonia Day on Nov. 2 and urge governments to take steps to fight pneumonia, the world’s leading killer of children.

Guantanamo Bay detainees to receive swine flu vaccine

by Mary J. Lewis on November 3, 2009

Guantanamo-bay

Guantanamo

SAN JUAN, Puerto Rico – Terrorism suspects held at the Guantanamo Bay naval base will soon get swine flu vaccines, despite complaints that American civilians should have priority, a military spokesman said Nov. 1 in a report by the Associated Press.

U.S. support could help halve child deaths worldwide in 15 years

by Mary J. Lewis on October 31, 2009

Bill-melinda_gates

Bill and Melinda Gates

WASHINGTON — In a joint speech to policymakers Oct. 27, Bill and Melinda Gates made the case that U.S. initiatives to fight AIDS, malaria and other diseases in poor countries are “America’s best investment for saving lives.”

IDSA strengthens mandatory immunization policy

by Ted Purlain on October 31, 2009

Dr

Dr. Anne Gershon

To better protect patients and health care workers, the Infectious Diseases Society of America recently strengthened its policy on mandatory immunization of workers. The strengthened statement applies to both seasonal influenza and 2009 H1N1 influenza.

Vaccinated moms less likely to have small or premature babies

by Mary J. Lewis on October 31, 2009

William_schaffner

Dr. William Schaffner

PHILADELPHIA — Pregnant women who get the flu vaccine are less likely to have babies who are premature or are small for their gestational age, according to two new studies.

Nanotherapeutics receives contract to develop smallpox drug

by Paul Tinder on October 31, 2009

Smallpox_slide_set

Smallpox

ALACHUA, Fla. — Nanotherapeutics Inc. has been awarded a $30.9 million, five-year contract from the National Institute of Allergy and Infectious Diseases to develop an inhaled version of the injectable antiviral drug cidofovir.

New video supports enhanced U.S. vaccine preparedness

by Mary J. Lewis on October 31, 2009

Bob_graham

Sen. Bob Graham

WASHINGTON, D.C. — The current shortage of H1N1 vaccine underscores the severe lack of U.S. preparedness in responding to pandemics, whether through natural disease transmission or manmade bioterrorist attacks.

FDA answers questions about common ingredients in U.S. vaccines

by Mary J. Lewis on October 29, 2009

Fda-logo

FDA demands that vaccines undergo a rigorous and extensive development program in the laboratory, as well as in animal studies and human clinical trials, to determine their safety and effectiveness.

Federal stimulus grant supports study of anti-nicotine vaccine

by Pat Dulnier on October 29, 2009

Dr-francis-collins

Dr. Francis Collins

Efforts to develop a vaccine capable of preventing tobacco addiction got a $10 million shot in the arm in the form of an American Recovery and Reinvestment Act grant.

Flu vaccine given during pregnancy keeps infants out of hospital

by Mary J. Lewis on October 29, 2009

Marietta_vázquez

Marietta Vázquez

NEW HAVEN, Conn. — Infants born to women who received influenza vaccine during pregnancy were hospitalized at a lower rate than infants born to unvaccinated mothers, according to preliminary results of an ongoing study.

First family takes flu shots; daughters take H1N1 vaccine too

by Rita Uplend on October 29, 2009

Obama-family

First Family

WASHINGTON — Yes, President Barack Obama and his family have had their shots. According to the White House, all four members of the Obama family have received their seasonal flu vaccine.

GlaxoSmithKline gives price pledge on trial malaria vaccine

by Mary J. Lewis on October 29, 2009

Christian_loucq

Christian Loucq

LONDON —More than 5,500 children across Africa have been given an experimental new malaria vaccine and the British drugmaker behind it, GlaxoSmithKline, promised Oct. 28 that price would be no hurdle if it works.

Cuban civil defense teams keep swine flu at bay

by Mary J. Lewis on October 29, 2009

Luis_estruch

Dr. Luis Estruch

HAVANA — Cuba is ready to use just about everything at its disposal, from its well-oiled civil defense system to the soldiers of a totalitarian government, to keep swine flu cases to a minimum.

South African correctional center quarantined after measles outbreak

by Pat Dulnier on October 29, 2009

Nosiviwe_mapisa-nqakula

Nosiviwe Mapisa-Nqakula

PRETORIA, South Africa — Dozens of measles cases has led to a 10-day quarantine and massive vaccination program at a correctional center in Johannesburg.

FDA panel wants more data on anthrax drug

by Mary J. Lewis on October 29, 2009

Anthrax-bacteria

Anthrax

WASHINGTON — Federal advisers said more data is needed to judge the effectiveness of Human Genome Sciences' anthrax treatment compared with existing anti-bacterial drugs, The Associated Press reported Oct. 27.

Commission says U.S. failing to address urgent biosecurity issues

by Daniel Purt on October 29, 2009

Talent

Jim Talent

The United States is failing to address its most urgent threat — biological proliferation and terrorism — concluded a report issued Oct. 21 by the bipartisan Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism.

Production delays put vaccine doses behind schedule

by Mary J. Lewis on October 29, 2009

Kathleen-sebelius

Kathleen Sebelius

WASHINGTON — Conceding that their original predictions about pandemic H1N1 influenza vaccine supplies were too optimistic, the government's top government health and safety officials today told vaccine-seekers to be patient — more is coming.

University study finds mercury levels normal in children with autism

by Mary J. Lewis on October 27, 2009

Hertzpicciotto_rs

Irva Hertz-Picciotto

Researchers at the University of California – Davis’ MIND Institute report that typically developing children and children with autism have similar levels of mercury in their blood streams.

New York suspends flu shot mandate for health care employees

by Ted Purlain on October 27, 2009

Gov_paterson

Gov. Paterson

The mandatory influenza immunization requirement for New York health care workers was suspended Oct. 22 so that the limited vaccine supplies can be used for populations most at risk of serious illness and death.

Brief shocks may deliver AIDS vaccines better

by Mary J. Lewis on October 27, 2009

Sandy_vasan

Sandhya Vasan

Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said Oct. 22.

Childhood vaccines at all-time high

by Rita Uplend on October 27, 2009

Margaret_chan

Dr Margaret Chan

Reversing a downward trend, immunization rates are at their highest ever and vaccine development worldwide is booming, according to an assessment released Oct. 21 by the World Health Organization, UNICEF and the World Bank.

Grants given for unconventional projects to fight infectious diseases

by Mary J. Lewis on October 27, 2009

Tachi_yamada

Dr. Tachi Yamada

ARUSHA, Tanzania — The Bill & Melinda Gates Foundation announced 76 grants of $100,000 each to pursue bold ideas for transforming health in developing countries.

Understanding how Thai vaccine worked is priority

by Mary J. Lewis on October 26, 2009

Anthony_fauci

Dr. Anthony Fauci

The priority for AIDS virologists in coming months, a leading researcher said, is to find out exactly how the Thailand vaccine, which gave 30 percent protection against HIV, worked.

Novavax launches study of H1N1 VLP Flu Vaccine in Mexico

by Ted Purlain on October 26, 2009

Rahul_singhvi

Rahul Singhvi

Novavax Inc. announced Oct. 23 that it has initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in collaboration with Avimex Laboratories and GE Healthcare.

Maine provides funding to give flu vaccines in schools

by Mary J. Lewis on October 26, 2009

Dora_anne_mills

Dora Anne Mills, Maine CDC

Maine’s Center for Disease Control and Prevention, part of the state Department of Health and Human Services, will offer funding to provide seasonal influenza and H1N1 influenza vaccines in K-12 schools.

Missouri allows vacine exemption for pregnant women, children

by Paul Tinder on October 26, 2009

Margaret_donnelly

Margaret Donnelly

Missouri’s top public health official granted an exemption Oct. 22 to allow pregnant women and parents of children younger than 3 to choose whether or not to receive flu vaccine containing a mercury-based preservative.

Health Canada Approves Pandemic H1N1 Flu Vaccine

by Mary J. Lewis on October 26, 2009

Leona_aglukkaq

Leona Aglukkaq

OTTAWA - Minister of Health Leona Aglukkaq announced that Health Canada has approved Arepanrix, a vaccine against the H1N1 flu virus.

Formulation used to fight bio-terrorism released for commercial use

by Mary J. Lewis on October 21, 2009

A U.S. government formulation designed to defend against a bio-terrorism attack is available for commercial use to eliminate the H1N1 Virus, MRSA, SARS and other dangerous bacterium and pathogens found in hospitals, schools and public institutions.

Michigan emergency preparedness campaign kicks off

by Mary J. Lewis on October 21, 2009

Do 1 Thing readies for its annual emergency preparedness campaign designed to help Michigan residents better prepare for emergencies and disasters.

Free emergency preparedness toolkit now available online

by on October 21, 2009

A new emergency preparedness toolkit from www.Do1thing.us is designed to help its partners better prepare employees, members and individuals for emergencies and disasters.

H1N1 vaccine ‘remarkably safe,’ NIH director says

by Daniel Purt on October 19, 2009

Collins_directorpage

Dr. Francis Collins

CHICAGO — There is nothing unique or scary about the new H1N1 flu vaccine that should keep people from getting it, said Dr. Francis Collins, director of the U.S. National Institutes of Health.

NIH Launches H1N1 flu vaccine trial in HIV-infected pregnant women

by Mary J. Lewis on October 18, 2009

Faucismilelabsmall

Anthony S. Fauci

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in HIV-infect

Many forgo vaccines that could prevent potentially lethal illnesses

by Paul Tinder on October 17, 2009

10966366

Gregory A. Poland

Infectious disease experts warn that many adults haven't received vaccinations for at least half a dozen other preventable diseases —

Vaccinating boys against human papillomavirus not cost-effective

by Mary J. Lewis on October 16, 2009

Kim

Dr. Jane Kim

BOSTON — Persistent infection with high-risk types of human papillomavirus, a sexually transmitted virus, is known to be a cause of cervical cancer.

FDA approves use of Gardasil to prevent genital warts in men, boys

by Rita Uplend on October 15, 2009

Gardasil_first_dose

The U.S. Food and Drug Administration announced Oct. 16 that it approved the use of the vaccine Gardasil to prevent genital warts caused by the human papillomavirus types 6 and 11 in males ages 9 to 26.

FDA OKs seasonal influenza vaccine Fluarix for pediatric use

by Mary J. Lewis on October 12, 2009

Fluarix_cropped

The U.S. Food and Drug Administration approved use of the seasonal influenza vaccine Fluarix for children ages 3 to 17.

FDA, FTC warn website marketing fraudulent H1N1 vaccine, treatments

by Pat Dulnier on October 11, 2009

Fda-logo

Internet scams are taking advantage of the public’s concern over H1N1, forcing two government agencies to act.

Albany Medical College to fund biodefense research of tularemia

by Mary J. Lewis on October 10, 2009

Alb_med_helipad

ALBANY, N.Y. — Albany Medical College has been awarded a $4.6 million grant to fund its biodefense research against Francisella tulare

U.S., Mexican and Canadian officials to collaborate against H1N1

by Ted Purlain on October 9, 2009

320_cp24_swine_030509

MEXICO CITY — Department of Homeland Security Secretary Jane Holl Lute joined her Mexican and Canadian counterparts in Mexico City to discuss continued collaboration to confront the spread of global H1N1 flu.

Businesses foresee problems in widespread H1N1 flu outbreak

by Mary J. Lewis on October 8, 2009

6a0105367efbd0970b01156f83b494970c-800wi

Dr. Blendon

BOSTON — Harvard School of Public Health researchers found that only one third of American companies believe they could sustain their business without severe operational problems if half their workforce were absent for two weeks because of H1N1.

UTEP focuses on TB vaccine research

by Daniel Purt on October 6, 2009

With all the attention on H1N1 and the seasonal flu, it might be easy to forget about other infectious diseases.

H1N1 vaccine puts focus on calls for faster delivery

by Paul Tinder on October 4, 2009

The United States expects 200 million doses of H1N1 flu vaccine by the end of the year, the result of a process that occurred at "unprecedented speed" since H1N1 was detected in April.

Emergent BioSolutions launches biothrax.com

by Mary J. Lewis on October 4, 2009

ROCKVILLE, Md. — Emergent BioSolutions has launched www.biothrax.com, a website that provides information about BioThrax, its vaccine for the prevention of anthrax infection.

Tuberculosis consortium, Vivalis to explore production capabilities

by Rita Uplend on October 2, 2009

The Oxford-Emergent Tuberculosis Consortium Ltd. has signed an agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A, the consortium’s new TB vaccine candidate.

CSL, others donate millions of doses of H1N1 vaccine to WHO

by Mary J. Lewis on October 1, 2009

CSL Limited, Australia’s leading biopharmaceutical company, has announced that it is donating 3 million doses of pandemic H1N1 2009 vaccine to the World Health Organization.

Novavax researching vaccine for common respiratory virus

by Pat Dulnier on September 27, 2009

ROCKVILLE, Md. — Novavax has received a grant to support preclinical research of a vaccine for the most commonly identified cause of lower respiratory illnesses in infants and young children.

AIDS vaccine expert encouraged by promising results

by Mary J. Lewis on September 27, 2009

When promising results from a large clinical trial of an AIDS vaccine regimen were announced recently, it was good news to the inventor of one of the vaccines used in the trial.

Virginia Tech wins $27 million contract for infectious disease research

by Daniel Purt on September 25, 2009

BLACKSBURG, Va. — Virginia Tech will use $27 million to support infectious disease research around the world.

FDA Approves New Vaccine for Prevention of Cervical Cancer

by Mary J. Lewis on September 24, 2009

The FDA approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus types 16 and 18.

Mayo Clinic offers flu vaccine allergy screenings

by Daniel Purt on September 23, 2009

ROCHESTER, Minn. — If you are concerned about allergic reaction to the influenza vaccine, Mayo Clinic offers an influenza vaccine allergy clinic.

Cholera vaccine seen safe, effective in India study

by Ted Purlain on September 20, 2009

A cholera vaccine has proved to be safe and effective in young children in a part of India where the disease is endemic, a new study in The Lancet says.

NIAID contracts awarded to help boost vaccines’ effectiveness

by Mary J. Lewis on September 19, 2009

BETHESDA, Md. — The National Institute of Allergy and Infectious Diseases awarded six research contracts on Oct. 9 to discover novel adjuvants, substances that can be added to vaccines to boost their effectiveness.

Scientists await the mutation (or not) of H1N1

by Mary J. Lewis on September 18, 2009

PHILADELPHIA — Infectious disease experts are awaiting an infinitesimal event of momentous importance: the mutation of the H1N1 influenza virus.

Flu vaccinations test public health readiness

by Paul Tinder on September 17, 2009

COLLEGE PARK, Md. — Mass vaccination clinics to protect against the 2009 H1N1 influenza virus offer public health officials a chance to hone their procedures and prepare for future emergencies, according to a University of Maryland expert.

Study to determine best H1N1 vaccine dose for asthmatics

by Mary J. Lewis on September 16, 2009

BETHESDA, Md. — People with asthma, especially those with severe cases, may need different doses of the H1N1 flu vaccine.

NIAID to fund development of advanced anthrax vaccine candidate

by Rita Uplend on September 14, 2009

Niaid_logo

Emergent BioSolutions Inc. announced in September 2009 that it received a grant from the National Institute of Allergy and Infectious Diseases to continue the development of an advanced anthrax vaccine candidates known as dmPA7909.

Emergent BioSolutions’ chief financial officer named SmartCFO of the Year

by Daniel Purt on June 15, 2009

Elsey_don

Don Elsey

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced June 15, 2009, that Don Elsey, its chief financial officer and senior vice president of finance and administration, has been named 2009 SmartCFO of the Year by SmartCEO Magazine.

Oxford-Emergent Tuberculosis Consortium signs commercial license deal with Vivalis

by Paul Tinder on May 5, 2009

Tuberculosis

Tuberculosis

OXFORD, United Kingdom; ROCKVILLE, Md.; and NANTES, France — The Oxford-Emergent Tuberculosis Consortium Ltd., announced the signing of a commercial license agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A.

Consortium signs deal to explore production of tuberculosis vaccine candidate

by Pat Dulnier on May 5, 2009

El-hibri_fuad

Fuad El-Hibri

OXFORD, United Kingdom; ROCKVILLE, Md.; and BERLIN — The Oxford-Emergent Tuberculosis Consortium Ltd. announced the signing of a commercial license agreement with ProBioGen, to evaluate large-scale commercial production capabilities for MVA85A.

TB vaccine candidate enters Phase IIb proof-of-concept trial in South Africa

by Pat Dulnier on April 22, 2009

Tuberculosis

TB

The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis Consortium Ltd., Isis Innovation Ltd., the Wellcome Trust and the University of Cape Town announce the start of a Phase IIb proof-of-concept clinical trial of a new TB vaccine.

Government extends deadline for plans to develop anthrax rPA vaccine

by Paul Tinder on April 22, 2009

Dept-hhs

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that the U.S. Department of Health and Human Services issued an additional amendment to its request for proposal for an anthrax recombinant protective antigen (rPA) vaccine.

Emergent BioSolutions takes steps to procure anthrax rPA contract

by Rita Uplend on April 16, 2009

Fda-logo

ROCKVILLE, Md. — The Department of Health and Human Services requested that bidders in the competitive range for a contract to develop an rPA vaccine candidate submit its product development plans to the FDA for review in advance of an award.

Emergent BioSolutions announces start of anthrax treatment trial

by Ted Purlain on March 17, 2009

Niaid_logo

National Institute of Allergy and Infectious Diseases

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced March 17, 2009, that the Phase I/II clinical trial for its anthrax immune globulin (AIG) therapeutic candidate has commenced with the initial treatment given to the first subject.

FDA approves Emergent BioSolutions’ supplemental biologics license application

by Paul Tinder on December 20, 2008

Fda-logo

Emergent BioSolutions Inc. announced that the U.S. FDA has approved its supplemental biologics license application for Anthrax Vaccine Adsorbed BioThrax, the only FDA-licensed vaccine to prevent disease caused by Bacillus anthracis.

U.S. includes BioThrax, Anthrax Immune Globulin in PREP Act

by Tina Redlup on October 9, 2008

Anthrax2

Anthrax

Emergent BioSolutions Inc. announced that two medical countermeasures included in its anthrax franchise have been included as covered countermeasures under the Public Readiness and Emergency Preparedness Act.

U.S. to purchase 14.5 million more doses of BioThrax

by Ted Purlain on October 1, 2008

Biothrax

BioThrax

Emergent BioSolutions Inc. announced that it has signed a contract with the U.S. Department of Health and Human Services to supply an additional 14.5 million doses of BioThrax for inclusion in the Strategic National Stockpile.

Emergent BioSolutions signs $29.7 million contract to develop anthrax vaccine

by Daniel Purt on September 26, 2008

Biothrax

BioThrax

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced Sept. 26, 2008, that it has signed a government contract valued at up to $29.7 million to further development of AV7909, a next generation anthrax vaccine candidate.

HHS says proposal to provide anthrax vaccine ‘technically acceptable’

by Paul Tinder on September 12, 2008

Biothrax

BioThrax

Emergent BioSolutions Inc. announced that the Department of Health and Human Services has informed the company that its proposal to provide a recombinant protective antigen anthrax vaccine (rPA) is technically acceptable.

Emergent BioSolutions gets $24 million to develop anthrax monoclonal antibody

by Ted Purlain on September 3, 2008

Anthrax2

Anthrax

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced Sept. 3, 2008, that it has received a contract from the Department of Health and Human Services for about $24.3 million to further develop of its anthrax monoclonal antibody AVP-21D9.

Emergent BioSolutions submits proposal to develop new anthrax vaccine

by Tina Redlup on July 31, 2008

Anthrax2

Anthrax

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced July 31, 2008, that it has submitted a proposal in response to a request by the U.S. Department of Health and Human Services for a recombinant protective antigen anthrax vaccine (rPA).

NIAID awards 2 grants to Emergent BioSolutions for vaccine development

by Ted Purlain on July 24, 2008

Niaid_logo

National Institute of Allergy and Infectious Disease

Emergent BioSolutions Inc. announced that it has secured two grants totaling more than $4.5 million from the NIAID to fund the continued development of the company’s recombinant botulinum (rBOT) and next-generation anthrax vaccine (NGAV) candidates.

Joint venture aims to develop advanced tuberculosis vaccine

by Pat Dulnier on July 23, 2008

Tuberculosis

TB

The University of Oxford and Emergent BioSolutions Inc. announced July 23, 2008, that they have formed the Oxford-Emergent Tuberculosis Consortium Ltd. to further develop MVA85A, a vaccine candidate for the prevention of tuberculosis.

Emergent BioSolutions initiates Phase II trial of oral typhoid vaccine candidate

by Ted Purlain on June 5, 2008

Abdun_nabi

Daniel J. Abdun-Nabi

ROCKVILLE, MD. —Emergent BioSolutions Inc. announced that dosing of patients has begun in a U.S. Phase II clinical trial of the company’s single-dose oral typhoid vaccine candidate.

Emergent BioSolutions acquires monoclonal anthrax product candidate

by Tina Redlup on March 6, 2008

Anthrax2

Anthrax

ROCKVILLE, Md. —Emergent BioSolutions Inc. announced that on March 6, 2008, it completed the acquisition of a group of anthrax monoclonal antibodies from AVANIR Pharmaceuticals, including Avanir’s lead product candidate, AVP-21D9.

Emergent BioSolutions appoints Jackson as chief scientific officer

by Paul Tinder on March 3, 2008

Jackson_james

James Jackson

ROCKVILLE, Md. —Emergent BioSolutions Inc. announced March 3, 2008, that W. James Jackson has been appointed chief scientific officer, effective immediately.

Emergent BioSolutions says typhoid vaccine candidate shows promise

by Pat Dulnier on January 9, 2008

Typhoid_salmonella_

Typhoid

ROCKVILLE, Md. — Emergent BioSolutions Inc. announced that its single-dose, drinkable typhoid vaccine candidate was highly immunogenic and well-tolerated with an acceptable safety profile in the population studied.

Emergent BioSolutions applauds passage, signing of barda legislation

by Paul Tinder on December 21, 2006

El-hibri_fuad

Fuad El-Hibri

GAITHERSBURG, Md. — Emergent BioSolutions Inc. applauded Congress and President George W. Bush on Dec. 20, 2006, as he signed into law the Pandemic and All-Hazards Preparedness Act.

More than 3 million doses of BioThrax delivered to HHS

by Ted Purlain on December 15, 2006

Biothrax

BioThrax

Emergent BioSolutions Inc. that it has successfully completed the fourth-quarter 2006 deliveries of more than 3 million doses of BioThrax (Anthrax Vaccine Adsorbed) to the Department of Health and Human Services.

Emergent BioSolutions’ CEO to ring stock exchange’s opening bell

by Tina Redlup on November 23, 2006

El-hibri_fuad

Fuad El-Hibri

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced that it would celebrate its recently completed initial public offering with the ringing of the opening bell of the New York Stock Exchange by chairman and CEO Fuad El-Hibri on Nov. 22, 2006.

NIAID gives 2 grants for development of anthrax immune globulin therapeutic

by Tina Redlup on August 31, 2006

Anthrax2

Anthrax

Emergent BioSolutions announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases totaling $3.8 million to support the development of the anthrax immune globulin (AIG) therapeutic product.

DHS approves BioThrax as a product for homeland security

by Paul Tinder on August 29, 2006

Dhs-logo

Emergent BioSolutions announced that the U.S. Department of Homeland Security has granted its application for designation and certification of BioThrax (Anthrax Vaccine Adsorbed) as a “qualified anti-terrorism technology.”

Mich. governor welcomes $75 million vaccine production facility

by on July 21, 2006

Fda-logo

LANSING, Mich. — Emergent BioSolutions announced the dedication of a $75 million vaccine production facility for its BioDefense Operations in a ceremony July 21, 2006, at its campus here.

Former DHHS secretary joins board of directors of Emergent BioSolutions

by Tina Redlup on June 21, 2006

Dept-hhs

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced June 21, 2006, that a former secretary of the U.S. Department of Health and Human Services has been named to its board of directors.

FDA: Vaccine safe, effective to prevent anthrax regardless of route of exposure

by Pat Dulnier on December 16, 2005

Anthrax-bacteria

Anthrax

GAITHERSBURG, Md. — Emergent BioSolutions Inc. announced that the FDA has issued a final order confirming that the company’s anthrax vaccine, BioThrax, is safe and effective for immunization against infection, regardless of the route of exposure.

Emergent BioSolutions starts clinical study of single-dose oral typhoid vaccine

by Rita Uplend on November 22, 2005

Chatfield_steven

Dr Steven Chatfield

GAITHERSBURG, Md. —Emergent BioSolutions Inc. announced the commencement of dosing of volunteer subjects in a clinical study in Ho Chi Minh City, Vietnam, to evaluate the safety and immunogenicity of the company’s single-dose oral typhoid vaccine.

Emergent BioSolutions’ typhoid vaccine achieves positive results in clinical study

by Ted Purlain on August 30, 2005

Typhoid_salmonella_

GAITHERSBURG, Md. — Emergent BioSolutions announced positive results from a Phase II clinical study evaluating a simplified dosing regimen for the company’s next-generation single-dose oral typhoid vaccine.

Emergent BioSolutions acquires Europe’s Microscience

by Daniel Purt on June 27, 2005

El-hibri_fuad

Fuad El-Hibri

GAITHERSBURG, Md. — Emergent BioSolutions announced that it acquired England-based Microscience Ltd., a privately held vaccine company primarily involved in the research and development of proprietary vaccines and immunotherapeutics.

Emergent BioSolutions, HPA announce botulinum vaccine collaboration

by Paul Tinder on January 14, 2005

El-hibri_fuad

Fuad El-Hibri

GAITHERSBURG, Md., and LONDON —Emergent BioSolutions and the British-based Health Protection Agency on Jan. 14, 2005, announced a two-year collaboration for the development of vaccines to prevent botulism.